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Summary
Back pain will affect up to 84 % of people at some point in their lives. It is a
major public health problem in Western society leading to disability and
economic loss through work absence, physician visits and hospitalisation. A
major cause of back pain is the natural degeneration of the intervertebral discs
(IVDs) and osteoarthritis of the facet joints which increase with age. Spinal
fusion is a common treatment that has been used for decades. The procedure
involves the fusion of two vertebrae restricting motion in the functional spinal
unit (FSU). Currently, tissue engineering methods are being researched to
develop facet cartilage and IVD repair and replacement therapies for early
intervention in the disease process with the aim of restoring tissue function and
motion. There is a need for pre-clinical simulations to test these novel early
intervention therapies.
The aim of this study was to characterise facet cartilage and IVD tissue in an
ovine model in order to develop models of the healthy and degenerated ovine
FSU which could be used in pre-clinical simulations of future therapies.
Ovine spines from animals of different ages were dissected and IVDs and
facets from cervical, thoracic and lumbar regions were studied using
photography, µCT and histology. The results showed that degeneration in the
FSU began at 5-6 years of age. Since tissue from one year old sheep was
skeletally immature, tissue from 3-4 year olds was accepted as healthy and
used for further characterisation in order for comparisons to be made between
ovine and human tissue.
IVDs and facet cartilage from cervical, thoracic and lumbar regions of the spines
of 3-4 year old sheep were characterised using photography, histology,
(haematoxylin and eosin, alcian blue, Sirius red and Miller’s elastin stains),
immunohistochemistry, assay for glycosaminoglycan (GAG) content and
indentation testing to determine the biomechanical properties. The cells were
isolated from FSU`s tissues, cultured and phenotyped using
immunofluorescence. Facet cartilage was rich in GAGs throughout the tissue
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structure with normal articular cartilage collagen distribution. The percentage of
GAGs in dry weight facet cartilage was 8.47 %. Elastin was also found within
the lamellae layers of the annulus fibrosus (AF) and cartilage end plate (CEP).
Immunohistochemistry showed high expression of collagen II, chondroitin
sulphate, collagen VI, collagen III and fibronectin in both facet cartilage and IVD
tissue with varying distributions and intensities. The isolated FSU cells showed
high expression of collagen types II, III and VI, fibronectin, CD44, SOX-9 and
chondroitin-6-sulphate.
Facet cartilage showed very similar characteristics to other articular cartilages in
terms of the key macromolecules present. Facet cartilage in the cervical region
appeared thicker and contained more GAGs in comparison to the thoracic and
lumbar regions. This may be due to the greater range of motion experienced in
the cervical region and the need for extra support. A relationship between the
presence of collagen types III and VI and elastin was also observed in facet
cartilage. This may be due to the similar role of these proteins in providing
anchorage of the chondrocyte to the ECM in facet cartilage.
In order to mimic degenerated human facets, ovine facets were treated with
chondroitinase ABC in order to remove GAGs from the cartilage. Eight cervical
facets were treated with 0.05 U.ml-1 (w/v) chondroitinase ABC solution and
analysed using photography, indentation, GAG assay, histology and
immunohistochemistry to determine their effect.
The chondroitinase ABC method was shown to remove GAGs from facet
cartilage, as seen in degenerated cartilage. This approach can be used to treat
ovine FSU’s to create degenerate models for in vitro pre-clinical simulations for
testing future therapies such as those developed through tissue engineering.
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Chapter 1: Introduction
1.1. Introduction
The spine is an important musculoskeletal structure, both in humans and other
vertebrate animals. Whilst providing the organism with stability and support, the
spine also gives rise to mobility such as flexion allowed by the presence of
associated muscles, ligaments and tendons. The spine allows the weight of an
organism to be distributed evenly and adapt to change. The essential spinal
nerves are protected within the vertebral column and the vertebral bones
produce bone marrow providing the structures with necessary blood cells. In
addition, the spine, through the vertebrate muscles, is able to absorb impact
forces, providing protection.
1.1.1 The Anatomy of the Human Spine
The vertebral column is composed of five regions. These are the cervical,
thoracic, lumbar, sacrum and coccyx regions. Together, the human spine
contains 24 vertebrae accompanied by intervertebral discs between each pair
linked together by ligaments and facet joints. In addition, the sacrum and coccyx
add an extra five and four fused vertebrae, respectively (Maurice, 1981; Grieve,
1991; Boszczyk et al., 2001B). This is shown in Figure 1.1.
Figure 1.1: The vertebral column showing how it is split into different regions.
The spine consists of four regions, the cervical, thoracic, lumbar and the sacrum and
coccyx region. (Derived from http://www.eurospine.org/p31000298.html)
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For all of the vertebrae along the spinal column, a vertebral body, which sits
between two intervertebral discs (IVDs), is attached to a laminal arch composed
of two laminae, via two pedicles. In the centre of the vertebra is a small cleft, the
spinal canal. This allows the spinal cord to pass through the column whilst
ensuring maximum protection. On each side of the laminal arch is a pair of
articular processes, superior and inferior. Behind the laminal arch is the spinous
process. For each vertebral section, this has a characteristic shape (Maurice,
1981; Boszczyk et al., 2001B). A diagram of a typical vertebra is shown in
Figure 1.2.
Figure 1.2: A typical vertebra in the spine. Each vertebra contains a vertebral body,
laminal arch, pedicles, spinal canal, articular processes/facets and spinous process.
(Derived from
http://waukesha.uwc.edu.lib.reserves/pdf/zillgitt/zoo170/diagrams2/axial%20skeleton/F
06.16%20Typical%20Vertebrae.jpg)
The cervical vertebrae (C1-C7) are located at the top of the vertebral column
starting at the base of the cranium. The first and second cervical vertebrae, C1
(atlas) and C2 (axis) respectively, fit together via the odontoid process (dens)
which allows C1 to rotate (Bland and Boushey, 1990). The thoracic vertebrae
(T1-T12) are located in between the cervical and lumbar vertebrae (Maurice,
1981; Grieve, 1991). The upper section of the thoracic spine is capable of less
motion in comparison to the lower section and contains a narrower spinal canal
which is generally small and circular in both sections. The superior facets lay at
upright angles (Crock and Yoshizawa, 1977; Bohlman et al., 1985). The lumbar
vertebrae (L1-L5) are very often associated with back pain as this is the part of
the vertebral column which supports the majority of body weight, stresses and
Spinous Process
Vertebral Body
Laminal Arch
Spinal Canal
Pedicle
Transverse
Process
Articular Process
/ Facet
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strains (Boszczyk et al., 2001B). Lumbar vertebrae are the largest and bulkiest
vertebrae containing a large intervertebral spinal canal. The sacrum and coccyx
make up the terminal end of the vertebral column located at the pelvic region.
The sacrum is composed of five sacral vertebrae (S1-S5) fused together whilst
the coccyx has three to four coccygeal vertebrae also fused together. (Maurice,
1981; Grieve, 1991; Fogel et al., 2004). All the vertebrae described are shown
in Figure 1.3.
Figure 1.3: The structure of human cervical, thoracic and lumbar vertebrae. A:
The atlas (C1) and axis (C2). The two structures fit together via the odontoid process
(dens) allowing the head to rotate. B: A typical cervical vertebra. The cervical vertebrae
consist of a spinous process, spinal canal and vertebral body and a pair of facets,
superior articular processes, pedicles, transverse processes, foramen and lamina. C: A
typical thoracic vertebra. The thoracic vertebrae consist of a spinous process, vertebral
body and spinal canal and a pair of superior articular processes, transverse processes,
pedicles, facets and lamina. D: A typical lumbar vertebra. The lumbar vertebrae consist
of a spinous process, vertebral body and spinal canal and a pair of transverse
processes, pedicles, articular processes and lamina.
(http://nobacksurgeryinfo.com/backanatomy.php;
http://www.zimmerspine.eu/z/ctl.op/global/action/1/id/9024/template/PC)
1.1.2 The Functional Spinal Unit
The functional spinal unit (FSU) is the smallest unit of the spine responsible for
physiological movement and exhibits kinetic features which represent that of the
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whole spine. Within the FSU are four major components. These include two
adjacent vertebrae and an IVD in between, separated by cartilage end plates
(CEPs), which are connected by ligamentous tissue and two facet joints on
either side. Spinal muscles and other related tissue surround the FSU
(Morishita et al., 2008). Although the biology of the FSU has not been
extensively characterised, the biomechanical characteristics have been widely
researched. A typical FSU is shown in Figure 1.4.
Figure 1.4: A human FSU. The FSU typically consists of vertebrae, CEPs, an IVD and
a pair of facet joints. FSU: Functional spinal unit.
(http://www.delawarebackpain.com/patient%20information/anatomy.htm)
1.2. The Composition of the FSU
The most important components of the FSU which allow its function are the
IVD, the CEPs and the facet joints. Each part is composed of different tissues
which act together to give rise to physiological movement and function.
1.2.1 Structural Components of FSU Tissues
The tissues which make up the FSU are comprised of cells and an extracellular
matrix (ECM). The ECM is comprised of collagens, non-collagenous proteins
and proteoglycans plus other minor glycoproteins. These molecules are directly
related to the function of the specific tissue and thus an understanding of their
structure and function is necessary.
1.2.1.1. Collagen
Collagen is found in great abundance throughout connective tissue in the
human body. It is highly organised within articular cartilage, the CEP and the
IVD providing a fibrous ultrastructure that is essential for its function in joints
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such as the facet joint and the IVD (Von der Mark, 1999; Nordin and Frankel,
2001). The basic biological unit of collagen is tropocollagen. Tropocollagen
consists of three polypeptide chains arranged in a left handed triple helix held
together by hydrogen bonds (Nordin and Frankel, 2001). Each procollagen
chain is composed of repeating units of the (Gly-X-Y)n where X and Y are
usually proline and hydroxyproline respectively. The synthesis and biosynthesis
of collagen is a complex multistep process.
Collagen propeptides are stabilised by intrachain disulphide bonds and an N-
linked carbohydrate group is added. Three α-chains form a triple helix which 
involves the alignment of the C- terminal domains to give a procollagen
molecule (Gelse et al., 2003). Modifications are carried out by procollagen Zn2+
dependant metalloproteinases which cleave N- and C-terminal propeptides to
form tropocollagen. Tropocollagen undergoes extensive cross-linking and self-
assembly (Kyle et al., 2009). The tropocollagen chains arrange themselves
around a central axis ensuring that glycine residues are positioned inside the
helix and bulkier residues are outside forming a close packed structure.
Tropocollagen molecules, typically 1.4 nm in diameter and 300 nm long,
polymerise to form collagen fibrils, typically 25-40 nm in diameter in human
articular cartilage. Covalent cross links are formed between tropocollagen
molecules which contribute to their high tensile strength and the physical and
mechanical properties of collagen fibrils. Hydrophobic and electrostatic
interactions also contribute to the stability between collagen monomers (Gelse
et al., 2003). Furthermore, collagen fibrils aggregate together to form a collagen
fibre (Nordin and Frankel, 2001; Kyle et al., 2009). Different collagen types
assemble themselves in different orientations. Collagen biosynthesis and
assembly is illustrated in Figure 1.5.
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Figure 1.5: The biosynthesis and assembly of collagen. Procollagen is synthesised
within the cell and secreted by exocytosis. Procollagen is converted to tropocollagen
before the collagen fibrils and fibres are assembled. (Derived from Culav et al., 1999)
There are three main types of collagen commonly found in cartilage; collagen
types II, IX and XI (Wotton et al., 1988; Bruehlmann et al., 2002). Each collagen
type forms a particular arrangement in relation to other collagen fibres (Wu et
al., 1992). Collagen type II is the major collagen component consisting of a
single triple helical domain and has a length of approximately three hundred
nm. It forms a network of fibrils in which proteoglycans, which contribute to
cartilage hydration (Section 1.2.1.2), are contained (Mayne, 1989). Collagen
type IX consists of three triple helical domains interlinked by flexible regions and
a globular domain with a length of one hundred and ninety nm. Finally, collagen
type XI contains a triple helix three hundred nm in length with an amino terminal
non-collagenous domain. Various other types of collagen exist within cartilage
including types III, VI and X. (Mayne, 1989; Wotton and Duance, 1994; Pullig et
al., 1999). The main types of collagen found in the IVD are collagens type I and
II. Type I is found largely in the outer annulus fibrosus (AF) whilst type II is
located largely in the inner AF and nucleus pulposus (NP) (Eyre and Muir,
1977). Previous studies have also reported the presence of collagen types III,
V, VI, IX, and XI in the AF and types VI, IX and XI in the NP (Eyre, 1988;
Roberts et al., 1991A; Roberts et al., 1991B; Boos et al., 1997). Whilst each
collagen type has its unique function, the main overall function of collagen is to
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provide mechanical support whilst resisting compressive forces and structural
stabilisation (Mendler et al., 1989).
1.2.1.2. Proteoglycans
Proteoglycans are macromolecules comprising glycosaminoglycan (GAG)
chains, surrounding a protein core and are produced by most eukaryotic cells. A
wide variety of proteoglycans exist which may have different functions. For
example, some proteoglycans provide cell surface receptors whilst others
provide physical support (Hardingham and Fosang, 1992).
Proteoglycans consist of a large protein core to which many highly charged,
large and extended GAGs including chondroitin sulphate and keratan sulphate
chains, are attached. The GAG chains consist of repeating disaccharides and
the size and ratio of these chains may change with age and/or disease.
Chondroitin sulphate contains 40-50 disaccharide units of glucuronic acid and
4/6-sulphated N-acetyl galactosamine (Chandran and Horkay, 2012). Earlier
research showed that chondroitin sulphate links to the protein core through
serine residues (Muir and Jacobs, 1967). Further work showed the presence of
a covalent glycosidic linkage between xylose and the hydroxyl group of serine in
the chondroitin sulphate-protein complex (Lindahl and Roden, 1966; Bushell et
al., 1977). Keratan sulphate consists of between 20-25 repeating disaccharides
of sulphated N-acetyl-glucosamine and galactose. The molecule is linked to the
protein core of a proteoglycan via serine and threonine residues via an N-
acetyl-galactosamine residue (Bray et al., 1967). A large majority of the keratan
sulphate chains lie next to a hexapeptide repeat domain with a higher number
of proline residues in the core protein (Heinegard, 2009). The structure of a
proteoglycan is illustrated in Figure 1.6.
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Figure 1.6: The structure of a proteoglycan. Repetitive disaccharides are attached
to a galactose-galactose-xylose carbohydrate chain which makes up the GAG. At
physiological pH 7.4, the CH2OSO3H and CH2OH groups lose their hydrogen atom to
form negatively charged groups. The GAG chondroitin sulphate makes a connection
with a serine residue on the core protein via a glycosidic bond. A proteoglycan is made
up of many GAGs that are covalently attached to a core protein. GAG:
Glycosaminoglycan. (Derived from http://csls-text.c.u-tokyo.ac.jp/active/11_02.html)
The GAGs are responsible for the physical properties of the proteoglycan.
Proteoglycans generally act to hydrate the ECM in which they are present. This
is possible due to the negatively charged GAGs which attract counter ions
leading to an osmotic pressure which therefore attracts water from the
surroundings. Proteoglycans are also capable of interacting with other
components and aid the molecular organisation of ECMs (Hardingham and
Fosang, 1992). Aggrecan is a large negatively charged aggregating
proteoglycan macromolecule present in cartilage. It has a bottle brush structure
which becomes enmeshed within the collagen fibres in articular cartilage
(Chandran and Horkay, 2012). Aggrecan attaches to a linear hyaluronan
molecule via a hyaluronic acid binding region (HABR). Hyaluronic acid is a GAG
comprised of the disaccharides D-glucuronic acid and D-N-acetylglucosamine
(Bushell et al., 1977; Chandran and Horkay, 2012). This interaction is stabilised
by a link protein. This stabilisation effect is vital for the function of healthy
tissues such as articular cartilage preventing the breakdown of proteoglycans
and ensuring they remain within the tissue. Three highly conserved globular
Chapter 1
10
regions are present within the aggrecan core protein. The first, G1, is the HABR
which is located at the N terminus containing a small amount of keratan
sulphate and few N-linked oligosaccharides. The second globular region is G2
which is found between the HABR (G1) and the keratan sulphate rich region.
Lastly, G3 is the core protein C-terminus (Nordin and Frankel, 2001). GAG
chains are located between the G2 and G3 domains. Chondroitin sulphate
makes up the majority of GAGs in the aggrecan monomer with up to 100
chains, whilst up to 30 keratan sulphate chains are found. In addition, between
eight and 10 short N- and O-linked oligosaccharides are distributed amongst the
GAGs chain (Chandran and Horkay, 2012). The structure of aggrecan as a
monomer and macromolecule is shown in Figure 1.7.
Figure 1.7: The structure of an aggrecan monomer and an aggrecan
macromolecule. A: An aggrecan monomer which has a bottlebrush-like architecture
consisting of three globular domains. B: The aggrecan macromolecule consists of
many aggrecan monomers attached to a linear hyaluronic acid molecule via the G1
domain. (Derived from Mankin et al., 2000)
The primary function of aggrecan is to distribute loads within joints and resist
compressive loads (Hardingham and Fosang, 1992). This is achieved by the
macromolecules extremely high fixed charge density which creates a high
osmotic environment therefore allowing water to be retained within tissue.
Keratan sulphate and dermatan sulphate have also been shown to contribute to
the function of aggrecan by binding with high affinity to collagen within the ECM
of cartilage (Rosenberg, 1992; Hedlund et al., 1999). The bottlebrush-like
structure of aggrecan also allows it to behave as a space-filling molecule and to
exert large frictional drag which in turns gives rise to decreased hydraulic
permeability and damping properties (Chandran and Horkay, 2012).
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Other minor proteoglycans present in the ECM of tissues such as cartilage and
the IVD are small leucine-rich proteoglycans (SLRPs). SLRPs can be divided
into three classes. Class I includes decorin and biglycan. Decorin carries one
chondroitin or dematan sulphate side chain and interacts with collagen fibrils
through one triple helix. Biglycan carries two chondroitin or dematan sulphate
chains and is a positive regulator of bone formation and mass. The class II
SLRPs include fibromodulin, lumican and proline arginine-rich end leucine-rich
repeat protein (PRELP). Fibromodulin carries up to four keratin sulphate side
chains and regulates the diameter of collagen fibrils, lumican is a major keratan
sulphate proteoglycan found largely in cartilage and PRELP is a cartilage matrix
protein involved in matrix organisation. Lastly, epiphycan is a class III SLRP
containing dermatan sulphate and is present in epiphyseal cartilage (Knudson
and Knudson, 2001).
1.2.1.3. Elastin
Elastin is an ECM protein and the major component of elastic fibres. The major
function of elastin is to provide elasticity and resilience in tissue where elastic
recoil is essential for maintaining tissue structure (Kyle et al., 2009). Elastin is a
highly insoluble cross-linked polymer of the monomeric protein tropoelastin.
Tropoelastin is composed of two major domains. These include a hydrophobic
domain and a cross linking domain. The hydrophobic domain is composed
largely of glycine, valine and proline residues whilst the cross linking domain is
rich in lysine and alanine. The alanine residues are important for providing gaps
allowing the lysine residues to be fully exposed. This is vital for cross linking.
The tropoelastin monomers become extensively cross linked in the ECM via the
lysine residues and form large complex arrays (Figure 1.11). Cross linking is
catalysed by various members of the lysyl oxidase (LOX) gene family. Most of
the 40 lysine residues are covalently cross linked by LOX. The mechanism by
which tropoelastin assembles into elastin is not very well understood. The cross
linking of tropoelastin is essential for the stabilisation of elastin. This protects
the protein from breaking down with age (Wagenseil and Mecham, 2007; Kyle
et al., 2009). Elastin in both forms is shown in Figure 1.8.
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Figure 1.8: The structure of elastin before and after elongation. The ECM protein
is composed of tropoelastin monomers which are cross linked via lysine residues.
When tissue is stretched, the monomers become elongated. ECM: Extracellular matrix.
(Derived from http://www.sigmaaldrich.com/life-science/biochemicals/biochemical-
products.html?TablePage=21735546)
Elastin interacts with microfibrils of fibrillin, the second major component of
elastic fibres. Fibrillins are cysteine-rich glycoproteins of which there are three
types (Sakai et al., 1991). These components are thought to provide a scaffold
to which elastin can undergo molecular alignment and cross linking (Wagenseil
and Mecham, 2007).
1.2.2 The IVD
The IVD is the largest avascular structure in the body and one of the most
important structures in the spine. The IVD is attached to fibrocartilage which is
blended in with the CEPs. The structure and composition of the IVD adapts to
changes which occur through ageing. The main function of the IVD is to provide
mechanical movement through six degrees of freedom including three
translations and rotations. In addition, the IVDs support body weight and muscle
loads and link adjacent vertebrae. The IVD is divided into two sections, the NP
and the AF, as shown in Figure 1.9 (Keyes and Compere, 1932).
Chapter 1
13
Figure 1.9: An ovine lumbar IVD attached to its vertebra. The IVD is divided into
two main sections, the NP and AF. IVD: Intervertebral disc, AF: Annulus fibrosus, NP:
Nucleus pulposus.
The AF is a tough collagenous structure arranged in lamellae layers comprised
largely of collagen types I and II. The AF surrounds the NP which is a soft
hydrophilic tissue in the centre of the IVD, consisting largely of water and
GAGs. The composition of the ECM of both the AF and NP is important for their
mechanical function (Urban et al., 2000; Roberts et al., 2006).
1.2.2.1. The NP
The NP is located in the centre of the IVD and consists of collagen fibers
distributed randomly in a highly hydrated extrafibrillar matrix. The main
components of the tissue are water (70-80 % of total weight), fibrillar collagens
(20 % dry weight) and proteoglycans (30-50 % dry weight). Non-collagenous
proteins are thought to make up the remainder of the dry weight (Eyre, 1979).
In the NP, type II collagen is the most abundant type. In addition, type IX, VI
and III collagen have also been identified and these collagens interact with type
II collagen fibrils forming an ECM network that surrounds the cells within the NP
(Eyre, 1979; Beard et al., 1980; Gan et al., 2003A; Gan et al., 2003B; Roughley,
2004). The major proteoglycans are aggrecan and versican, alongside small
proteoglycans including decorin, biglycan, lumican and fibromodulin (Roberts et
al., 1994; Urban et al., 2000). Melrose and Ghosh (1988) also identified elastin
and fibronectin in the NP but did not characterise the distribution of these
proteins in detail.
The concentration of GAGs within the NP is important for its function. GAGs
form negatively charged groups, COO- and SO4-, at physiological pH due to
Annulus Fibrosus
Nucleus Pulposus
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ionisation. This attracts extracellular cations such as Na+ within the NP
achieving neutralisation. As a result, the ionic concentration within the NP is
greater than that of the surrounding tissues. An osmotic pressure is thus
created due to the attraction of water to the NP. This leads to high water content
and a swelling pressure which acts on the AF and CEPs. During muscular
activity, when pressure upon the IVDs increases the water content is at its
highest (Urban et al., 2000). This observed pressure allows hydration to be
maintained and gives rise to the hydrodynamic and viscoelastic properties of
the NP (Melrose et al., 2001). Elastin has also been reported to be present
within the bovine NP (Yu et al., 2002). In this study, orcein immunostaining was
used to visualise elastic fibres and their orientations were described. The elastic
fibres appeared to run horizontally from the AF straight across the NP. In the
sagittal plane, the fibres were shorter and radiated into the inner AF. In the
central region of the NP, elastic fibres were aligned parallel to each other whilst
near the end plate region the fibres were still parallel but vertically positioned
towards the endplate (Yu et al., 2002). As the main function of elastin is to allow
tissues to return to their original orientation, elastic recoil after flexion, torsion
and extension, it is an essential macromolecule and it would be of interest to
investigate elastin distribution in the human NP. Elastin has been reported to
make up 1.7 % of the dry weight of both the AF and NP in human IVDs (Mikawa
et al., 1986). Although this is a low percentage, the distribution of the elastin
fibres is undoubtedly vital to the mechanical function.
The NP has a low cell density in comparison to other tissues. The NP is the
remnant of the embryonic notochord. In humans, most notochordal cells, from
early embryonic development, disappear within the first few years of life
although some remain (O’Halloran and Pandit, 2007). It is unknown whether the
lost cells are replaced by migrating cells from the AF or whether they
differentiate into chondrocytes. It is known, however, that the cells of the NP are
chondrocyte-like and are essential for maintaining appropriate levels of
macromolecules through their synthesis and breakdown which contribute to the
physiological and biomechanical functions of the NP (Gruber and Hanley,
2003). The chondrocytes of the NP are round in appearance and exhibit
cytoplasm filled cellular processes. These cytoplasmic processes link adjacent
Chapter 1
15
cells together forming cell clusters. With age, the processes become thinner
leading to large extracellular spaces. However, there have been reports
suggesting that cell cluster formation is associated with IVD degeneration which
may be due to a matrix repair response (Johnson et al., 2001). The NP has a
low partial pressure of oxygen (pO2) and an acidic pH in comparison to the AF
(Holm et al., 1981). This is likely to have great impact on the cells and molecular
synthesis.
1.2.2.2. The AF
The AF surrounds the NP and makes up the remaining part of the IVD. In
contrast to the soft NP, it is composed of tough collagen fibres arranged in
lamellae in a proteoglycan matrix attached to the adjacent vertebra or the CEPs
depending on location. These lamellar layers have a low percentage of water
and aggrecan and a high percentage of collagen (Urban et al., 2000; Roberts et
al., 2006). The layers are interwoven with each other and incomplete around the
structure as shown in Figure 1.10.
Figure 1.10: The structure of a typical AF. The AF is split into three distinct regions:
the outer AF, the inner AF and the interlamellar septae. AF: Annulus fibrosus
(Bruehlmann, 2002).
The AF is rich in both collagen types I and II in both human and animal tissues.
The outer annular region is high in collagen type I, which accounts for
approximately 70 percent of the dry weight. The inner region is nearly pure type
II collagen (Eyre and Muir, 1977; Schollmeier et al., 2000). In addition, the
proteoglycan content has been reported to increase towards the inner annular
region, increasing the hydration, whilst the collagen content decreases (Roberts
et al., 1994). This is mostly in the form of aggrecan, aggregated with hyaluronic
acid. This is a major factor involved in resisting compressive forces generated in
the FSU (Chelberg et al., 1995).
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As in the NP, elastin has an important role in the AF. Elastin has previously
been located in bovine IVDs within the AF (Yu et al., 2002). The elastic fibres
were found to run parallel to the collagen fibres in the outer AF and were
radially distributed in the inner AF forming a criss-cross pattern. Elastic fibres
were particularly abundant in between lamellar layers of the AF, more so in the
outer AF (Bruehlmann et al., 2002). These features are believed to contribute
to the realignment of the AF after loading and deformation which is essential
since collagen fibres do not have great extensibility. Similar features exist in the
human AF where there is an abundant and highly organised elastic fibre
network (Yu et al., 2005).
The organisation of cells has been reported to vary across the bovine AF and
has been divided into two sections based on cell morphology, the inner and
outer regions (Bruehlmann et al., 2002; Horner et al., 2002). The cells produce
collagens and the ECM and like the NP, are present at very low density in
comparison to other tissues. The outer layer of the bovine AF is composed
mainly of fusiform shaped cells which have long, thin processes. The inner
bovine AF contains spherical connective tissue cells which have only one or two
short processes. Between the bovine lamellar layers is a connective tissue cell
population of another type, the interlamellar cells. In this region the cells are flat
and disc-shaped. Their cellular processes are typically broad and flat with many
branching sites extended in various directions (Bruehlmann et al., 2002).
1.2.3. The CEP
The CEPs separate the IVDs from the bone on the vertebral body. They have
very important tensile and compressive biomechanical properties which support
the IVDs when they function as well as providing stability and decreasing
friction. The CEP makes direct connections with the IVD through the inner
lamellae of the AF (Hukins, 1988). An important function of the CEPs is to
provide a barrier allowing diffusion of essential nutrients to occur from the
vertebral body to the IVD (Moore, 2000). Vascular terminations at the end plate
have been studied by Crock & Goldwasser (1984) in greyhounds and they
concluded through radiological and histological techniques that the central
region is essential for the metabolic processes of the IVD. The rims of the end
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plate into which the annular fibres are rooted do not allow any solute transfer.
The central and annulus regions have been shown to be fully permeable (Holm
et al., 1981). However, as the CEP matures it undergoes mineralisation and
resorption and is replaced by bone, limiting this function (Bernick and Caillet,
1982; Oda et al., 1988; Moore, 2006).
The human CEP has been studied to some extent previously (Maroudas et al.,
1975; Roberts et al., 1989; Roberts et al., 1991B; Roberts et al., 1994). It was
described as a layer of hydrated proteoglycans within a network of collagen II
fibrils. Proteoglycans appear to be important for regulating the transport of
essential molecules through the IVD. This layer is less than 1 mm thick and
thinnest towards the centre where the NP is present. The chondrocytes within
the cartilage are homogeneously arranged but lack the specific structure
displayed in articular cartilage (Maroudas et al., 1975; Roberts et al., 1989). The
ECM of the CEP appears to be rich in collagen types II and X. Collagen X is
important in cartilage calcification and has been found mainly in the central
region of the CEP and increases in presence with age (Lammi et al., 1998).
1.2.4. The Facet Joints
The facets joints are paired synovial joints found in each FSU along the length
of the vertebral column (Figure 1.11). They comprise two facets, the superior
and inferior articular processes, articulating together. The superior facet is a
large posterior and medially facing process, whereas the inferior one is a
smaller laterally facing process (Kalichman and Hunter, 2007). The main
function of the facet joints is to enable motion of the vertebral column whilst
resisting other forces including compression, shear and rotation (Haher et al.,
1994). Facet joints are part of a ‘three joint complex’ (two facet joints and an
IVD) and contain articular cartilage, a joint capsule lined with synovial
membrane and a joint space filled with synovial fluid. Some studies have been
previously carried out to investigate the joint (Bogduk et al., 1984; Taylor and
McCormick, 1991; Ziv et al., 1992; Yamashita et al., 1996; Inami et al., 2000;
Boszczyk et al., 2001A; Boszczyk et al., 2001B; Yoganandan et al., 2003; Elder
et al., 2009; Varlotta et al., 2011A; Varlotta et al., 2011B). The majority of these
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studies however are focused on the facet joint as a whole, in particular the
biomechanical aspects. Studies on the facet cartilage itself are lacking.
Figure 1.11: Facet joints along two FSUs. The facets joints are composed of two
superior and two inferior facets which interlock together. (Derived from
http://www.triangledisc.com/anatomy.php)
1.2.4.1. Articular Cartilage
Articular cartilage has a white and shiny appearance. In the facet joints, the
cartilage covering the bone is thickest at the centre (Bogduk and Twomey,
1987; Buckwalter and Mankin, 1997; Temenoff and Mikos, 2000). Within
articular cartilage there are different types of macromolecules, however, there is
only one type of cell, the chondrocyte. The ECM comprises collagen,
proteoglycans and non-collagenous proteins in tissue fluid (Buckwalter and
Mankin, 1997; Temenoff and Mikos, 2001; Sandell and Aigner, 2001). Blood
vessels and nerves are not present.
Chondrocytes make up a small proportion of articular cartilage; however, they
are the most important component. This is due to the ability of chondrocytes to
replace the ECM enabling the volume of cartilage to be maintained at the
correct level whilst also maintaining the unique mechanical properties. At
different zones within cartilage, chondrocytes can appear to be different in size
and shape. In addition, structural features needed to sense mechanical
changes within the matrix are also essential, such as cilia and other
intracytoplasmic filaments. The highly metabolically active chondrocyte cells are
very different and unique compared to other cell types. They are able to
produce collagen, proteoglycans and non-collagenous proteins and arrange
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them into a cartilaginous ECM (Buckwalter and Mankin, 1997; Temenoff and
Mikos, 2000). Chondrocytes sit in a pericellular environment within chondrons
or lacunae enclosed by a fibrillar pericellular capsule (Poole, 1997). The canine
pericellular environment surrounding the chondrocyte has been reported to be
rich in GAGs such as aggrecan with high concentrations of hyaluronan and link
protein (Poole et al., 1991). Fibronectin has also been shown to be present
within the pericellular matrix alongside the small proteoglycan decorin which is
thought to mediate collagen-proteoglycan interactions and may interact with
other macromolecules within chondrons (Glant et al., 1985; Scott, 1993). There
is also collagen present within the pericellular matrix including type XI and II.
Water contributes up to 80 percent of the cartilage wet weight. Other
components of the tissue fluid include gases, small proteins and metabolites. In
order to balance the negative charge of proteoglycans, a large amount of
cations are also present within the tissue fluid. Oxygen and nutrients are
supplied to the articular cartilage through the exchange of tissue fluid with
synovial fluid of the joint capsule. (Buckwalter and Mankin, 1997; Temenoff and
Mikos, 2000).
The collagen content of the ECM of articular cartilage is composed of types II,
VI, IX, X, XI, XII and XIV (Mackie et al., 2011). The collagen fibres are
organised into a tight meshwork which trap proteoglycan molecules. It is this
structure which gives rise to mechanical properties of stiffness and strength in
cartilage. Type II collagen is the most abundant making up almost ninety five
percent of the collagen content in articular cartilage (Buckwalter and Mankin,
1997; Temenoff and Mikos, 2000). Various collagen types have been shown to
be expressed in articular cartilage which has been shown to make up
approximately two thirds of its dry weight. The importance of collagen in
articular cartilage is due to its ability to form extensive cross links which gives
rise to its material strength. The organisation of the collagen fibrils within
articular cartilage varies in each zone. In the superficial zone, the fibrils run
parallel to the surface and are thin with a small diameter. Below the superficial
zone into the transitional zone the organisation of collagen is much more
random with thicker fibrils. In the radial zone, the collagen fibrils bundle together
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and orient themselves perpendicular to the surface (Eyre, 2002). The major
collagen types in articular cartilage, including types II, IX and XI, do not appear
to differ between the zones although this has been reported to change with
maturation when the proportion of collagen II increases from 80 % to 90 %. The
main function of collagen IX is to coat thin fibril surfaces by forming cross links.
Collagen XI has a similar function and is also known to cross link with itself and
collagen II and coat thin fibrils in the pericellular matrix (Eyre, 2002). Other
minor collagens have been shown to exist in articular cartilage. This includes
type I and III collagen which are both found in soft connective tissues such as
the skin and muscle. These collagens are often associated with tissue repair
and are expressed by osteoarthritic cartilage. Under these conditions, types I
and III collagen co-exist together with type III making up a greater proportion
than type I (Gay and Miller, 1978). Another study reported the expression of
collagen III in the absence of collagen I in the superficial and transitional zones
in osteoarthritic cartilage (Aigner et al., 1993). However, a later study found that
collagen type III is expressed in healthy articular cartilage (Wotton and Duance,
1991A). In addition to this, collagen III has been reported to co-localise with
collagen II as a minor but regular component (Wu et al., 1996). Collagen VI is
another collagen type found in articular cartilage and is thought to make up less
than 1% of the total collagen content (Eyre et al., 1987). Its main function is to
provide integrity to the structure of cartilage and acts as a bridging molecule by
anchoring chondrocytes to the surrounding ECM (Pullig et al., 1999). Studies
have shown that collagen VI is located next to the cell membrane of
chondrocytes in the pericellular matrix (Poole et al., 1987; Poole et al., 1988).
Collagen X is found in the calcified zone of articular cartilage and is expressed
by hypertrophic chondrocytes. It has important functions in the formation and
development of the growth plate and calcified cartilage (Mayne, 1989; Eerola et
al., 1998).
Two classes of proteoglycans are commonly found in articular cartilage. These
include large aggregating proteoglycans or aggrecan and small proteoglycans
such as the leucine rich proteoglycans decorin, biglycan and fibromodulin
(Mackie et al., 2011). In addition, non-aggregating proteoglycans are also
found. Most of the interfibrillar space in the ECM of articular cartilage is
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occupied by aggrecan molecules described previously. Aggrecan enables
GAGs to be fixed to the matrix whilst stabilising and organising the interaction
with the collagen fibres. This anchoring function also prevents displacement of
the macromolecules during deformation (Buckwalter and Mankin, 1997;
Temenoff and Mikos, 2000).
Non-collagenous proteins comprise proteins with associated monosaccharides
and oligosaccharides. Although wide varieties are thought to exist within
articular cartilage, most are poorly understood. A common function of some of
these proteins is to organise and maintain the structure of the ECM. Anchorin II
and cartilage oligomeric matrix protein (COMP) have been studied to some
extent and both proteins have been shown to bind to chondrocytes. This may
help stabilise interactions between chondrocytes and collagen fibres in the ECM
(Buckwalter and Mankin, 1997; Temenoff and Mikos, 2000).
Within typical, healthy articular cartilage, four cellular zones are found (Figure
1.12). These include the superficial, transitional, radial and calcified zones in
order of depth (Broom, 1984; Buckwalter and Mankin, 1997).
Figure 1.12: The organisation of collagen fibres into four zones in general
articular cartilage. The structure consists of four major zones which lie above
subchondral bone. (Derived from
http://www.pt.ntu.edu.tw/hmchai/Biomechanics/BMmaterial/Cartilage.htm)
The first layer, the superficial zone, at the surface consists of collagen fibres
and flat chondrocytes. The ECM within this zone contains large amounts of
fibronectin and water. In addition, a higher proportion of collagen and smaller
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amount of proteoglycans are seen in comparison to other zones giving this
region of cartilage great tensile strength. The transitional zone contains clusters
of chondrocytes in groups of three or four which are rounder in appearance.
The ECM contains a larger number of collagen fibres and PG molecules and
smaller amounts of water and collagen fibrils. The deep zone or radial zone also
contains clusters of spherical chondrocytes; however, they are larger in groups
of six to eight and stack on top of each other at right angles to the surface. The
calcified zone is the deepest layer covering the subchondral bone. The
chondrocytes found in this area are small and it has been suggested that there
is very low metabolic activity in this region of cartilage due to the high content of
calcified ECM (Bogduk and Twomey, 1987, Buckwalter and Mankin, 1997;
Temenoff and Mikos, 2000).
1.2.4.2. The Joint Capsule
The main function of the joint capsule is to limit rotational forces whilst resisting
backward sliding motions which result during extension (Cyron and Hutton,
1981). The macroscopic and microscopic morphology of the human facet joint
capsule consists of a fibrous capsule and synovial membrane (Yamashita et al.,
1996). The synovium of the human joint capsule appears as a white, smooth
tissue. Synovial cells produce the macromolecules present in synovial fluid
which lubricates the joint. The synovium attaches to articular cartilage on one
facet surface and stretches over the joint to the articular cartilage of the
opposite facet (Bogduk and Twomey, 1987).
1.2.4.3. Synovial Fluid
Synovial fluid fills the space between two articular cartilage surfaces and
nourishes them within the joint capsule. It is an ultrafiltrate of the blood,
excluding haemoglobin and fibrinogen, and contains additives that are
synthesised and excreted by the synovium. Its main function is to provide
articular cartilage with lubrication and protection (Jay et al., 2007; Katta et al.,
2008a). The main components of synovial fluid include hyaluronate and lubricin.
Hyaluronate (Section 1.2.1.2.) gives the fluid viscosity whilst lubricin reduces
friction during articulation. Lubricin is a mucinous glycoprotein produced by
synoviocytes, the cells which line the joint capsule, and chondrocytes in the
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superficial zone of articular cartilage (Section 1.2.4.1.; Jay et al., 2007; Katta et
al., 2007). Other macromolecules are also present within synovial fluid which
contributes to its lubricating properties. Small quantities of GAGs including
chondroitin-4-sulphate, chondroitin-6-sulphate and keratan sulphate are present
(Katta et al., 2007).
1.3. The Biomechanics of the FSU
The spine supports the loads of the body whilst allowing six degrees of motion.
The characteristics of these actions are defined by spinal biomechanics. Spinal
biomechanics has been researched extensively and information concerning
features such as spinal stability, torque resistance, intervertebral pressure and
load bearing characteristics are readily available. When describing the
geometry and motion of the FSU, a three axis coordinate system, involving an
x, y and z axis, are used when referring to displacements such as rotation and
translation. The FSU has six degrees of freedom (Smith and Fernie, 1991).
1.3.1. Load Bearing Characteristics in the FSU
If an axial load is applied to the vertebral column, axial compression on the IVD
occurs. If the load is applied away from the centre of rotation, the vertebral
column will bend whilst the upper vertebrae move in relation to the lower
vertebrae (Smith and Fernie, 1991). The movements may be limited by the
facet joints and the spinal ligaments which can also affect the extent of flexion
(Smith and Fernie, 1991). The distribution of load along a healthy and
degenerated FSU is shown in Figure 1.13.
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Figure 1.13: The distribution of load along a FSU as a percentage during
standing. Left image: healthy disc, right image: degenerated IVD. IVD: Intervertebral
disc. (from Adams and Dolan, 2005)
1.3.1.1. Compressive Load and the IVD
The AF of the IVD has layered collagenous fibres which are well suited for
withstanding large compressive loads acting in various directions through the
IVD. The fluid present in the NP deforms under pressure. However, due to its
nature, the volume cannot be compressed. Therefore, compression forces are
transmitted in all directions to allow deformation. As a result, when load is
applied, the height of the NP decreases whilst the radial distance increases
towards the AF. This eventually leads to equilibrium between the opposing
tensions within the AF. The orientation of the fibres within the AF plays an
important role in the mechanical properties of the IVD. For example, during
circumferential loading, the fibres in that direction may reorient to increase their
mechanical properties (Guerin and Elliot, 2006). As circumferential loading is
the most common type of tensile loading, the fibres in this direction have the
greatest tensile properties. Compressive forces are exerted on the CEPs above
the NP. However, the deformation of the cartilage is small because it is
attached to the vertebral body, therefore, the fluid in the NP does not undergo
deformation in this direction. As the fluidity of the NP is determined by the
proteoglycan and water content, any changes to this property will in turn alter
the biomechanics of the IVD (Bogduk and Twomey, 1987).
1.3.1.2. Load Transmission and Motion in the Facet Joints
The facet joints provide the steady motion of the spine whilst preventing injury
by limiting some movement. They play a major role in load transmission (Ewing
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et al., 1972). As the posture of spinal column extends, the facet loads between
two FSU’s increases from between 22 and 25 % to 30 % of the applied load.
Furthermore, the facet loads have been reported to be greater, up to 49 %, for
FSU’s affected by osteoarthritis. During full extension of the spinal column, the
lower facet joints have been reported to support 16 % of the applied load. The
facet joints resist torsion due to their bony interactions (Adams and Hutton,
1980; Adams and Hutton, 1981; Adams and Hutton, 1983; Yang and King,
1984). A study has also been carried out to determine the peak forces acting on
the facet joints for different motions (Schendel et al., 1993). It was found that
while extension produced large forces on the facets, flexion generated none.
They concluded that peak forces were found at the lateral and inferior margins
of the superior facets.
1.3.2. Cartilage Biomechanics
Articular cartilage covers the facets of the FSU and exhibits low friction. The
cartilage provides the facet joints with the essential biomechanical
characteristics needed to maintain joint motion including wear resistance and
shock absorbance (Ziv et al., 1992; Lu and Mow, 2008; Varlotta et al., 2011A;
Latif et al., 2012). The most important components of articular cartilage in
relation to its function and biomechanics are the synovial fluid and cartilage
ECM (Mow et al., 1980; Mow and Hayes, 1997; Schmidt et al., 2007A; Schmidt
and Sah, 2007B). The movement of synovial fluid acts as a lubricant for the joint
space in between the articulating cartilage surfaces. Articular cartilage is under
constant tensile pressure which results from the balance between swelling
forces and tensile strength during equilibrium. Swelling forces arise
continuously within cartilage as a result of high concentrations of negatively
charged proteoglycans. The macromolecules expand to occupy a large space;
however, as the ECM is a collagen mesh, the molecules are prevented from
reaching their full volume in solution. In addition, mobile counter ions are
present within the tissue fluid which together causes the tissue to swell through
the addition of water. The permeability of articular cartilage is low which
indicates that the pressure generated is large. As a result of pressure, due to
swelling or physical compression, fluid flows in and out of cartilage. This in turn
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generates high frictional resistance which leads to the viscoelastic behaviour of
articular cartilage.
1.3.3. Cartilage Lubrication
Surface friction exists between two un-lubricated surfaces rubbing against each
other. The amount of friction generated is dependent on the surface area and
strength of the two objects. In order to minimise surface friction, such as in
synovial joints, lubrication is essential. A number of different lubrication regimes
operate in cartilage to allow minimal friction under a range of different loading
conditions. These many different lubrication mechanisms can be categorised
under three main types occurring in synovial joints: fluid film, boundary and
biphasic lubrication.
In fluid film lubrication, lubricant fills the joint space and keeps the two surfaces
apart such as the superior and inferior articular process in the facet joint
(Dowson et al., 1969; Radin and Paul, 1972; Wright and Dowson, 1976;
Schmidt et al., 2007A; Schmidt and Sah, 2007B). In boundary lubrication the
fluid film is negligible and the two surfaces touch; however, they are protected
by boundary lubricants. In synovial joints effective boundary lubricants are
thought to be hyaluronate and phospholipids. These molecules line the surface
and prevent direct contact between the asperities of the surfaces (Katta et al.,
2008A).
Biphasic lubrication is thought to be the most important in articular cartilage.
This is described as follows. The initial load is supported by the fluid phase of
the cartilage tissue. As load increases it is gradually passed to the solid phase
of collagen and proteoglycans as water flows out. The coefficient of friction is
lower when load is carried by the fluid phase as compared to the solid phase.
The biphasic lubrication mechanism operates over long periods of load bearing.
During movement, the water content of the previously loaded tissue is
replenished as the load is transferred to a different contact area on the surface
of the cartilage. Continuous movement allows for the fluid phase to continue
bearing the load at a lower coefficient of friction than if the load was borne by
the solid phase (Katta et al., 2008A).
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1.4. Spinal Degenerative Disease
With age, spinal degenerative disease slowly develops. As a result of this
natural process, each age group has a particular set of spinal characteristics.
Spinal degenerative disease occurs as a result of continuous loads acting on
the vertebral column which change the morphology and biochemical
composition mainly of the intervertebral discs and facet joints. These spinal
degenerative changes are referred to as spondylopathia deformans and can be
subdivided based on the location of the degeneration. One common symptom
of spinal degeneration is lower back pain which affects up to 84 % of the
population at one point during their lifetime (Taylor and Twomey, 1986; Wang et
al., 1989; Prescher, 1998; Mosley et al., 2012). There are potential risk factors
associated with spine degeneration. For example, osteoarthritis is likely to
increase with age. Also, an occupation involving the lifting of heavy objects and
repetitive bending may increase susceptibility. Lifestyle and nutrition are also
important factors (Pathria et al., 1987). Currently, two imaging techniques are
commonly used to diagnose spinal degenerative disease. These are computed
tomography (CT) and magnetic resonance imaging (MRI). Both techniques are
used to image abnormal changes such as articular cartilage thinning. However,
studies comparing the effectiveness of CT and MRI have shown that MRI is less
sensitive for detection of degenerative changes compared to CT imaging (Modic
et al., 1984; Nelemans et al., 2001).
1.4.1. Degeneration of the Human IVD
The IVD allows load to be resisted by compression. In order to regulate the
homeostasis of the tissue in the AF and the NP, a balance between anabolism
and catabolism is constantly maintained. This is possible through regulatory
molecules such as cytokines, growth factors and enzymes. However, due to
degenerative pathology and age, this balance may be disrupted. This has been
reported to eventually lead to the loss of essential macromolecules including
proteoglycans and up-regulation of matrix-degrading enzymes (Antoniou et al.,
1996; Urban et al., 2000; Cassinelli et al., 2001; Cs-Szabo et al., 2002; Urban
and Roberts, 2003; Masuda et al., 2004A; Masuda and An, 2004B; An et al.,
2006). Degeneration often results in a loss of IVD height and in turn prevents
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the IVD from rehydrating after loading, increasing compressive stiffness (Kurtz
and Edidin, 2006). In addition, IVD cells have been reported to cluster when
becoming degenerate (Johnson et al., 2001).
The enzymes reported to be responsible for the degradation of the IVD are
matrix metalloproteinases (MMPs) (Goupille et al., 1998; Roberts et al., 2000;
Freemont et al., 2002; Gruber and Hanley, 2003; Le Maitre et al., 2007). MMPs
are secreted as inactive pro-forms which must be activated by cleavage of their
N-terminal cysteine which exposes their Zn2+ catalytic site. There are four main
subgroups of MMPs, the collagenases, stromelysins, gelatinases and
membrane metalloproteinase. Each MMP within all four classes are capable of
cleaving at least one component of the ECM (Goupille et al., 1998).
The collagenases include MMPs 1, 8 and 13, and specifically cleave the triple
helix of type I, II and III fibrillar collagens. These collagens are particularly
important as they have been shown to make up over eighty per cent of the total
collagen content in the IVD (Eyre, 1988). Collagen fragments may then be
further cleaved by MMPs 2 and 9; the gelatinases, high levels of which have
been found in degenerated IVDs (Crean et al., 1997). In addition, MMP 3, also
known as stromelysin, may also further degrade collagen fragments whilst also
degrading proteoglycans, including aggrecan, and fibronectin. Aggrecan has
been shown to be degraded by both MMPs and aggrecanase (Lark et al., 1997;
Roberts et al., 2000).
The level of tissue inhibitors of metalloproteinases (TIMPs) plays an important
role in the degeneration of the IVD. Four main types of TIMPs are known with
TIMP-1 and TIMP-2 being the most studied. They bind non-covalently to MMPs
and lead to inactivation (Goupille et al., 1998). Some MMPs are more resistant
to TIMPs than others, such as MMP-7, and studies have shown that TIMP-1
and TIMP-2 are up regulated in degenerate IVDs suggesting an attempt to
restore homeostasis (Le Maitre et al., 2004). Overall, however, the level of
TIMPs is lower than that of MMPs leading to a deregulation of normal
homeostasis (Le Maitre et al., 2007).
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Cytokines have also been shown to play an important role in the degenerative
IVD by causing inflammation and pain (Le Maitre et al., 2007). These cytokines
can be divided into two groups, proinflammatory cytokines and anti-
inflammatory cytokines. Proinflammatory cytokines are released during local
inflammation and disappear after inflammation has passed. These include TNF-
α and IL-1. Anti-inflammatory cytokines are induced by proinflammatory 
cytokines and have a tissue-repair function. These include IL-4 and IL-6 (Xing et
al., 1998; Igarashi et al., 2004). IL-1 is thought to be involved in the regulation of
ECM catabolism (Cawston et al., 1999). Both of its isoforms, α and β, have 
been shown to increase the release of PGs and the production of degradative
enzymes in the IVD. IL-1 has been reported to induce the production of MMPs
whilst decreasing the production of TIMPs and also increase the production of
pain mediators such as the eicosanoid prostaglandin E2 by human IVD cells
(Martel-Pelletier et al., 1994; Kang et al., 1997). A report by Nemoto et al.
showed that IL-1 increased MMP 3 production (Nemoto et al., 1994). These
studies suggest that the role of IL-1 in degeneration is to cause matrix
degradation and pain (Freemont et al., 2002).
IVD degeneration may occur as a result of poor nutrition to the CEPs and
exposure to factors such as cigarette smoke and trauma (Urban et al., 1977).
There are several features and types of degenerative disease associated with
the IVD. For example, osteophytes, also referred to as bone spurs, are small
bone structures. They are believed to develop as a result of axial compression
which squeezes the NP and in turn causes bulging of the AF. The annular
bulging leads to the dislocation and tearing of the AF from the vertebral body
rims (Osti et al., 1992). Osteophytes are then formed from the elevated
periosteum (Northfield, 1973). Their formation is thought to be accompanied by
enlarged synovial fat pads in an attempt to cushion the surrounding area and
increase their size to replace the lost tissue (Taylor and Twomey, 1986).
Chondrosis intervertebralis is a collective term used to describe two features of
osteoarthritis in the spine. These are the loss of water from the NP and the
decrease in height of the IVD. The IVD appears very dry and yellow/brown in
appearance. The main effect of these changes is the reduction of the elasticity
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of the IVD. The condition has been reported to worsen with age, with chronic
overloading reported to increase the rate of development (Miller et al., 1988;
Prescher, 1998; Sarzi-Puttini et al., 2005). Similarly, osteochondrosis
intervertebralis is a condition in which the structure of the IVD changes and its
height decreases. During this process it is common for the CEPs to be affected
and occasionally completely destroyed. The cartilage cells may even proliferate
forming ossifications. Ossifications may also be triggered by the production of
blood vessels in the IVDs (Prescher, 1998).
1.4.2. Facet Joint Osteoarthritis: Spondylarthrosis
Spondylarthrosis is a collective term used to describe the degenerative changes
which occur in the facet joints. Spondylarthrosis appears to affect mainly the
cervical and lumbar regions of the vertebral column. This is due to the wide
range of motion in the cervical region and the large load applied to the lumbar
region. Similarly to IVD degeneration, its frequency increases with age (Ziv et
al., 1992; Prescher, 1998; Moore et al., 1999; Tischer et al., 2006; Kalichman
and Hunter, 2007; Uhrenholt et al., 2008; Gellhorn et al., 2012; Simon et al.,
2012; Wilke et al., 2012).
Recent work has suggested that cervical endplate arthrosis precedes facet
arthrosis (Master et al., 2012). However, several earlier studies investigated the
possibility that IVD degeneration leads to facet joint degeneration (Dunlop et al.,
1984; Pathria et al., 1987; Swanepoel et al., 1995; Fujiwara et al., 1999; Gries
et al., 2000). For example, if the IVD height within a FSU decreases, an
increased load will be applied to the facet joint which will, in turn, lead to
damage and cause pain. In addition, the loss in height may dislocate the
articular processes of the facet joints placing the joint capsules under major
stress. Changes in the IVD may also lead to cartilage erosion which decreases
the joint space and allows the production of osteophytes. However, this remains
debatable. There are neurons which surround and innervate the facet joint,
such as the cervical facet joints, which have been shown to contain nervous
tissue in the human and rat (Pathria et al., 1987; Kallakuri et al., 2012; Kras et
al., 2013). This is likely to be a major cause of pain following facet degeneration
and its decreased joint space.
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Osteoarthritis of the facet joints has been reported to exhibit similar features to
that of other diarthrodial joints (Grenier et al., 1987; Moore et al., 1999). A
common feature of the condition is cartilage degradation and the formation of
osteophytes (Kalichman et al., 2008). Fibrillation of cartilage has also been
shown to occur such as vertical tears and tangential splits (Bogduk and
Twomey, 1987). Studies have suggested that facet joint defects are more
common on the superior facets rather than the inferior facets (Taylor and
Twomey, 1986; Wang et al., 1989). These points may be under considerable
load and stress especially if the IVD is also undergoing degeneration (Jinkins,
2004). When the cartilage degrades, the joint capsule also becomes smaller,
narrower and thin. This therefore limits the motion of the joint.
Proteoglycan degradation plays a major part in the degeneration of the ECM
which leads to cartilage erosion. IL-1 is thought to be involved in cartilage
catabolism by switching chondrocytes from anabolism to catabolism. TGF-β 
regulates cartilage anabolism therefore a net increase in IL-1 induces the
breakdown of cartilage at the molecular level (Cawston et al., 1999). As
collagen makes up a large proportion of the structural proteins in cartilage,
collagenases are also involved. The catabolism and loss of aggrecan is
believed to also contribute to the development of erosion in articular cartilage.
As catabolism of the macromolecule increases by proteolysis via aggrecanase,
the population of hydrophilic GAGs decreases. As a result, the structure and
therefore function of articular cartilage is lost (Caterson et al., 2000; Sandell and
Aigner, 2001).
Studies have been carried out to investigate the pathological changes in the
facet joint during degeneration (Taylor and Twomey, 1986; Fletcher et al., 1989;
Moore et al., 1999; Gries et al., 2000; Kyriakos et al., 2000; Boszczyk et al.,
2001A; Boszczyk et al., 2003; Tischer et al., 2006; Kalichman and Hunter,
2007; Uhrenholt et al., 2008; Gellhorn et al., 2012). Histological analysis carried
out by Taylor and Twomey (1986) showed that degenerative changes in the
lumbar facet joints occurred through aging, including severe cartilage fibrillation,
gross thickening and irregularity of the calcified zone and an increase in
collagen content in the superficial zone. In addition, there was a decrease in the
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number of cells which appeared to have smaller nuclei and take up less
haematoxylin than healthier cells and the subchondral bone plate decreased in
thickness. A study conducted by Fletcher et al. (1989), who studied age related
changes in the cervical facet joints, reported loss of articular cartilage and
disorganised cortical margins. Histological analysis revealed a thin layer of
articular cartilage which had a sparse matrix that was less basophilic than
healthy cartilage and contained degenerated chondrocytes. There was an
absence of menisci, which were present in younger, healthier specimens, and
osteophytes were reported. Immunohistochemical analysis carried out on the
ECM of a degenerated human posterior lumbar facet joint capsule by Boszczyk
et al. (2003) showed that type I, III and VI collagens were found distributed
throughout the joint capsule as in healthy joints. However, a large amount of
collagen II was detected around the entire joint. GAGs such as keratan sulphate
and chondroitin 4 and 6 sulphate were distributed widely in the degenerated
joints. In particular, chondroitin-6-sulphate was found around the attachment of
the joint capsule. There was an abundance of aggrecan and link protein which
was detected throughout the joint. The authors reported extensive fibrocartilage
proliferation around the posterior capsules, evident largely at the margins, and
suggested that this feature of degeneration was due to the fact that the
posterior capsule is the main ligamentous structure of the FSU which resists
axial torsion (Boszczyk et al., 2003).
1.4.3. Degeneration of the FSU with Age
Histological, biochemical and biomechanical differences have been reported to
occur in FSUs of different ages (Bernick and Cailliet, 1982; Miller et al., 1988;
Moore et al., 1999; Urban et al., 2000; Urban et al., 2003; Roberts et al., 2006).
For example, decreased PG content, loss of disc height and increased
compressive stiffness occurs with age. These changes have been commonly
identified and tracked via the use of grading systems (Weishaupt et al., 1999;
Gries et al., 2000; Sive et al., 2002; Kettler and Wilke, 2006; Tischer et al.,
2006; Li et al., 2011; Varlotta et al., 2011A; Lee et al., 2012). Various grading
systems exist in the literature depending on the tissue type, the type of
degeneration present and the method used to analyse it. For example,
histological changes can be identified through the use of stains such as
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haematoxylin and eosin and alcian blue. A grading system that can be used on
these tissue sections includes examining the AF, NP, CEP and subchondral
bone for changes in their structure including lamellar disorganisation, cell
necrosis, trabecular thickening and cartilage thinning (Gries et al., 2000).
Another system involves grading the degeneration features within the IVD. This
includes the presence of cell clusters, fissures, haematoxyophilia and
demarcation (Gries et al., 2000; Sive et al., 2002). Degenerative changes have
also been identified through other methods such as MRI and CT imaging.
Features such as facet joint space have been measured and graded on a scale
from zero to three (Weishaupt et al., 1999). Furthermore, photography can be a
useful tool for examining the physical appearances of surfaces such as the
facet cartilage and joint capsule. Facet surfaces have been graded by
assessing the glossiness of the surface to reflect the amount of defects present
(Tischer et al., 2006; Kettler et al., 2007).
1.5. Current Therapies for the Degenerated Functional Spinal Unit
Degeneration of the IVD and facet joints is a major factor contributing to lower
back and neck pain (Lewinnek and Warfield, 1986). Back pain will affect up to
84 % of people at some point in their lives. It is a major public health problem in
Western society leading to disability and economic loss through work absence,
physician visits and hospitalisation (Maniadakis and Gray, 2000). Research into
treatment strategies is currently ongoing and involves spinal fusion, total disc
replacement (TDR) and tissue substitution therapies including tissue
engineering. Spinal fusion is a procedure whereby two or more vertebrae are
fused together by removing one or more IVDs and replacement using a bone
graft or bone graft substitute. This process may or may not involve the use of
materials such as plates, screws or cages. The aim of spinal fusion is to remove
the source of pain, the IVD, and restrict motion of one or more FSUs (Chou,
2013). Despite the fact that spinal fusion is commonly used today, it is not the
desirable method of treatment as the function of the tissues is not restored and
some patients may develop additional disease in FSUs adjacent to the fusion
site, due to compensatory motions. For this reason, tissue engineering has
received much attention over the last decade and has great potential for the
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development of effective treatments which restore tissue function and eliminate
pain (Yang and Li, 2009). In addition to tissue engineering another common
approach with the aim of restoring function to the FSU of vertebrae includes
TDRs (van den Broek et al., 2012). This section summarises the recent
advancements made in approaches to therapy.
1.5.1. Analgesics
Certain groups of drugs are commonly prescribed to patients suffering from
various forms of back pain in attempt to relieve their pain. These drugs improve
quality of life rather than offering a permanent cure to their condition. They all
have advantages and disadvantages in relation to their benefits, risks and cost
(Chou et al., 2007).
Non-steroidal anti-inflammatory drugs (NSAIDS), such as aspirin, are the most
common class of drugs administered to patients suffering from lower back pain.
Studies have investigated their effect on patient symptoms showing that they
are effective for acute back pain (Koes et al., 1997, van Tulder et al., 2000).
However, limitations associated with these drugs also need to be considered,
such as the gastrointestinal and renovascular risks (Hernandez-Diaz and
Rodriguez, 2000). A safer drug that can be used instead of NSAIDs is
acetinophen, which is also lower in cost. The drug is weaker than a NSAID but
can be used effectively in the first instance as pain relief for acute lower back
pain (Towheed et al., 2003; Lee et al., 2004B; Wegman et al., 2004).
Other drugs include opioid analgesics or tramadol which is given to patients
who do not respond to either NSAIDs or acetaminophen (Furlan et al., 2006;
Martell et al., 2007). Skeletal muscle relaxants including tizanidine, carisoprodol
and dantrolene have also been reported to provide relief for lower back pain but
may cause side effects relating to the central nervous system (van Tulder et al.,
2003). Tricyclic antidepressant drugs and herbal therapies are also commonly
used today in the clinic (Staiger et al., 2003; Gagnier et al., 2007).
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1.5.2. Physical and Rehabilitation Medicine
As the cause for most back pain in the general population is muscular, physical
and rehabilitation medicine is commonly used today. This includes various
treatments such as exercise therapy, massage and superficial cold and heat
(Abenhaim et al., 2000; Furlan et al., 2002; French et al., 2006). The type of
treatment prescribed will depend on the individual needs of the patient and
different patients will find some methods more effective than others (Deyo et al.,
1983; Deyo et al., 1986; van Middelkoop et al., 2011). Although many of these
treatments have been reported to relieve back pain for some patients, the
condition is rarely cured especially for non-muscular related back pain.
1.5.3. Spinal Fusion
Spinal fusion was first described in 1911 and used to treat a variety of spinal
disorders. It involves the fusion of two or more vertebrae using materials such
as screws and bone grafts and prevents motion in order to eliminate pain
(Chou, 2013). Spinal fusion is commonly carried out today and has been
reported to lead to some improvement in quality of life (Lee and Langrana,
2004B; Djurasovic et al., 2011). However, several studies have shown that this
procedure leads to adjacent segment disease (ASD) (Hsu et al., 1988; Schlegel
et al., 1996; Chen et al., 2001; Phillips et al., 2002). ASD is an abnormality in
the FSUs next to a spinal fusion. This includes IVD degeneration such as
herniated NP (Park et al., 2004). In addition, spinal fusion does not restore
function of the diseased FSU and can lead to other complications (Deyo et al.,
1993). As a result, this may not be the ideal form of treatment for many patients.
1.5.4. Total Disc Replacements
Total disc replacements (TDRs) have been studied since the 50s following the
success of total hip and knee replacements. They aim to restore and maintain
motion within an FSU thereby preventing degeneration in adjacent FSUs and
eliminating pain. TDRs that have been used clinically include the Charitè,
ProDisc L, Maverick, Acroflex and Flexicore (van den Eerenbeemt et al., 2010).
The Charitè TDR was the first available TDR and has a dual bearing surface
enabling the centre of rotation to move as the implant articulates. Three types of
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the Charite TDR exist. All types consist of two highly polished cobalt-chromium-
molybdenum end plates articulating with a core composed of ultra-high
molecular weight polyethylene (UHMWPE). The differences between the three
types are due to changes in end plate thickness and the number of teeth
anchoring them onto the vertebra (Putzier et al., 2006). The clinical success of
the Charitè TDR was reported in 1997 after a 51 month follow up and in 2005
after an 11.3 year follow up (Lemaire et al., 1997; Lemaire et al., 2005). The
results from these studies showed good/excellent results reporting infrequent
pain that did not require medication and continuation of activity in the same job
within three months of arthroplasty. The Charitè TDR has proven to effectively
restore motion and functionality within the FSU in the absence of facet joint
degeneration.
Another TDR that has been used clinically is ProDisc L. This is similar to the
Charitè and is composed of a UHMWPE core which articulates with two
concave cobalt-chromium-molybdenum alloy endplates. Studies have claimed
that the TDR is safe for use in patients and effective in restoring a normal range
of motion and is statistically more effective than spinal fusion (Zigler et al., 2007;
van den Eerenbeemt et al., 2010).
The Maverick disc is a metal on metal ball and socket TDR resembling the
ProDisc L. It consists of two metal plates and articulates with a small radius
core. It does not allow for pure translation and is therefore semi-constrained
(Mayer, 2005). A study by Le Huec et al. showed an overall clinical outcome of
86 % success (Le Huec et al., 2004).
There are, however, concerns regarding whether overall clinical outcome is
beneficial using the Charitè, ProDisc L and Maverick TDRs as these are all ball
and socket designs which lead to rigid axial motion therefore providing motion
which is different to that in the natural IVD. This may lead to facet overloading,
adjacent segment disease and wear. In terms of these factors TDRs are not
superior to spinal fusion. This led to the development of the first deformable
TDR, the Acroflex (van den Broek et al., 2012). The AcroFlex TDR was
composed of two titanium end plates which were bound together by a hexane-
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based polyolefin rubber core. However, the material was shown to fail under
mechanical loading and was abandoned (Fraser et al., 2004). The Flexicore
was developed and similarly to AcroFlex contains two titanium endplates and
the classic ball and socket design. However, studies indicate a small overall
success rate and little clinical improvement compared to spinal fusion (van den
Eerenbeemt et al., 2010).
Currently, non-ball and socket TDR devices are being developed to avoid
issues with range of motion in order for natural IVD biomechanics to be
mimicked. These include polycarbonate urethane designs such as the Physio-L.
However, these still need to be studied clinically over the longer term to
determine the success in vivo (van den Broek et al., 2012).
1.5.5. Facet Joint Therapies
Common procedures to reduce the pain within the facet joints are intra-articular
injections of local anaesthetics and steriods, medial branch blocks and radio
frequency neurolysis. Although thought to be effective, there is no way of
biologically accessing the effectiveness of these forms of treatment. Numerous
studies have been carried out to evaluate the clinical outcome of intrarticular
injections to reduce pain (Esses and Moro, 1993; Zdeblick, 1995). However,
many of these studies were flawed due to false positive results arising from
poor study design. For example, a study by Lilius et al. (1989) which
investigated the effectiveness of lumbar steroid facet joint injections included
patients with neurological deficits and did not report their diagnosis. The results
from this study failed to exclude the placebo group. Another study by Barnsley
et al. (1994) included patients who were victims of whiplash and might not have
had pain originating from the cervical facet joints. A study by Carette et al.
(1991) included results from a placebo group in the overall success rate.
However, the results of a review which looked into a wide range of therapeutic
facet joint interventions concluded moderate evidence for short and long term
lumbar facet joint pain relief for intra-articular injections, moderate evidence of
cervical and lumbar facet joint pain relief using medial branch blocks and
moderate to strong evidence of cervical and lumbar facet joint pain relief using
radiofrequency facet neurolysis (Boswell et al., 2005).
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Facet fusion systems have been described for many years. Recently, a fuse
system has been developed for fusing lumbar facet joints called the TruFUSE,
an allograft milled bone dowel. It was designed to be a less intrusive method of
spinal fusion specifically for the facet joints. The clinical success rates have so
far been promising with 95 % of patients in one study showing signs of spinal
stability (Maroon et al., 2013). However, this study was conducted by only one
surgeon on 41 patients. Further clinical studies involving larger groups will need
to be conducted to provide a more accurate assessment of this form of
treatment.
1.6 Novel Approaches for the Treatment of the FSU
Tissue engineering is an approach to the problem of repair or replacement of
degenerate tissues. It involves designing and manufacturing neo tissues in vitro
with a view to restoration or replacement of a diseased or damaged tissue in
vivo. This is a highly multidisciplinary activity involving bioengineering and
biomechanics through to cellular and molecular developmental biology and
morphogenesis. Three factors believed to be essential in tissue engineering
are; inductive signals, responding cells and the ECM or ‘scaffold’. The
microenvironment of a natural ECM in particular can be replicated by the use of
important macromolecules such as collagen, proteoglycans and GAGs (Reddi,
2000). Tissue engineering aims to develop tissues in vitro which can be used to
replace tissues in patients that are degenerated or are likely to degenerate. This
approach is favoured over the use of synthetic replacements due to its
regenerative capacity.
The generation of new FSU tissue, including the IVD, CEP and facet cartilage,
via tissue engineering is highly desirable. Methods have been investigated to
generate tissue engineered articular cartilage; however these are limited to in
vitro studies or studies in animals (Kheir et al., 2011; Shahin and Doran, 2011).
Tissue engineering methods have been used to produce an AF and NP in vitro
(Rong et al., 2002; Sato et al., 2002; Gan et al., 2003B). Many recent studies
have focused on tissue engineering of the NP as this tissue is believed to be the
initial site of IVD degeneration (Yang and Li, 2009). However, other authors
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argue that in patients with severe IVD degeneration, without a functional AF, the
NP product itself will fail to regenerate the IVD as the AF is essential for
resisting pressure (Jin et al., 2013).
Despite the fact that tissue engineering in the spine aims to restore tissue
function and maintain movement and flexibility, there are various limitations
which need to be addressed before this approach can be translated to the clinic.
The first issue to consider is the source from which the cells are obtained and
the cell type. There are a range of cell types that can be used including
autologous or allogeneic cells of adult or embryonic origin. The cells may be
obtained from the same tissue type that will be repaired or may be sourced from
a different tissue. The optimal cell type has not yet been identified as there are
limitations associated with each. Autologous cells isolated from the IVD may
seem ideal, but problems arise due to the low cell number within the IVD and
the varying cell phenotypes within the structure (Mwale et al., 2004). In addition,
isolation of IVD cells would involve trauma to the AF and NP, causing
biochemical and biomechanical damage to these structures which may
potentially lead to further degeneration. Even if cells were successfully obtained
from the tissue, the issue of cell viability and metabolic activity would need to be
considered, as a large proportion of IVD cells have been shown to die through
apoptosis due to cell senescence (Gruber and Hanley, 1998). Autologous adult
stem cells could also present limitations due to the lack of information on the
characteristic molecular profile of AF and NP cells which would cause
uncertainty as to whether the stem cells might be differentiated to the correct
phenotype (Kandel et al., 2008). Embryonic stem cells have been shown to be
capable of producing IVD tissue (Ahmed et al., 2007). However, the use of
these cells is very controversial and there are safety and immunological issues
associated with their use.
There are a wide range of biomaterials which have been studied as scaffolds for
tissue engineering in the spine. Most of these biomaterials have advantages
and disadvantages associated with them and there are many factors that need
to be taken into consideration when deciding on the ideal scaffold. Once an
ideal tissue engineered IVD is developed, whether it be a tissue engineered NP
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or an IVD consisting of both an AF and NP, the method of implantation needs to
be carefully considered. This is likely to have a marked effect on whether tissue
engineered products will succeed in the clinic. Invasive surgery is not ideal but
in many approaches would be unavoidable. For a whole tissue engineered IVD
to be implanted, there would need to be some form of bony end plate to allow
the implant to integrate with the vertebral body via bone ingrowth (Porto Filho et
al., 2005; Kandel et al., 2008).
The success of tissue engineered implants may be limited by factors such as
disc nutrition and mechanical loading. The CEP provides a barrier for the
diffusion of nutrients from the blood vessels which surround the IVD such as
capillaries which penetrate the subchondral plate. The CEP commonly becomes
calcified during degeneration which limits nutrient and oxygen supply to the IVD.
As the IVD cells generate ATP through glycolysis alone, this leads to low
glucose supply and the accumulation of lactic acid. This in turn leads to
degeneration of the IVD. Therefore, if the CEP is calcified, a tissue engineered
IVD would soon degenerate irrespective of its healthy state at insertion. The
mechanical properties of the IVD will ultimately depend on the organisation and
composition of the macromolecules within the tissue. Therefore the mechanical
properties of the natural IVD would need to be replicated to enable correct
physiological responses in vivo. If the implant does not have the correct levels
of macromolecules and is reliant on the cells producing the ECM once
implanted, issues may arise due to the slow matrix production and turnover of
IVD cells. It may therefore take months or years to regenerate the implant for
the ECM to be similar to that of the native tissue (Kandel et al., 2008).
In all cases, it is important to consider patient specificity. All forms of tissue
engineering of the IVD may not be applicable to all patients. For example, a
patient in the early stages of IVD degeneration may only need a cell-based
treatment whereas a patient in the later stages of IVD degeneration is likely to
benefit from a whole tissue engineered IVD using a scaffold.
Various biomaterials have been investigated over the last decade as support
scaffolds for IVD cells, retaining them in a particular location and allowing them
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to naturally produce an ECM in vitro. Examples of these are chitosan based
hydrogels, type II collagen/aggrecan/hyaluronan, fibrin/hyaluronan, poly(L-lactic
acid) (PLLA)-hyaluronan nanofibres and hyaluronic acid. Each has advantages
and disadvantages with regard to future clinical use.
1.6.1. Hydrogels for NP Replacement
Various hydrogels have been developed and researched as potential NP
therapies (Sun et al., 2001; Park et al., 2005; Boyd and Carter, 2006; Roughley
et al., 2006; Bader and Rochefort, 2008; Chou and Nicoll, 2008; Halloran et al.,
2008; Yang and Li, 2009; Park et al., 2011). Hydrogels are a favourable
biomaterial as they would be easy to administer to the patient in an injectable
form in a relatively non-invasive way and prepared in a simple and controllable
manner. Hydrogels allow the NP cells to be kept in a 3D environment, allowing
cell-matrix interactions to be maintained which is essential for cell proliferation,
differentiation and survival (Boyd and Carter, 2006). In addition, hydrogels
facilitate diffusion of nutrients and metabolites to and from cells (Drury and
Mooney, 2003).
Chitosan is a polymer of glucosamine and N-acetyl glucosamine and can be
induced to form a hydrogel by two methods, self-association or covalent cross
linking. Bovine NP cells were incorporated into a chitosan-based hydrogel and
maintained in tissue culture (Roughley et al., 2006). It was shown that the
scaffold was able to retain the proteoglycans produced by the entrapped cells
using either method of hydrogel induction. The authors concluded that this
approach may be used for NP regeneration. The benefit of this study is that the
therapy, if successfully developed, could be administered to the patient in the
form an injection through the AF into the NP. This would be a relatively non-
invasive procedure in comparison to IVD replacements. Polymerisation can be
controlled in situ which would allow for easy administration. In addition, cellular
entrapment of hydrogels does not depend on scaffold pore size.
Another injectable scaffold that has been developed involved the use of
collagen type II, aggrecan and hyaluronan (Halloran et al., 2008). In this study,
bovine NP cells, previously isolated and expanded in monolayer culture, were
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seeded onto the enzymatically cross-linked injectable scaffold. This scaffold
consisted of all the major macromolecules found in the ECM of the NP. In order
to increase the biomechanical properties of the hydrogel whilst retaining its
injectable qualities, microbial transglutaminases (mTGases) were used to cross
link the proteins within the scaffold. The results showed that cell viability and
phenotype was maintained for over seven days in vitro. However, mTGase
concentrations of greater than 50 µg.ml-1 had a negative effect on cell viability,
which in turn meant that there was a need to compromise between scaffold
stability and cell viability.
A further study, also looking into developing an injectable NP replacement, was
carried out by Chou and Nicoll, involving the use of photocrosslinked alginate
hydrogels to encapsulate bovine NP cells (Chou and Nicoll, 2008). Alginate is a
polysaccharide derived from brown algae which forms cross links in the
presence of calcium. However, this means stability is dependent on calcium
which may not be available in vivo. Therefore this study used ultraviolet (UV)
light to initiate polymerisation. The results showed that the NP cells within the
scaffold were capable of producing and maintaining proteoglycans which
maintained osmotic pressure in vitro. In addition, the equilibrium Young’s
modulus was maintained. However, the findings showed that increasing the
cross links within the scaffold compromised cell viability. In addition, greater
cross linking may give rise to a stiffer gel putting the essential elastic properties
of the NP at jeopardy.
In order to tackle the issues surrounding biomechanical strength and cell
viability Park et al. investigated an injectable scaffold made from silk-fibrin and
hyaluronic acid (Park et al., 2011). As fibrin/hyaluronan scaffolds had previously
been shown to degrade rapidly (Park et al., 2005), a silk component was mixed
with the fibrin/hyaluronan scaffold to improve the biomechanical strength and
reduce shrinkage of the scaffold. The results showed that appropriate
biomechanical and biochemical properties including uniform NP cell distribution
were achieved. In addition, degradation of the scaffold was decreased whilst
maintaining NP cell growth. A limitation of the study was reduced cell
proliferation with increased silk content. Although a compromise must be
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reached between these two factors the study achieved this and appears
promising for further studies in NP regeneration.
1.6.2. Tissue Engineering of the AF
Some forms of degenerative disc disease such as disc herniation are more
suitable for treatment which involves replacing parts of the AF through which
the NP has escaped. For these cases, tissue engineering a patch of AF to fill
the defect and integrate with the undamaged tissue is more applicable than
attempting to replace the whole IVD. It would also be more cost effective and
less invasive.
Various studies have been carried out in AF tissue engineering using scaffolds
similar to those used in NP tissue engineering such as porous silks,
alginate/chitosan, nanofibrous polyurethane, electrospun poly(ϵ-caprolactone), 
atelocollagen honeycomb, collagen/GAG and poly-D-L-lactide (PDLLA)/bioglass
foams (Sato et al., 2002; Saad and Spector, 2004; Nerurkar et al., 2007; Shao
and Hunter, 2007; Helen and Gough, 2008; Chang et al., 2009; Yang et al.,
2009; Koepsell et al., 2011; Bhattacharjee et al., 2012; Jin et al., 2013).
Scaffolds used in tissue engineering of the AF can be divided into the two
categories. These are single unit, which are subdivided into orientated and non-
orientated with respect to the lamellae layers, and biphasic which represents
both the inner and outer layers of the AF. Many of these studies have shown
positive results and could be further developed to be implanted into patients.
However, the studies are still in the early stages and the authors have not
indicated how the constructs could be tested and used clinically.
Porous silk scaffolds have received great attention due to the nature of silk
fibroin, a protein polymer made by silk worms. Silk fibroin is the strongest
known natural fiber, shows resistance to failure and naturally degrades in vivo
after two years (Chang et al., 2007). A study by Chang et al. (2009) investigated
whether porous silk scaffolds were able to support AF cell attachment and ECM
accumulation. The authors found that cells successfully adhered to the scaffold
and synthesised collagen and proteoglycans. However, the scaffold
represented the general AF structure rather than an inner or outer AF. This may
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lead to structural variations if it was implanted into a patient. In addition, the
scaffold was only tested in vitro. There was no mention of how the construct
would be implanted into the patient in the future. Other studies using the
materials above have also succeeded in producing promising biological results
for in vitro tissue engineered AF replacements but fail to identify the method by
which they envisage the construct will be tested for in vivo use.
1.6.3. Tissue Engineering of the Whole IVD
In addition to NP and AF replacements, other studies have focused on
developing a whole tissue engineered IVD using a dense scaffold for the AF
together with a hydrogel component for the NP (Mizuno et al., 2004; Mizuni et
al., 2006). Mizuno et al. developed a tissue engineered IVD using a synthetic
nonwoven mesh of polyglycolic acid fibres and an alginate gel containing ovine
IVD cells (Mizuno et al., 2006). The IVD was then transplanted into mice and
analysed at time points up to 16 weeks. The results revealed that shape was
maintained in vivo and tissue/ECM formation had occurred. Certain
biomechanical properties including compressive modulus and hydraulic
permeability increased and decreased, respectively, with time. The authors
stated that by 16 weeks, mechanical and biochemical composition was similar
to that of the native tissue. However, further work needs to be carried out to
ensure that identical properties are reached. Other challenges still need to be
addressed including how the implant could be scaled to the size of a human
IVD and delivered into the patients’ spine and how it would be integrated with
surrounding tissues.
Other materials used to generate both an AF and NP include using hyaluronic
acid-nanofibrous and poly(caprolactone)/chitosan scaffolds (Nesti et al., 2008;
Wan et al., 2008). Both of these studies reported acceptable biomechanical
properties, ECM production and cell morphology.
1.6.4. Tissue Engineering of the Facet Cartilage
Various studies have researched ways of tissue engineering articular cartilage
(Mahmoudifar and Doran, 2005; Schulz and Bader, 2007; Stapleton et al., 2010;
Kheir et al., 2011; Shahin and Doran, 2011). Currently, facet cartilage has not
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been tissue engineered. A study by Elder et al. (2010) attempted to create a
tissue engineered replacement of the facet cartilage using a common process
known as decellularisation. This procedure involves the removal of cells and
immunogenic cellular proteins and nucleic acids whilst preserving the function
of the ECM. Decellularisation is ideal for cartilage tissue engineering as the
major functions of the tissue are due to the ECM. In addition, successful studies
have been carried out on cartilage from other joint areas including the knee
using this method (Kheir et al., 2011). The results from the Elder study,
however, failed to report an effective method for decellularisation of facet
cartilage. A compromise between the complete removal of DNA content and the
maintenance of biochemical and biomechanical properties was not achieved.
However, the study is a starting point for research in tissue engineering of facet
cartilage which is likely to grow in the future.
1.7. The Need for Pre-Clinical Models
Many studies, as described in Section 1.6, have attempted to produce
substitution therapies for the spine by tissue engineering. However, what many
authors fail to address is how these products will be pre-clinically tested for their
effectiveness and safety. This is a vital step before they can be used in patients.
Once a potential substitution therapy is created, ideally the next step in its
development towards clinical use would be testing using a pre-clinical in vitro
model, prior to testing in living animals and then patients. One approach
towards developing a pre-clinical in vitro model is to utilise natural joint tissue in
a whole joint simulator, which reproduces the natural biomechanical motions of
the spine. Ideally, the tissue engineered replacement or substitution therapy
would be tested in both healthy joint tissue and joint tissue representative of the
degenerated form of the tissue of interest in a simulator. The product would
then be applied to the model, as it would in vivo, and then analysed following a
period of simulation.
There are a number of factors limiting the use of human tissue for the
development of in vitro models. These include availability of fresh tissue and
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the wide variation in human tissue, including geometrical and mechanical
differences with regard to age, sex, bone quality and degenerative changes
(Sheng et al., 2010). The sheep was chosen as the animal model for this study
and was used throughout the entire study. This was due to its close
resemblance to the human spine in terms of the anatomical, biomechanical,
biochemical and biological properties, for example axial rotation as shown in
Figure 1.14.
Figure 1.14: A biomechanical profile of the human, calf, sheep, pig and kangaroo.
The median degree of range of motion is shown in left and right axial rotation in each
FSU (White and Panjabi, 1990; Alini et al., 2008).
Studies have identified various similarities between the human and ovine spine
(Moore et al., 1999). For example, the dimensions of the ovine spine such as
vertebral body height, facet height, facet width and IVD height all show
similarities, which support the use of ovine spine for research in all cervical,
thoracic and lumbar regions (Wilke et al., 1997; Kandziora et al., 2001). A
biological similarity is the rapid decrease of notochordal cells in the NP after
birth. This has been reported to occur in humans but not in other animals such
as the mouse, pig and rabbit. This may have an effect on disc degeneration
since the notochordal cells and the NP cells have very different morphology and
function which could interfere with studies of the IVD (Hunter et al., 2003;
Hunter et al., 2004). Furthermore, biochemical changes with age have been
identified in both the sheep and human relating to altered metabolism and
Chapter 1
47
proteoglycan synthesis by IVD fibrochondrocytes in addition to IVD calcification
(Bayliss et al., 1988).
As the sheep is a quadruped animal there are some differences to the human
spine with regards to load. A common misconception is that the lumbar region
of the human spine is under greater load than that in the sheep. However, it can
be argued that the ovine lumbar IVDs are more heavily loaded due to muscle
contraction and tension of ligamentous tissues, which attempt to stabilize the
spine horizontally, and this is thought to require greater force from these tissues
than vertical alignment (Alini et al., 2008). This may explain why BMD has been
reported to be up to four times higher in animals such as sheep in comparison
to humans (Wilke et al., 1999). This needs to be taken into consideration during
all studies using animals and their tissues.
Important differences between the sheep and human spines include the
presence of secondary ossification centres. The primary centre is located at the
central core of the vertebral body in both human and sheep. However, the
secondary centre in the sheep is found above and below the physeal plates
whilst in humans is present at the circumferential parts (Alini et al., 2008). In
addition to this, the sizes of the FSUs vary between human and sheep, with the
latter being much smaller in size. In humans, the diameter and disc height of the
vertebrae increases throughout the length of the column unlike in the sheep in
which the diameter stays fairly constant, with disc height being larger in the
cervical than the lumbar region (Wilke et al., 1997). The number of vertebrae in
the thoracic region also differs between the species with the human spine
containing 12 and the sheep having 13.
1.8. Conclusions
Much of the literature available on the FSU focuses largely on spinal
biomechanics. As spinal degeneration is a common disease affecting up to 84
% of individuals at one point in their lives, effective treatment is vital. The latter
part of this review summarised some treatments that have been developed so
far with their respective advantages and disadvantages. TDRs help to restore
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motion in the FSU but do not bring functionality back to the tissue. Tissue
engineering aims to restore tissue function as well as motion but is still in its
infancy. For this reason, the development of pre-clinical in vitro models of FSU
systems is essential for pre-clinical testing of these novel therapies.
As illustrated in this review, the individual tissues of the FSU have been
characterised to some extent. These include the NP, the AF and the facet joint
cartilage. However, knowledge of the biology of the FSU as a whole is lacking.
In particular, the characteristics of the facet joints and CEPs in natural and
degenerated states. In order to begin to develop early intervention therapies for
the FSU, knowledge of the biology in health and disease is essential.
1.8.1. Aims and Objectives
The aims of this study were to characterise facet cartilage, CEP, AF and NP
cells and tissues from cervical, thoracic and lumbar FSUs of healthy sheep.
Objectives
 To conduct an anatomical study of ovine FSUs to determine any
changes that occur in these tissues with age and whether differences
occur between different breeds of sheep.
 To determine the age of sheep from which healthy and degenerate
tissues can be obtained.
 To characterise the FSU tissue obtained from sheep in the healthy age
group using histological, immunohistochemical and biochemical methods
and to determine the phenotype of the cells isolated from the tissues
using immunocytochemistry.
 To determine the biomechanical properties of healthy ovine facet
cartilage using indentation methods.
 To treat ovine facet cartilage with chondroitinase ABC to mimic the
biotribological properties of degenerated human facet joint cartilage.
This study was carried out in parallel with three other studies as summarised in
Figure 1.15. The vision at Leeds is to develop in vitro ovine models of healthy
Chapter 1
49
and degenerated FSUs. These will then be used to test facet
cartilage/CEP/AF/NP substitution therapies.
Figure 1.15: Four studies at Leeds, including the study described in this thesis,
running parallel to each other. Study one is the current study involving the
characterisation of the ovine FSU and the development of a degenerated ovine FSU.
Study two involved the characterisation of degenerated human FSUs, whilst studies
three and four focused on the experimental and computational simulation of the in vitro
ovine FSU model. FSU: Functional spinal unit.
Study 1: The biology of the
ovine FSU: facet cartilage
and intervertebral disc
Study 2: Biological
characterisation of
degeneration of human
FSU`s
Study 3: Computational
simulation of the in vitro
ovine FSU model
Study 4: Experimental
simulation of the ovine FSU
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Chapter 2: Materials and Methods
2.1. General Materials
2.1.1. Chemicals and Reagents
All chemicals and reagents used throughout the study are presented in
Appendix I.
2.1.2. Solutions
Alcian Blue
Alcian blue stain was prepared by dissolving 1 g of Alcian blue in 100 ml of 3 %
(v/v) acetic acid. The pH was adjusted to 2.5 by adding either 6 M HCl or 6 M
NaOH drop wise. This was stored at room temperature for up to six months.
Antibiotic Solution
Antibiotic solution was prepared by dissolving 25 ml Nystatin (250 U.ml-1), 40 µL
gentamycin (20 µg.ml-1), 1 ml polymixin B (200 µg.ml-1), 500 µL vancomycin (50
µg.ml-1), 20 mg imipenem (200 µg.ml-1), 10 ml amphotericin B (25 µg.ml-1) and
100 µL aprotinin (10 KIU) in 63 ml of phosphate buffered saline (PBS). The
solution was divided into 12.5 ml aliquots in universals before storing at -20 ºC
for up to six months.
Antibody Diluent
Antibody diluent was prepared by dissolving 600 µL 10 % (w/v) sodium azide
and 300 µL 5 % (w/v) bovine serum albumin (BSA) in 59.1 ml tris buffered
saline (TBS). The pH was adjusted to 7.6 by adding either 6 M HCl or 6 M
NaOH drop wise and stored at 4 ºC for up to three months.
Chondroitinase ABC Solution
Chondroitinase ABC solution was prepared by dissolving 0.61 g trizma base
and 0.49 g sodium acetate in 50 ml distilled water. The pH was adjusted to 8.0
by adding either 6 M HCl or 6 M NaOH drop wise before adding distilled water
to a final volume of 62 ml. One ml of 5 % (w/v) bovine serum albumin (BSA)
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was added. Nyastatin (25 ml, 250 U.ml-1), 40 µL gentamycin (20 µg.ml-1), 1 ml
polymixin B (200 µg.ml-1), 500 µL vancomycin (50 µg.ml-1), 20 mg impenem
(200 µg.ml-1), 10 ml amphotericin B (25 µg.ml-1) and 100 µL aprotonin (10 KIU)
were added to the solution before 0.05 U.ml-1 chondroitinase ABC was added.
The solution was divided into 12.5 ml aliquots in universals before storing at -20
ºC for up to six months.
Dimethylene Blue Solution
1,9 Dimethylene blue (DMB) solution for the GAG assay was prepared by
dissolving 16 mg of DMB into 5 ml of ethanol and 2 ml of formic acid using a
magnetic stirrer. Sodium formate (2 g) was added and the volume was
increased to 1000 ml using distilled water. The pH was adjusted to 3.0 by
adding formic acid drop wise. The solution was stored at room temperature for
up to three months.
EDTA Solution
EDTA solution 12.5 % (w/v) was prepared by dissolving 12.5 g of NaOH and
125 g of EDTA in 875 ml distilled water. The pH was adjusted to 7.0 by adding
either 6 M HCl or 6 M NaOH drop wise. The solution was stored at room
temperature for up to three months.
Glycosaminoglycan Assay Buffer
GAG assay buffer was prepared by combining 137 ml 0.1 M sodium di-
hydrogen orthophosphate with 63 ml 0.1 M di-sodium hydrogen
orthophosphate. The pH was adjusted to 6.8 using 6 M HCl or 6 M NaOH and
stored at room temperature for up to three months.
Glycosaminoglycan Digestion Buffer
Glycosaminoglycan (GAG) digestion buffer was prepared by dissolving 0.79 g
L-cysteine hydrochloride and 0.19 g disodium ethylenediaminetetracetic acid
(EDTA) in 1000 ml PBS. The pH was adjusted to 6.0 by adding either 6 M HCl
or 6 M NaOH drop wise. The solution was stored at room temperature for up to
six months.
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Papain Digestion Buffer
Papain digestion buffer (50 U.ml-1) was prepared by dissolving 500 units of
papain (2.8 U.mg-1) in 10 ml of GAG digestion buffer. The solution was used
immediately.
Permeabilisation Buffer
Permeabilisation buffer was prepared by dissolving 0.05 g saponin in 100 ml tris
buffered saline (TBS). The solution was used immediately.
Phosphate Buffered Saline
Phosphate buffered saline (PBS) was prepared by dissolving 10 PBS tablets in
1000 ml of distilled water. The solution was stored at room temperature for up to
one month.
Picro Sirius Red Stain
Picro Sirius red stain was prepared by dissolving 0.1 g Sirius red in 100 ml
aqueous saturated picric acid solution. The solution was stored at room
temperature for up to six months.
Poly(methyl methacrylate) Cement
Poly(methyl methacrylate) (PMMA) cement was made up by gently mixing by
hand approximately 44 g of the powder form (Cold Cure) with 25 g of liquid
monomer. This was carried out over a ventilated specimen table. The cement
was used immediately.
Substrate Chromagen
Substrate chromogen for immunohistochemistry was prepared by adding 20 µL
liquid 3,3-diaminobenzidine (DAB) chromogen to 1 ml substrate buffer. The
solution was used immediately.
Tris Buffered Saline
Tris buffered saline (TBS) was prepared by mixing 25 ml 2 M tris-HCl with 50 ml
3 M NaCl and 925 ml distilled water. The pH was adjusted to 7.6 by adding 6 M
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HCl or NaOH drop wise. The solution was stored at room temperature for up to
one month.
Tween Buffer
Tween buffer (0.05 %) was prepared by adding 500 µL of Tween 20 to 1000 ml
of TBS buffer. The pH was adjusted to 7.6 by adding 6 M HCl or 6 M NaOH
drop wise. The solution was stored at room temperature for up to one month.
2.1.3. Antibodies
All antibodies used throughout the study are presented in Tables 2.1 to 2.3.
Antigen and
Clone
number
Host & Type Isotype Dilution Antigen
Retrieval
Positive
control
tissue
Supplier
CD44
MA1-80974
Rat
monoclonal
IgG1 1:50 N/A Ovine
Cartilage
Thermo
Scientific
Chondroitin-
6-sulphate
MK-302
Mouse
Monoclonal
IgG1 1:200 Proteinase
K
Ovine
Cartilage
Abcam
Chondroitin
sulphate
CS-56
Rabbit
Polyclonal
IgG 1:50 Proteinase
K
Ovine
Cartilage
Sigma
Collagen I
5D8-G9
Mouse
monoclonal
IgG1 1:50 Proteinase
K
Ovine
Ligament
Chemicon
(Millipore)
Collagen II
COLL-II
Mouse
monoclonal
IgG1 1:200 Proteinase
K
Ovine
Cartilage
Chemicon
(Millipore)
Collagen III Rabbit
Polyclonal
IgG 1:100
(IFF)
1:50
(IHC)
Proteinase
K
Ovine
Ligament
Abcam
Collagen V
IE2-IE4
Mouse
monoclonal
IgG2a 1:50 N/A Ovine
Ligament
Chemicon
(Millipore)
Collagen VI Rabbit
Polyclonal
IgG 1:200 Proteinase
K
Ovine
Cartilage
AbD
Serotec
Collagen X
COL-10
Mouse
Monoclonal
IgM 1:50 Proteinase
K
Ovine
Cartilage
Abcam
Desmin
DE-U-10
Mouse
Monoclonal
IgG1 1:50 Proteinase
K
Ovine
Muscle
Abcam
Fibronectin
IST-3
Mouse
Monoclonal
IgG1 1:200 Proteinase
K
Ovine
Ligament
Sigma
Aldrich
Osteocalcin
OC4-30
Mouse
monoclonal
IgG2a 1:100 Proteinase
K
Ovine
Bone
Abcam
SOX-9 Rabbit
Polyclonal
IgG 1:50 Proteinase
K
Ovine
Cartilage
Chemicon
(Millipore)
Table 2.1: Primary antibodies used throughout the study. IFF: Indirect
Immunofluorecence, IHC: Immunohistochemistry.
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Type Conjugate Dilution Supplier
Goat anti-mouse FITC (Alexa Fluor
488)
See Table 2.12 Invitrogen
Rabbit anti-rat FITC (Alexa Fluor
488)
See Table 2.12 Invitrogen
Goat anti-rabbit FITC (Alexa Fluor
488)
See Table 2.12 Invitrogen
Table 2.2: Secondary antibodies used throughout the study. FITC: Fluorescein
isothiocyanate.
Antigen Type Host Supplier
Aspergillus niger
glucose oxidase
Isotype
control
IgG1
Mouse DAKO Ltd
Ovalbumin-DNP Isotype
control
IgG2a
Rat DAKO Ltd
Unknown Isotype
control
IgM
Mouse DAKO Ltd
Unknown IgG Rabbit Invitrogen
Table 2.3: Isotype control antibodies used throughout the study.
2.1.4. Equipment, Consumables, Plastic and Glassware
All equipment, consumables, plastic and glassware used in experiments are
summarised in Appendix 1 and 2.
2.2. General Methods
2.2.1. Washing and Disinfection of Equipment
Following use, dissection instruments were washed and scrubbed under hot
water and placed into Virkon for five hours. They were then transferred to a
beaker containing 1 % Trigene disinfectant and left overnight. The following
day, the instruments were washed with tap water and distilled water before
being sprayed with ethanol and left to dry and sterilised. Glassware was
washed thoroughly with tap water and placed into Trigene for approximately 24
hours. It was then rinsed with tap water and distilled water before being dried
and sterilised if required.
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Before using the class II safety cabinet for cell culture work, the surfaces inside
were sprayed with Virkon and then 70 % (v/v) ethanol. Everything placed into
the cabinet was sprayed with 70 % (v/v) ethanol including gloved hands.
2.2.2. Sterilisation
Instruments and equipment were sterilised by dry heat by placing into an oven
set at 180 ºC for four hours. Alternatively, objects unsuitable for high
temperature and solutions were moist heat sterilised. This involved autoclaving
at 121 ºC, 15 psi for 20 minutes.
2.2.3. pH Measurements
In order to measure the pH of solutions, a Jenway 3020 electronic pH meter
was used. Firstly, the meter was calibrated by placing it into three solutions at
pH 4, 7 and 10, made from buffer tablets dissolved in distilled water. To adjust
the pH of solutions, 6 M HCl or 6 M NaOH was added drop wise whilst the
solution was being stirred.
2.2.4. Microscopy
A bright field upright Olympus BX51 microscope was used to view histological
and immunohistochemical tissue sections. The microscope was set up for
standard Köhler illumination. A bright field upright Olympus BX51 microscope
was used to view cells labelled with fluorescent secondary antibodies. A BX51-
RFA fluorescent illuminator was set up for fluorescence imaging using either
fluorescein isothiocyanate (FITC) or 4,6-diamidino-2-phenyllindole (DAPI) filters.
An optical Olympus CK-40-SLP microscope was used to view cells during cell
culture studies set up for standard Köhler illumination. Images were captured
from both microscopes using an Evolution MP Colour Digital camera that was
controlled by Cell B imaging software version 7.
2.2.5. Ovine Tissue Dissection
2.2.5.1. Procurement of Tissue and Dissection
Sheep were slaughtered either on the day (cell isolation) or the day before
(tissue characterisation) delivery at an abattoir (M & C Meats, Leeds) by electric
Chapter 2
57
stun to the head and severance of the neck. The carcass was hung and
skinned. Inspection and authorisation was carried out by a veterinary officer
from the meat hygiene service. The spine was extracted via incisions made to
the left and right sides of the spine and was delivered intact to the University of
Leeds.
2.2.5.2. Dissection for Tissue Characterisation
The spine was placed on a working bench and excess surrounding ligamentous
tissue, muscle and fat was removed from around the FSUs of interest (Figure
2.1).
Figure 2.1: An ovine three year old Suffolk spine. A: The spine after delivery. B: The
spine after the removal of surrounding soft tissue.
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The spine was divided up into three regions; cervical, thoracic and lumbar
(Figure 2.2).
Figure 2.2: Cervical, thoracic and lumbar regions of a three year old ovine
Suffolk Mule spine. All vertebrae are labelled depending on their vertebral level. L:
Lumbar, T: Thoracic, C: Cervical.
In the cervical region, the FSUs C4/C5 and C6/C7 were removed by slicing
through the IVDs of adjacent FSUs C3/C4 and C5/C6 with a scalpel and
carefully cutting through the neighbouring facet joint capsules and the
surrounding tissue. With gentle force, the neighbouring FSUs (C3/C4 and
C5/C6) were separated. For the thoracic region, the ribs were removed from
around the FSUs of interest by carefully slicing through the rib joint with a
scalpel. A similar approach to the cervical FSUs was applied to remove FSUs
T8/T9 and T11/T12. Lastly, FSUs L1/L2 and L3/L4 were removed from the
lumbar region.
FSUs C4/C5, T8/T9 and L3/L4 were photographed whole. Following the method
above, the FSUs were separated and photographed. The IVDs were removed
L1
L2
L3
L4
L5
T1
L6
T2
T3
T4
T5
T6
T7
T8
T9
T10
T11
T12
T13
C2
C1
C7
C6
C5
C4
C3
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using a scalpel by carefully cutting through the CEP in order to keep the IVD as
intact and complete as possible. The IVD was photographed in transverse
orientation. Lastly, the facets, both superior and inferior, were removed using a
hack saw. Both IVDs and facets were immediately fixed for histological analysis
(Section 2.2.7.1).
FSUs C6/C7, T11/T12 and L1/L2 were immediately stored at -20 ºC until
scanned using µCT (Section 2.2.12). Following scanning, all FSUs were sliced
in the mid sagittal plane using a bone saw (Figure 2.3).
Figure 2.3: An ovine FSU cut sagittally in half using a bone saw. A: A C6/C7 FSU
being cut with the blade of the bone saw. B: Half of an L1/L2 FSU after the blade of the
bone saw had sliced through it.
The left half of the FSU was moved 2 mm to the left of the FSU and sliced for
the second time resulting in a 2 mm sagittal slice. The facets, both inferior and
superior, were removed from the remaining left half of the FSU using a hack
saw before being photographed. In the same manner, the facets were cut in the
mid horizontal plane to give 2 mm slices. Both IVD and facets were immediately
fixed for histological analysis (Section 2.2.7.1).
2.2.5.3. Dissection for Cell Isolation
The bench space was prepared by taping yellow plastic bin liners and spraying
with 70 % (v/v) ethanol twice before the spine was placed onto it. A Bunsen
burner flame was lit in the centre of the dissection area to ensure sterility.
Within two hours of slaughter, the spine was placed onto the prepared bench
space. All ligamentous tissue, fat and muscle around the spine were removed
A B
FSU
Blade Clamp Clamp
FSU
Blade
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using a sterile scalpel and forceps. For thoracic regions of the spine, the ribs
were removed by carefully slicing through the rib joint with a sterile scalpel. The
location of the IVD was found and a sterile scalpel was used to cut carefully
through the IVD and the respective facets. The spine was forcefully separated
in the middle of the disc revealing the AF and the NP as shown in Figure 2.4.
The AF and NP tissues were removed using a sterile scalpel and forceps and
placed into a sterile pot of 40 ml Dulbecco’s modified Eagle medium (DMEM)
culture medium containing 10 % (v/v) fetal bovine serum (FBS), 2 mM L-
glutamine and 100 U.ml-1 penicillin/streptomycin. Once the IVD had been
removed, the CEP was scraped off the middle region of the IVD, where the NP
had been attached, and placed into a separate pot containing DMEM culture
medium. The inferior and superior facets were located and removed using bone
clippers. The cartilage from these was scraped off the bone using a sterile
scalpel and placed into a separate pot containing 40 ml DMEM culture medium.
All pots containing tissue in DMEM were transferred to a safety cabinet before
cell isolation (Section 2.2.8.1).
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Figure 2.4: A section of an ovine lumbar spine through the IVD. The images show
the different parts of the spine including the AF, NP, transverse and spinous process,
facets and spinal cord. AF: Annulus fibrosus, IVD: Intervertebral disc, NP: Nucleus
pulposus.
2.2.6. Photography
All photography was carried out using a Canon camera. Whole FSUs were
photographed with the anterior side placed on the bench. Separated FSUs were
photographed revealing the facets of the FSU of interest pointing upwards. The
transverse IVDs were photographed either separated or on the vertebral body
depending on thickness. IVD sagittal slices were photographed immediately.
Facets were placed into PBS to wash off any material/tissue on the surface of
the cartilage before being photographed.
For the anatomical study of ovine FSUs (Chapter 3), the photographs of facets
from the FSUs C6/C7, T11/T12 and L1/L2 were graded for degeneration blindly
by two independent graders using the grading system shown in Table 2.4.
Transverse
Process
Spinous ProcessSpinal Cord
Facet
Nucleus Pulposus
Annulus Fibrosus
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Grade Features
1 Overall glossy surface with occasional occurrence of small,
peripherally circumscribed defects.
2 A dull, slightly uneven surface.
3 A more uneven surface with some full cartilage defects between
preserved cartilage.
4 Considerable defects of the cartilage surface up to eburnation of
the entire cartilage in extreme cases.
Table 2.4: Grading system used to grade facet cartilage degeneration from digital
images based on the surface of the cartilage (Tischer et al., 2006).
2.2.7. Histology
2.2.7.1. Tissue Fixation and Decalcification
Ovine IVD and facet slices (2 mm) were immersed in a solution of 10 % (v/v)
neutral buffered formalin solution for 16-20 hours. After this, the tissue was
removed from formalin and placed into a solution of PBS for 30 minutes on a
plate rocker (Bibby Sterlin Ltd.) at 160 rpm. The PBS solution was replaced with
fresh PBS and left on the shaker for a further 30 minutes. The PBS solution was
replaced with 12 % (w/v) EDTA buffer (Section 2.1.2) for approximately two
weeks (one week per 1 mm thickness of tissue). EDTA buffer was replaced
after one week. The bone was cut with a scalpel to confirm that it was soft
enough to be sectioned.
2.2.7.2. Tissue Processing
Sagittal IVD slices were prepared by removing the bone on either side of the
IVD so that approximately 1 cm was left on each side. These samples and the
facet samples were then placed into histology cassettes before the tissue was
processed using an automated tissue processor (Leica Microsystems) on
programme eight for IVD tissue and programme nine for facet tissue according
to Table 2.5.
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Pot Number Reagent Programme 8 Programme 9
1 10 % (v/v) NBF 2 hours 1 hour
2 70 % Alcohol 2 hours 1 hour
3 90 % Alcohol 2 hours 1 hour
4 100 % Alcohol 2 hours 20 min 2 hours 20 min
5 100 % Alcohol 2 hours 20 min 3 hours 20 min
6 100 % Alcohol 5 hours 20 min 4 hours 20 min
7 Xylene 1 hour 1 hour
8 Xylene 1 hour 30 min 1 hour 30 min
9 Xylene 3 hours 2 hours
10 Molten Wax 1 hour 30 min 1 hour 30 min
11 Molten Wax 3 hours 2 hours
12 Molten Wax 1 hour 1 hour
Table 2.5: Tissue processor programme 8 and 9. All samples were immersed in
pots 1-12 for different amounts of time depending on the programme number. NBF:
Neutral buffered formalin (10 %).
2.2.7.3. Paraffin Wax Embedding
Once the tissue had completed processing, the histology cassettes were
removed from the tissue processor and transferred to molten wax in a wax
oven. Metal wax block moulds were filled with molten wax and the tissue
sample was placed in the wax in the correct orientation. The plastic cassette
base was placed on top of the mould and wax was added to the top of this. The
wax was left to cool and harden at room temperature. The wax block was
removed from the mould leaving the cassette base attached. Excess wax was
trimmed from the edges of the plastic base. The wax blocks were stored at
room temperature and cooled at -20 ºC for three hours before prior to
sectioning.
2.2.7.4. Sectioning of Paraffin Wax Blocks
The paraffin blocks were attached to the microtome in order to section the
blocks at a thickness of 5 µm. Once the sections were cut they were transferred
to a paraffin section mounting bath set at 40 ºC allowing them to float flat on the
water surface. The sections were mounted onto glass slides by dipping the slide
into the water allowing the section to adhere to the glass. The slides were
allowed to dry on a hotplate between 56 and 60 ºC for approximately three
hours.
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2.2.7.5. Haematoxylin & Eosin Staining
Slides containing tissue sections were placed into a slide holder and immersed
into dewax xylene (1) for 10 minutes, dewax xylene (2) for 10 minutes, 100 %
ethanol (1) for three minutes, 100 % ethanol (2) for two minutes and 100 %
ethanol (3) for two minutes and 70 % (v/v) ethanol for two minutes. The sections
were immersed in running tap water for three minutes and immersed into
haematoxylin for one minute. Sections were rinsed under tap water until the
water became clear. Sections were immersed in eosin for three minutes, 70 %
(v/v) ethanol for five seconds, 100 % ethanol (3) for one minute, 100 % ethanol
(2) for two minutes, 100 % ethanol (1) for three minutes, clean xylene (1) for 10
minutes and clean xylene (2) for 10 minutes. Each section was mounted using
DPX mountant and a coverslip was carefully placed on top. The slides were
viewed by light microscopy the following day.
2.2.7.6. Alcian Blue Staining
The appropriate slides, containing tissue sections up to 48 hours old, were
placed into a slide holder and immersed into dewax xylene (1) for 10 minutes,
dewax xylene (2) for 10 minutes, 100 % ethanol (1) for three minutes, 100 %
ethanol (2) for two minutes, 100 % ethanol (3) for one minute and 70 % (v/v)
ethanol for two minutes. The slides were placed under running tap water for
three minutes and immersed in alcian blue solution 1 % (w/v) for 15 minutes.
Slides were placed under running tap water for one minute before being rinsed
in distilled water. Slides were immersed in periodic acid for five minutes, rinsed
in distilled water three times and placed into Schiffs reagent for 15 minutes.
Slides were placed under running tap water for five minutes immersed into
haematoxylin for 90 seconds and rinsed under running tap water until the water
ran clear. Slides were immersed in 70 % (v/v) ethanol for five seconds, 100 %
ethanol (3) for one minute, 100 % ethanol (2) for two minutes, 100 % ethanol (1)
for three minutes, clean xylene (1) for 10 minutes, and clean xylene (2) for 10
minutes. Each section was mounted with DPX mountant and a coverslip was
placed on top. The slides were left to set overnight and viewed by light
microscopy the following day.
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2.2.7.7. Sirius Red/Miller’s Elastin Staining
Slides containing tissue sections were placed into a slide holder and immersed
into xylene for 10 minutes, twice. The slides were washed sequentially in 100 %
industrial methylated spirits for two minutes three times and 70 % (v/v) ethanol
for two minutes. Sections were immersed under running tap water for three
minutes and then into 5 % (v/v) potassium permanganate in distilled water for
five minutes before rinsing using distilled water. Sections were immersed into 1
% (v/v) oxalic acid in distilled water for two minutes before rinsing in distilled
water twice for one minute and four minutes. Sections were immersed in 70 %
(v/v) ethanol for one minute and 95 % (v/v) ethanol for one minute before
staining in Miller’s stain for one hour. Sections were rinsed in 70 % (v/v) ethanol
until they ran clear, immersed in 95 % (v/v) ethanol for one minute and rinsed
under running tap water for two minutes. Sections were stained in haematoxylin
for 10 minutes before being rinsed under running tap water for one minute and
rinsing in distilled water for 30 seconds. Sections were stained using 0.1 %
(w/v) picro Sirius red for one hour before rinsing in distilled water and blotting
dry. Finally the sections were immersed into 70 % (v/v) ethanol for five seconds
and into 100 % (v/v) industrial methylated spirits three times for five seconds,
two and three minutes before immersion into clean xylene for 10 minutes, twice.
All sections were mounted using DPX mountant and a glass cover slip and
viewed by light microscopy the following day.
2.2.7.8. Grading of Histological Sections for Tissue Degeneration
Histology sections were graded for degeneration following staining with H&E.
Transverse IVD sections were graded using the system shown in Table 2.6.
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Grade Fissures Cell clusters Demarcation Haematoxophilia
0 No fissures No cell clusters Clear demarcation No loss of
haematoxophilia
1 Fissures present
within the NP
Less than 25%
of cells formed
into clusters
Limited loss of
demarcation
Limited loss of
haematoxophilia
2 Fissures
extending to
junction of NP
and AF
25-75% of
cells formed
into clusters
Substantial loss of
demarcation
Substantial loss of
haematoxophilia
3 Fissures
extending to
within AF
Over 75% of
cells formed
into clusters
Complete loss of
demarcation
Complete loss of
haematoxophilia
Table 2.6: The histological grading system used for grading degeneration in
transverse IVD sections (Sive et al., 2002).
Each of the four degeneration features were given a grade out of three and
combined to give a total grade out of 12. Sagittal IVD sections were graded for
degeneration using the system shown in Table 2.7. A grade was given for each
of the four features and combined to give a total score out of 16. This number
was divided by four to give the final grade. Facet sections were graded for
degeneration using the grading system in Table 2.8. A grade was given for each
of the four features and combined to give a total score out of 16. This number
was divided by four to give the final grade.
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Table 2.7: The histological grading system used to grade degeneration in sagittal IVD sections. AF: Annulus fibrosus, BEP: boney end plate,
CEP: cartilage end plate, NP: Nucleus pulposus (Gries et al., 2000).
Grade AF NP CEP Margins/
Subchondral Bone
1 Intact lamellae, narrow inter-
lamellar matrix, intact AF
attachment, vessels only in outer
third
Homogeneity, absence of
clefting
Uniform thickness, intact
attachment to bone, uniform
calcification <1/5 of depth,
uniform cell distribution
Even thickness of BEP, lamellar
bone only, distinct junction with
CEP, few vascular intrusions into
CEP
2 Minor lamellar splitting and
disorganisation, minor widening
of matrix, minor disorganisation
of attachment, rim lesion without
reparative reaction
Minor clefting, minor cell
necrosis, minor posterior
displacement of AF, minor
chondron formation
Minor cartilage thinning, small
transverse fissures, irregular
thickening of calcified cartilage,
few invading vascular channels,
small chondrons
Slightly uneven BEP, schmorl’s
nodes, minimal remodelling of
BEP, small marginal
osteophytes
3 Moderate lamellar
disorganisation, moderate
widening of matrix, moderate
fissuring of attachment, radiating
fissures not involving outer third,
minimal chondroid metaplasia,
cystic degeneration, vessels in
outer and middle third, rim lesion
with minor reparative reaction
Moderate clefting, moderate cell
necrosis, cystic degeneration,
posterior displacement within
annulus, centripetal extension of
collagen, moderate chondron
formation
Marked cartilage thinning,
marked thickening of calcified
zone, many transverse fissures,
many vascular channels, many
chondrons.
Moderately uneven BEP,
vascularised schmorl’s nodes,
moderate trabecular thickening,
defect in bone lamellae, minimal
fibrosis tissue in marrow spaces,
medium sized osteophytes
4 Extensive lamellar
disorganisation, radiating tears
extending into outer third,
extensive chondroid metaplasia,
vessels in all zones, rim lesion
with marked reparative reaction
Complete loss of NP, loose body
formation, marked chondron
formation
Total loss of cartilage,
calcification of residual cartilage,
widespread fissuring
Marked uneven BEP, ossified
schmorl’s nodes, large
osteophytes, marked trabecular
thickening, marked fibrosis of
marrow spaces, cartilage
formation
Chapter 2
68
Table 2.8: The grading system used to grade degeneration in histological sections of the facets (Gries et al., 2000).
Grade Cartilage Osteochondral
Junction
Subchondral
Bone
Margins
1 Smooth intact surface, orderly
chondrocytes distribution,
orderly collagen framework
Uniform tidemark, calcification
<1/5 cartilage thickness
Uniform lamellar, subchondral
bone plate, uniform vascular
budding into cartilage
Smooth articular margin, normal
synovium, normal capsule
2 Tangential surface flaking,
minimal chondrocyte death, few
chondrons
Minimal irregularity of tidemark,
calcification 1/5-1/4 cartilage
Minor thickening of trabeculae,
small fissures at bone-cartilage
junction, occasional fibrous
tissue formation
Small osteophytes, minimal
capsular fibrosis
3 Fissures <1/2 total depth, loss of
cartilage <1/2 depth, moderate
chondrocytes death, many
chondrons
Marked irregularity of tidemark,
calcification ¼-1/2 cartilage
Moderate trabecular thickening,
woven bone formation, moderate
fibrous tissue formation
Moderate osteophytes, minimal-
moderate appositional new
bone, fibrocartilage formation,
moderate capsular fibrosis,
minimal-moderate synovial
thickening
4 Deep fissures, areas of total
cartilage loss, entensive
chondrocyte death
Calcification >1/2 cartilage Eburnation of exposed bone,
bone sclerosis, cysts, extensive
fibrosis
Extensive and large
osteophytes, marked
appositional new bone, marked
capsular thickening, marked
synovial thickening
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2.2.8. Cell Culture
2.2.8.1. Cell Isolation
The tissue was transferred to a class II safety cabinet and cut into 1 mm3 pieces
using a sterile scalpel. These were placed into solutions of Dulbecco’s modified
Eagle’s medium (DMEM) containing 0.1 % (w/v) collagenase and 0.1 % (w/v)
hyaluronidase and incubated on a rotator at 37 ºC (5% CO2 (v/v) in air)
overnight. The following day, the digested tissue solution was filtered by
passing through a 100 µm cell sieve. The cell suspension was centrifuged at
200 g for 10 minutes at room temperature. The supernatant was discarded and
the pellet was resuspended in 5 ml of supplemented DMEM culture medium
and transferred into 75 cm3 flasks.
2.2.8.2. Passage and Maintenance
Cells were cultured in standard 75 cm3 culture flasks at 37 ºC, 5 % (v/v) CO2 in
air. The culture medium used consisted of DMEM medium supplemented with
10 % FBS (v/v), 100 U.ml-1 penicillin, 100 U.ml-1 streptomycin and 2 mM L-
glutamine. Once cells had become confluent within their flasks, cells were
passaged. This was achieved by removing the medium by suction and washing
with 5 ml PBS. Once the PBS had been removed, 3 ml trypsin-EDTA 1X
solution was added and the flasks placed in an incubator at 37 ºC, 5 % (v/v)
CO2 in air for five minutes. The flask was viewed under a microscope to ensure
the cells had detached from the flask and 9 ml of culture medium was added.
Approximately 4 ml of the cell suspension was added to two new T-75 culture
flasks containing 16 ml of fresh culture medium and placed in an incubator at 37
ºC, 5 % (v/v) CO2 in air. The culture medium was changed the following day and
every two days after until the cells became confluent.
2.2.8.3. Cell Count and Viability
The cells were passaged (Section 2.2.8.2) and transferred to a sterile 60 ml pot
to ensure that aggregates of cells were separated by gentle pipetting. Cell
suspension (500 µL) and 500 µL of Trypan blue were mixed together in a bijoux
and 20 µL of the suspension was placed onto a haemocytometer. The number
of live cells, which had not taken up the dye, in 10 large squares was counted
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as shown in Figure 2.5. This number was divided by 10 to obtain the number of
cells in one large square and multiplied by the dilution factor of two. The number
was multiplied by 104 to give the number of cells per ml. In order to determine
the cell viability, the number of live cells and the total number of both live and
dead cells in 10 squares was counted. The number of live cells was divided by
the total number of cells and this was multiplied by 100.
Figure 2.5: A haemocytometer grid. The image shows all the visible squares used to
count cells. Two of these grids are present in a standard haemocytometer. In this
study, five red squares were used to count the cells for each grid. Therefore, ten red
squares were counted in total.
2.2.8.4. Cryopreservation
Cells were trypsinised by adding trypsin-EDTA solution and neutralising it with
culture medium once the cells had detached from their culture flasks. The cell
suspension was transferred to a centrifuge tube and centrifuged at 150 g for 10
minutes. The cells were resuspended in 10 % (v/v) dimethyl sulfoxide (DMSO)
in culture medium sterilised using a 0.2 µl filter. A viable cell count was
performed and the cell solution was transferred 1 ml at a time into cryovials so
that each contained up to 106 cells. The cryovials were transferred to a Mr
Frosty isopropanol cryopreservation container and then placed into a -80 ºC
freezer for 24 hours before being transferred to liquid nitrogen.
2.2.8.5. Cell Revival from Frozen
A frozen vial of cells was thawed in a 37 ºC water bath for approximately two
minutes. Culture medium (1 ml) was added into the cell vial and washed. The
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cell suspension was transferred into a 60 ml pot containing 10 ml of warm
medium. The cell suspension was transferred to a 75 cm3 culture flask and a
further 10 ml of warm medium was added to the flask. The flask was placed in
an incubator at 37 ºC, 5 % (v/v) CO2 in air.
2.2.9. Indirect Immunofluorecent Labelling of Cell Markers
2.2.9.1. Indirect Immunofluorescence
Cells were plated onto multi spot slides with each spot containing approximately
800 cells. The cells were fixed in 1:1 ice cold solution of acetone and methanol
for two minutes before being left to dry in a fume hood for one hour. The slides
were transferred to an air tight case before being stored at -20 ºC until required
for staining.
The slides were removed from the -20 ºC freezer and thawed at room
temperature for 30 minutes before being rinsed under running tap water for 10
minutes. The slides were transferred to four-well slide holders and each well
was flooded with TBS and incubated for five minutes at room temperature. The
TBS was decanted and replaced with permeabilisation buffer (Section 2.1.2)
and incubated for five minutes. This was removed and 10 µL of the primary
antibody, diluted in antibody diluent, was added to each spot on each slide and
incubated for one hour at room temperature in a moist environment. Each well
was flooded with Tween buffer (Section 2.1.2) and placed on a rocking table for
10 minutes at room temperature, this was repeated and then the buffer was
replaced with TBS (Section 2.1.2) for 10 minutes at room temperature, twice.
Secondary antibody (10 µL), diluted in antibody diluent (Section 2.1.2), was
added to each spot on each slide and the slide holder was covered with
aluminium foil and incubated for 30 minutes at room temperature in a moist
environment. The slide wells were flooded with Tween buffer twice and TBS
twice each for 10 minutes on the rocking table whilst the slide holder was
covered with foil. Hoechst dye (10 µL: 1 µg.ml-1), diluted in TBS, was added to
each spot on each slide and incubated in the dark for 10 minutes at room
temperature. The slides were finally washed with PBS three times, each for
three minutes, before mounting with DABCO-glycerol 9:1 and covering with a
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cover slip. The slides were kept in a box at 4 ºC overnight before being viewed
by fluorescent microscopy the following day.
2.2.9.2. Antibody Dilution Titrations
Cells were plated onto multi spot slides with each spot containing approximately
800 cells. The cells were fixed in 1:1 ice cold solution of acetone and methanol
for two minutes before being left to dry in a fume hood for one hour. The slides
were transferred to four well slide holders and each well was flooded with
distilled water and left for two minutes. The water was decanted and replaced
with permeabilisation buffer (Section 2.1.2) and incubated for five minutes at
room temperature. Permeabilisation buffer was removed and a thin piece of
paper towel was used to dry the spaces in between the spots on the slides.
Immediately after, 10 µL of the primary antibody diluted in TBS at 1:50, 1:100,
1:150 and 1:200 was added in this order to each of the four spots along three
columns of spots on the multi spot slides. After one hour, each well was flooded
with Tween buffer (Section 2.1.2) and placed on a rocking table for three
minutes and then replaced with TBS (Section 2.1.2) for three minutes twice. A
thin piece of paper towel was used to dry the spaces in between the spots on
the slides and immediately before 10 µL of secondary antibody diluted in TBS at
1:100, 1:200 and 1:300 was added in that order to each of the three rows to all
four spots on each row. The slide box was covered with aluminium foil and
incubated for 30 minutes at room temperature. The slide wells were flooded
with Tween buffer and TBS twice each for three minutes. A thin piece of paper
towel was used to dry the spaces in between the spots on the slides before 10
µL of Hoechst (1 µg/ml), diluted in TBS, was added to each spot on each slide
and incubated in the dark for 10 minutes at room temperature. The slides were
finally washed with TBS and distilled water, each for three minutes, before
mounting with DABCO-glycerol 9:1 and covering with a cover slip. The slides
were kept in a box at 4oC overnight before being viewed by fluorescent
microscopy the following day. All antibodies were diluted in antibody diluent.
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2.2.10. Immunohistochemical Analysis of Tissue Sections
2.2.10.1. DAKO EnVision Method
Paraffin wax sections of tissue on superfrost plus slides were dewaxed in two
sequential washes of xylene for 20 minutes in total. The sections were washed
in three sequential washes of 100 % methanol for three, two and two minutes
followed by 70 % ethanol for two minutes. The sections were washed under
running tap water for three minutes. Drops of ready-to-use proteinase K were
placed onto all tissue sections and incubated at room temperature for 20
minutes for antigen retrieval. All slides were immersed in 3 % (v/v) hydrogen
peroxide in PBS for 10 minutes before being immersed under running tap water
for three minutes. A hydrophobic barrier pen was used to draw a circle around
each section on each slide before rinsing in TBS for four minutes. Drops of dual
endogenous enzyme block were added to each section and incubated for 10
minutes at room temperature. All slides were washed with TBS for 10 minutes
on a rocking table twice. The appropriately diluted primary antibody was added
to each section and incubated at room temperature for one hour. All slides were
washed in 0.05 % (v/v) Tween in TBS for 10 minutes on a rocking table twice
followed by washing in TBS buffer for 10 minutes on a rocking table twice.
Drops of polymer-horse radish peroxidise (HRP) were added to each section
and incubated for 30 minutes at room temperature in the dark. The previous
wash step was repeated. The chromagen, 3,3-diaminobenzidene (DAB) was
added to each section and incubated for 10 minutes at room temperature. All
sections were washed in distilled water for four minutes, four times before being
immersed in haematoxylin for 10 seconds and washed under running tap water.
Slides were immersed in 70 % (v/v) ethanol for five seconds followed by
sequential washes in 100 % methanol for one, two and three minutes. Sections
were immersed in clean xylene for 20 minutes before mounting in clean DPX
mountant and a glass cover slip. Slides were viewed using light microscopy the
following day.
2.2.10.2. Streptavidin-Biotin Method
All slides were treated with xylene and washed sequentially in alcohol as
described previously (Section 2.2.10.1). Antigen retrieval was achieved using
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drops of ready-to-use proteinase K which were placed onto all tissue sections
and incubated at room temperature for 20 minutes. All slides were immersed in
3 % (v/v) hydrogen peroxide in distilled water for 10 minutes at room
temperature and rinsed under running tap water for five minutes. After circling
each section with a hydrophobic barrier pen, the slides were washed in TBS for
four minutes. Streptavidin block was added to all sections and allowed to
incubate for 10 minutes before rinsing in TBS for 10 minutes, three times. This
was repeated for the biotin block. The appropriately diluted primary antibody
was added to each section and incubated at room temperature for one hour.
After rinsing in TBS for 10 minutes, three times, the appropriately diluted
secondary antibody with 10 % (v/v) serum of the tissue source was added to
each section and incubated at room temperature for 30 minutes. The previous
washes were repeated. Horseradish peroxidise streptavidin was added to each
section and incubated at 37 ºC in a moist environment for 45 minutes. Previous
wash steps were repeated. DAB substrate was added to each section and
allowed to incubate for 20 minutes before the reaction was terminated by
immersing under running tap water for five minutes. All slides were immersed in
haematoxylin, washed in alcohol and immersed in clean xylene as previously
described (see Section 2.2.10.1.) before mounting with DPX mountant and a
glass cover slip. Slides were viewed using light microscopy the following day.
2.2.11. Assay for Sulphated GAGs (GAG assay)
FSUs for all assays were thawed intact overnight at 4 ºC before dissecting and
cutting the appropriate tissue into approximately 1 mm2 sized pieces. Finely cut
tissue (~10 mg) was placed into pre-weighed bijous and freeze dried for four to
five days until a constant dry weight was achieved. Papain (5ml; 50 U.ml-1) in
digestion solution (Section 2.1.2) was added and the mixture left to incubate in
a 60 ºC water bath for 48 hours alongside digestion solution-only negative
controls. Primary standard solution was made using 10 mg chondroitin sulphate
B and 10 ml GAG assay buffer (Section 2.1.2). This was diluted in a 1:10
dilution of in GAG assay buffer plus 50 U.ml-1 papain to give nine standard
concentrations of 0, 3.125, 6.25, 12.5, 25, 50, 100, 150 and 200 µg.ml-1. The
test solution was used neat and diluted at 1:10, 1:50, 1:100 and 1:500 in 1:10
50 U.ml-1 papain in GAG assay buffer. All standards, blanks and test solutions
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(40 µL) were added to a clear, flat-bottomed 96 well plate in triplicate. DMB dye
solution (250 µL; Section 2.1.2) was added to each well and placed on a plate
shaker at 60 rpm for two minutes. The optical densities of each well were
measured at 525 nm using a micro plate spectrophotometer. Blank values were
subtracted from all standard and test values before a standard curve was
plotted of chondroitin sulphate B concentration against absorbance. The
unknown values were interpolated using linear regression of the standard curve
before dilutions were factored and GAG concentrations were deduced.
2.2.12. µCT Analysis of FSUs
Scanco Medical µCT80 and µCT100 were used to scan the FSU specimens.
The µCT80 was originally used but developed a fault half way through the
study. This was then replaced with the µCT100 to scan the remaining
specimens.
The FSUs C6/C7, T11/T12 and L1/L2 from each spine used in the anatomical
study (Chapter 3) were scanned. Each FSU was placed into a cylinder-shaped
specimen holder and was kept in place by the use of damp foam pads to
prevent movement during scanning. Specimen holders of 73 mm and 88 mm
were used. The specimen holder was then either attached to a metal rod
(µCT80) or slotted into a position on a carousel (µCT100).
The following settings were used:
 Tube energy: 74 kVP, 114 µA
 Voxel size: 74 x 74 x 74 µm
 Integration time: 300 ms
 Resolution: Standard
 Filter: aluminium 0.5 mm (calibration 3)
All scans were analysed to determine the bone properties of the ovine vertebrae
for each FSU. This involved determining the thickness (in terms of number of
slices) of the vertebrae and then determining the middle slice. Once this was
achieved, the length across the vertebrae (of the middle slice) was measured in
order to determine the area of the circle which identified the region of interest to
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analyse. The range of slices which would give a depth of 1 cm was determined
and this circle was applied to each of the slices. Finally, the lower and upper
threshold values of bone and bone marrow were determined in order to
generate the values for total volume (TV), bone volume (BV), BV/TV, trabecular
number, trabecular spacing, trabecular thickness and hydroxyapetite (HA)
concentration.
In addition to bone properties, disc height was measured in three areas
including the left and right sides of the IVD and in the centre.
The facet joint gap was measured at six places for each facet joint as shown in
Figure 2.6. This was carried out for three slices in the scan each at equal
distance along the height of the left and right facet joint. A total of 18
measurements were taken for each facet joint.
Figure 2.6: A µCT image of a pair of ovine thoracic facets joints. The red lines
indicate where measurements were taken in mm.
2.2.13. Indentation Testing
In order to determine the deformation properties of facet cartilage, a method
previously developed in Mechanical Engineering at Leeds was adopted (Latif et
al., 2012).
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2.2.13.1. Pin Extraction
In order to test facet cartilage using indentation, pins of the facets were first
obtained. Pins were only obtained from cervical facets since these were the
only facets that had cartilage surfaces of sufficient area and flatness.
Throughout the pin extraction process, PBS was used to keep the facet
cartilage hydrated.
A pair of facet joints were separated and kept hydrated using a cloth soaked in
PBS on the facet surface. The facets were orientated in a metal block before
PMMA cement (Section 2.1.2.) was carefully added to mould them in place. The
pedicles were potted in the cement leaving the facets well above the cement
surface. Approximately 40 minutes later, the mould was removed from the block
and placed in a secure clamp. Hand held tools were used to mark the
circumference of the pin (4 mm diameter) on the cartilage surface. An electric
drill was then used to cut into the bone and remove the pin. The facet pins were
wrapped in paper towels soaked in PBS and stored in bijous at -20 ºC for up to
one week.
2.2.13.2. Indentation Test to Determine the Deformation Properties
An indentation test rig previously used to test 4 mm facet cartilage pins was
used as illustrated in Figure 2.7 (Latif et al., 2012).
Figure 2.7: The indentation test rig used to determine the indentation properties
of facet cartilage. LVDT: Linear variable differential transformer, PBS: Phosphate
buffered saline (adapted from Latif et al., 2012).
Indenter
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The facet pin was fitted in a specimen adapter and holder and tightened using
an Allen key. The specimen was then placed into a fixed-based fixture and filled
with PBS until the surface of the cartilage was covered.
A 2 mm flat indenter was fitted at the end of the force transducer giving a total
shaft weight of 0.24 N. Upon release of the indenter, the movement of the shaft
was monitored by the linear variable differential transformer (LVDT) and the
force monitored by the piezoelectric force transducer as shown in Figure 2.8.
Data from these were transferred through an analogue-to-digital converter and
stored in a computer using the software LabVIEW 8.0 (National Instruments
Corporation, Austin, Texas, USA). The test was run for approximately 60
minutes until equilibrium had been reached.
2.2.13.3. Needle indentation for Determination of Cartilage
Thickness
A needle tip with a diameter of 0.8 mm was used to determine the facet
cartilage thickness. The procedure for needle indentation was the same as that
described in Section 2.2.13.2 above.
The thickness measurement was determined by observing the difference in
position of the needle from when it contacted the cartilage surface to when it
reached the subchondral bone.
2.2.14. Degeneration Model of Ovine Facet Cartilage using Chondroitinase
ABC
Whole facets dissected as described in Section 2.2.5.2 were transferred into
universals containing 12.5 ml antibiotic solution (Section 2.1.2.). The universals
were placed on an orbital shaker (120 rpm) at 4 ºC for 18 hours. The solutions
were replaced with 12.5 ml 0.05 U.ml-1 chondroitinase ABC solution (Section
2.1.2.) and placed on an orbital shaker (120 rpm) at 37 ºC for 16 hours. All
facets were washed with PBS twice for 30 minutes on an orbital shaker (rpm
120) at 4 ºC. The facets were stored at -20 ºC on PBS moistened filter paper
until analysed.
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2.2.15. Statistical Analysis
All numerical data was analysed using GraphPad Prism software, version 6.0
and/or Microsoft Office Excel 2007.
The inter-rater reliability (kappa) test was performed to measure the level of
agreement between graders on the assignment of categories of a categorical
value (Chapter 3). The resulting value was between 0.1-0.
Kappa Interpretation
<0 Poor agreement
0.0-0.20 Slight agreement
0.21-0.40 Fair agreement
0.41-0.60 Moderate agreement
0.61-0.80 Substantial agreement
0.81-1.00 Almost perfect agreement
Table 2.9: The interpretation of kappa scores. Kappa measures the level of
agreement between graders on the assignment of categories of a categorical value.
All parametric numerical data are presented as means ± standard deviation.
One way analysis of variance was used for comparison of data from more than
two groups. Significance was accepted when the difference of the means was
less than 0.05. The Tukey’s multiple comparisons test was used in GraphPad
Prism to determine significant differences between the groups.
For percentage data, the data was arcsine transformed in order to fulfil the
assumption of normally distributed data, required by analysis of variance. The
arcsine transformed values were then averaged and the standard deviation was
calculated. The upper and lower limits were then calculated as follows:
 Upper limit = mean + standard deviation
 Lower limit = mean – standard deviation
The mean, upper and lower limits values were then back transformed to
percentages for presentation.
For data in the form of grades (analysis of degenerative changes using images
and histological sections), the data for different groups was compared using the
Kruskal-Wallis test followed by determination of difference between groups
(p<0.05) using the Dunn’s multiple comparisons test.
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Correlation coefficients between the age of sheep and parameters analysed
were determined using Spearman`s rank correlation (graded data) or Pearson’s
moment correlation (parametric data). The extent of the correlation from the r
values generated from these tests was determined using Table 2.10.
r value Correlation
0-0.4 No correlation
0.4-0.6 Weak correlation
0.6-0.8 Good correlation
0.8-1.0 Excellent correlation
Table 2.10: The significance of r values generated from the Spearman’s rank
correlation and Pearson’s moment correlation.
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2.3 Validation of Methodologies
The majority of the methods used during this study had not been previously
applied to ovine tissue or FSU tissue. It was therefore necessary to validate the
methods used as indicated below.
2.3.1. Determination of the Working Dilutions of Primary and Secondary
Antibodies using Indirect Immunofluorescence and
Immunohistochemistry
A range of primary antibody dilutions were tested against a range of secondary
antibody dilutions (using the method described in Section 2.2.9.2 and 2.2.10.2)
to determine the working concentrations for all primary antibodies used for
indirect immunofluorescence and as a guide to the dilution range for
immunohistochemistry. The antibodies were tested on FSU cells including facet,
CEP, NP and AF cells from a five to six year old sheep. Dilutions of the primary
antibody were 1:50, 1:100, 1:150 and 1:200 and dilutions of the secondary
antibodies were 1:100, 1:300 and 1:500. A chessboard method of recording the
result of each combination was used. Three positives were assigned for very
strong fluorescence, two positives were assigned for good fluorescence, one
positive was assigned for visible fluorescence and a negative for no
fluorescence. An example of the chessboard titration for antibodies to collagen
II is shown in Figure 2.8.
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A
primary antibody dilution:
secondary antibody dilution:
1:50 1:100 1:150 1:200
1:100 ++ ++ +++ +++
1:300 ++ - ++ +++
1:500 + + ++ ++
B
primary antibody dilution:
secondary antibody dilution:
1:50 1:100 1:150 1:200
1:100 + + ++ ++
1:300 ++ + ++ ++
1:500 + - + +
C
primary antibody dilution:
secondary antibody dilution:
1:50 1:100 1:150 1:200
1:100 ++ + ++ ++
1:300 + - ++ +
1:500 ++ + +++ ++
D
primary antibody dilution:
secondary antibody dilution:
1:50 1:100 1:150 1:200
1:100 ++ + ++ ++
1:300 + + ++ +
1:500 ++ + + +
Figure 2.8: Collagen II antibody titrations. Chessboard results A: facet cartilage
cells, B: CEP cells, C: NP cells, D: AF cells showing the combinations of 1:50, 1:100,
1:150 and 1:200 dilutions of primary antibody against 1:100, 1:300 and 1:500 diluted
secondary antibody. +++: very good fluorescence, ++: good fluorescence, +: positive
fluorescence, -: no fluorescence. The tables indicate that the best combination for all
cells was a 1:200 primary antibody dilution and 1:100 secondary antibody dilution.
The results of the titrations carried out for all other antibodies used to
characterise the FSU cells are summarised in Table 2.11.
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Antibody Primary Antibody
Dilution
Secondary
Antibody Dilution
Secondary
Antibody
CD44 1:50 1:500 Rabbit ant-rat
Chondroitin-6-
sulphate
1:200 1:300 Goat anti-
mouse
Collagen I 1:50 1:100 Goat anti-
mouse
Collagen III 1:100 1:300 Goat anti-rabbit
Collagen V 1:50 1:500 Goat anti-
mouse
Collagen VI 1:200 1:500 Goat anti-rabbit
Collagen X 1:50 1:100 Goat anti-
mouse
Desmin 1:50 1:300 Goat anti-
mouse
Fibronectin 1:200 1:500 Goat anti-
mouse
Osteocalcin 1:100 1:300 Goat anti-
mouse
SOX-9 1:50 1:300 Goat anti-rabbit
Table 2.11: Summary of all working primary and secondary antibody dilutions.
Antibody details are shown in Table 2.1.
2.3.2. Determination of the Effect of Passage Number on Expression of
Markers by FSU cells
Before characterising the FSU cells it was important to understand their
behavior in monolayer culture and whether expression of certain markers
changed with passage number. Previous work carried out on chondrocytes in
monolayer culture has shown that it is common for them to dedifferentiate to
fibroblasts at passage six (von der Mark, 1977; Nadzir et al., 2011). To
investigate this, the FSU cells including AF, NP, CEP and facet cartilage cells
from a five to six year old sheep were cultured in monolayer. Tissue was
selected from random FSUs to obtain a mixture of different cells types from
different levels to investigate. The cells were transferred onto multispot slides
and immunostained with antibodies specific for known chondrocyte markers
including chondroitin-6-sulphate, CD44, collagen I and II and SOX-9 at passage
four, six and eight. This was repeated for each cell type three times. In addition
to this, the morphology of the cells in the culture flasks was also monitored for
any changes. Examples of this are shown in Figure 2.9.
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Figure 2.9: Facet cartilage cells in monolayer culture. A: passage two, B: passage
three, C: passage four, D: passage five, E: passage six.
The images in Figure 2.9 show that the morphology of the cells remained thin
and elongated throughout passaging in monolayer culture. No changes were
observed in morphology between the passages.
The results obtained for the expression of various markers by the cells over
time in culture are summarised in Table 2.12.
BA C
D E
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Cell:
Passage:
Antibody:
F
4
F
6
F
8
C
4
C
6
C
8
A
4
A
6
A
8
N
4
N
6
N
8
CD44 +++ +++ - +++ +++ +++ +++ +++ +++ +++ +++ +++
Chondroitin
-6-sulphate
++ + ++ ++ + ++ ++ + ++ ++ + ++
Collagen I - ++ - - ++ - - ++ - - ++ -
Collagen II ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
SOX-9 ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
Table 2.12: The phenotype of all cell types. F: facet cartilage, C: CEP, A: AF, N: NP,
at passage four, six and eight based on immunofluorescent stain intensity: +++: very
good, ++: good, +: positive, -: negative.
The results from these studies showed that collagen type II and SOX-9
expression was maintained throughout all the passages. Chondroitin sulphate
expression was reduced at passage six but regained expression at passage
eight. CD44 expression was lost at passage eight for facet cartilage cells.
Collagen type I was not expressed at passage four or eight but was at passage
six. As some changes in expression of these markers were apparent at
passage six and collagen type I expression was not present at passage four, it
was concluded that FSU cells could be analysed reliably for up to four
passages.
The original indirect immunofluorescence method used in these preliminary
studies differed from that described in Section 2.2.9.1 (Method C). Originally,
the washing times between the addition of antibodies to the cells were only
three times each for three minutes (once in Tween buffer and twice in TBS).
Furthermore, the slides were not washed under running tap water for 10
minutes and the antibodies were diluted in TBS (Method A). Figure 2.10 show
examples of images obtained after using method A.
Chapter 2
86
Figure 2.10: CEP cells stained with three different primary antibodies using in
direct immunofluorescence using method A. A: Chondroitin-6-sulphate, B: Collagen
II, C: Collagen III. CEP: cartilage end plate. Method A was similar to that described in
Section 2.2.9.2 except the slides were not washed under running tap water for 10
minutes, the washing times were reduced to three times each for three minutes and the
antibodies were diluted in TBS.
Background staining was observed around the cells after using Method A
(Figure 2.10). As a result of this, the method was changed to Method B. Method
B involved washing the slides initially under running tap water for 10 minutes
prior to rinsing in TBS for five minutes. Primary antibodies were diluted in
antibody diluent (Section 2.1.2) and the washing steps were altered to two
washes with tween buffer for 10 minutes each and two washes in TBS for 10
minutes each. In addition to this, permeabilisation buffer was excluded from the
method as it was thought to disturb the morphology of the cells.
Following the revised procedure (Method B), examples of the resulting images
are shown in Figure 2.11.
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Figure 2.11: AF cells immunostained with three different primary antibodies
using in direct immunofluorescence Method B. A: Chondroitin-6-sulphate, B:
Collagen II, C: Collagen X. AF: Annulus fibrosus. Method B differed from Method A in
that the slides were initially washed under running tap water, antibodies were diluted in
antibody diluent, washing times were increased to 10 minutes and permeabilisation
buffer was not used.
The images in Figure 2.11 show that the immunofluorescent stain was not
sufficiently been taken up by the cells. This was likely due to the elimination of
permeabilisation buffer from the staining procedure. As a result, the same
method was used in future characterisation experiments but an extra step was
included by incubating the slides with permeabilisation buffer for five minutes
prior to the addition of the primary antibody (Method C: Section 2.2.9.1).
2.3.3. Validation of Methods for the Immunohistochemical Staining of
Tissues Sections
All antibodies were optimised on control tissue sections (Table 2.3.). The initial
method used to detect selected tissue markers using antibodies was the
Streptavidin-Biotin method (Section 2.2.10.2.). As this did not give rise to any
positive staining for all antibodies, the DAKO Envision method was then used
(Section 2.2.10.1.).
Collagen II
Detection of collagen II was initially carried out on ovine femoral head cartilage
using the DAKO Envision method without antigen retrieval (Figure 2.10A and
2.10B). The resulting images showed that only very faint staining was observed
throughout the cartilage in comparison with the isotype control. As a result of
this, proteinase K was used for antigen retrieval (Section 2.2.10.3.). The
resulting images of this showed much darker staining in comparison to the
CBA
Chapter 2
88
isotype control and sections without proteinase K treatment (Figure 2.12). The
staining was observed throughout the cartilage as predicted and therefore the
antibody was concluded to be validated using this method.
Figure 2.12: The validation of immunohistochemical staining using antibodies to
collagen II on ovine femoral head cartilage. A: Collagen II (1:200) labelled ovine
femoral head cartilage using the Envision method. B: IgG1 (1:100) labelled ovine
femoral head cartilage using the Envision method. C: Collagen II (1:200) labelled ovine
femoral head cartilage using the Envision method and proteinase K antigen retrieval.
D: IgG1 (1:100) labelled ovine femoral head cartilage using the Envision method and
proteinase K antigen retrieval.
Chondroitin-6-Sulphate
Detection of chondroitin-6-sulphate was initially carried out on ovine femoral
head cartilage using the DAKO Envision method without antigen retrieval
(Figure 2.13A and 2.13B). The resulting images showed that no staining was
observed in comparison to the isotype control. As a result of this, proteinase K
was used for antigen retrieval (Figure 2.13A and 2.13B). After this, the staining
appeared much darker in colour when compared to the isotype control. The
staining was present mainly in the superficial, transitional and deep zones. This
is where it was expected and therefore the antibody was concluded to be
validated using this method.
A DCB
Chapter 2
89
Figure 2.13: The validation of immunohistochemical staining using antibodies to
chondroitin-6-sulphate on ovine femoral head cartilage. A: Chondroitin-6-sulphate
(1:200) labelled ovine femoral head cartilage using the Envision method. B: IgG1 (neat)
labelled ovine femoral head cartilage using the Envision method. C: Chondroitin-6-
sulphate (1:200) labelled ovine femoral head cartilage using the Envision method and
proteinase K antigen retrieval. D: IgG1 (neat) labelled ovine femoral head cartilage
using the Envision method and proteinase K antigen retrieval.
Collagen I
Detection of collagen I was initially carried out on ovine spinous ligament using
the DAKO Envision method without antigen retrieval (Figure 2.14A and 2.14B).
The resulting images showed no positive staining. As a result, proteinase K
antigen retrieval was used to improve this (Figure 2.14C and 2.14D). The
results showed that after proteinase K antigen retrieval, the tissue was still not
stained positively for collagen I. The primary collagen I antibody was then
incubated overnight at 37 ºC to test whether this might give rise to positive
staining. The results from this showed that the ligament was intensely stained
with collagen I after proteinase K treatment and overnight incubation of the
primary antibody at 37 ºC in comparison to the isotype control (Figure 2.14E
and 2.14F). Therefore, this was concluded to be the method for collagen I
staining was validated for ovine tissues.
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Figure 2.14: The validation of immunohistochemical staining using antibodies to
collagen I on ovine spinous ligament. A: Collagen I (1:50) labelled ovine ligament
using the Envision method. B: IgG1 (1:5) labelled ovine ligament using the Envision
method. C: Collagen I (1:50) labelled ovine ligament using the Envision method and
proteinase K antigen retrieval. D: IgG1 (1:5) labelled ovine ligament using the Envision
method and proteinase K antigen retrieval. E: Collagen I (1:50) labelled ovine ligament
using the Envision method, proteinase K antigen retrieval and 24 hour incubation at 37
ºC. F: IgG1 (1:5) labelled ovine ligament using the Envision method, proteinase K
antigen retrieval and 24 hour incubation at 37 ºC.
Collagen III
Detection of collagen III was initially carried out on ovine ligament tissue using
the DAKO Envision method without antigen retrieval. With this approach, no
positive staining was observed (Figure 2.15A and 2.15B). The procedure was
repeated using proteinase K for antigen retrieval (Figure 2.15C and 2.15D)
however the results showed a similar negative result. To improve the staining, a
lower dilution of 1:50 instead of 1:100 of collagen III was used alongside
proteinase K antigen retrieval (Figure 2.15E and 2.15F). The result of this was
negative when compared to the isotype control and it was concluded that false
positive staining was present in the negative control. To eliminate this, prior to
the addition of the primary antibody, the slides were incubated with 20 % (v/v)
swine serum in antibody diluent for five minutes before washing in TBS for three
minutes. Using this method staining was observed to be positive in the outer
regions of the ligament in comparison to the isotype control (Figure 2.15G and
2.15H).
A CB
E
D
F
Chapter 2
91
Figure 2.15: The validation of immunohistochemical staining using antibodies to
collagen III on ovine spinous ligament. A: Collagen III (1:100) labelled ovine
ligament using the Envision method. B: IgG (1:100) labelled ovine ligament using the
Envision method. C: Collagen III (1:100) labelled ovine ligament using the Envision
method and proteinase K antigen retrieval. D: IgG (1:100) labelled ovine ligament using
the Envision method and proteinase K antigen retrieval. E: Collagen III (1:50) labelled
ovine ligament using the Envision method and proteinase K antigen retrieval. F: IgG
(1:50) labelled ovine ligament using the Envision method and proteinase K antigen
retrieval. G: Collagen III (1:50) labelled ovine ligament using the Envision method,
proteinase K antigen retrieval and blocking with swine serum. H: IgG (1:50) labelled
ovine ligament using the Envision method, proteinase K antigen retrieval and blocking
with swine serum.
Collagen VI
Detection of collagen VI was initially carried out on ovine femoral head cartilage
using the DAKO Envision method without antigen retrieval. The results using
this method showed staining around the lacunae in the cartilage (Figure 2.16A
and 2.16B). However, the intensity of the stain was not as strong as expected.
Therefore, the method was repeated with proteinase K antigen retrieval. The
results from this showed a greater intensity of staining around the lacunae but
also staining within the ECM (Figure 2.16C and 2.16D). As the isotype control
also gave rise to positive staining within the ECM this was concluded to be due
to non-specific binding. As a result, 20 % (v/v) swine serum in antibody diluent
was added prior to the addition of primary antibody and incubated for five
minutes before washing with TBS for three minutes. Using this method, the
staining around the lacunae of the cells was intense and the background
staining in the ECM was eliminated in both the antibody and isotype control
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samples (Figure 2.16E and 2.16F). Therefore, this method was concluded to be
the optimal one for use with collagen VI antibodies.
Figure 2.16: The validation of immunohistochemical staining using antibodies to
Collagen VI on ovine femoral head cartilage. A: Collagen VI (1:200) labelled ovine
femoral head cartilage using the Envision method. B: IgG (1:200) labelled ovine
femoral head cartilage using the Envision method. C: Collagen VI (1:200) labelled
ovine femoral head cartilage using the Envision method and proteinase K antigen
retrieval. D: IgG (1:200) labelled ovine femoral head cartilage using the Envision
method and proteinase K antigen retrieval. E: Collagen VI (1:200) labelled ovine
femoral head cartilage using the Envision method, proteinase K antigen retrieval and
blocking with 20 % (v/v) swine serum for five minutes prior to primary antibody
incubation and washing in TBS for three minutes. F: IgG (1:200) labelled ovine femoral
head cartilage using the Envision method, proteinase K antigen retrieval and blocking
with 20 % (v/v) swine serum for five minutes prior to primary antibody incubation and
washing in TBS for three minutes.
Collagen X
Staining for collagen X was initially carried out on ovine femoral head cartilage
using the DAKO Envision method without antigen retrieval. The results from this
showed faint staining in the calcified zones in comparison to the isotype control
(Figure 2.17A and 2.17B). In an attempt to intensify the staining in the calcified
zone, proteinase K was used for antigen retrieval. The results from this showed
positive staining in the calcified zone in comparison to the isotype control but
also staining in the ECM which was not expected (Figure 2.17C and 2.17D). In
addition to this, staining was observed around the cells within the cartilage in
the isotype control. As a result, the method was repeated with proteinase K
antigen retrieval and blocking with 20 % (v/v) swine serum in antibody diluent
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for five minutes and washing with TBS for three minutes prior to the addition of
primary antibody.
Figure 2.17: The validation of immunohistochemical staining using antibodies to
collagen X. on ovine femoral head cartilage A: Collagen X (1:50) labelled ovine
femoral head cartilage using the Envision method. B: IgM (1:3) labelled ovine femoral
head cartilage using the Envision method. C: Collagen X (1:50) labelled ovine femoral
head cartilage using the Envision method and proteinase K antigen retrieval. D: IgM
(1:3) labelled ovine femoral head cartilage using the Envision method and proteinase K
antigen retrieval.
Desmin
Detection of desmin was initially carried out on ovine spinous muscle using the
DAKO Envision method without antigen retrieval. The results using this
approach showed no positive staining in comparison with the isotype control
(Figure 2.18A and 2.18B). Therefore the method was repeated using proteinase
K as antigen retrieval. The results showed intense positive staining in
comparison to the isotype control (Figure 2.18C and 2.18D). This method was
therefore concluded to be validated for use of desmin antibodies on ovine
tissue.
Figure 2.18: The validation of immunohistochemical staining using antibodies to
desmin on ovine spinous muscle. A: Desmin (1:50) labelled ovine muscle using the
Envision method. B: IgG1 (neat) labelled ovine muscle using the Envision method. C:
Desmin (1:50) labelled ovine muscle using the Envision method and proteinase K
antigen retrieval. D: IgG1 (neat) labelled ovine muscle using the Envision method and
proteinase K antigen retrieval.
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Fibronectin
Detection of fibronectin was initially carried out on ovine ligament tissue using
the DAKO Envision method without antigen retrieval. The results from this
approach showed no positive staining within the ligament tissue (Figure 2.19A
and 2.19B). The experiment was repeated using proteinase K antigen retrieval
which showed darker staining around the edges of the tissues in comparison to
the isotype control (Figure 2.19C and 2.19D). Therefore this method was
concluded to be validated for use of fibronectin antibodies on ovine tissues.
Figure 2.19: The validation of immunohistochemical staining using antibodies to
fibronectin on ovine spinous ligament. A: Desmin (1:50) labelled ovine ligament
using the Envision method. B: IgG1 (neat) labelled ovine ligament using the Envision
method. C: Fibronectin (1:200) labelled ovine ligament using the Envision method and
proteinase K antigen retrieval. D: IgG1 (neat) labelled ovine ligament using the
Envision method and proteinase K antigen retrieval.
Osteocalcin
Detection of osteocalcin was initially carried out on ovine femoral head bone
using the DAKO Envision method without antigen retrieval. The results using
this approach showed no positive staining when compared to the isotype control
(Figure 2.20A and 2.20B). As a result, proteinase K was used as an antigen
retrieval method. This method gave a dark positive stain in comparison to the
isotype control (Figure 2.20C and 2.20D). Therefore, this method was
concluded to be validated for the use of osteocalcin antibodies on ovine tissue.
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Figure 2.20: The validation optimisation of immunohistochemical staining
antibodies to osteocalcin on ovine femoral head bone using. A: Osteocalcin
(1:100) labelled ovine bone using the Envision method. B: IgG1 (neat) labelled ovine
bone using the Envision method. C: Osteocalcin (1:100) labelled ovine bone using the
Envision method and proteinase K antigen retrieval. D: IgG1 (neat) labelled ovine bone
using the Envision method and proteinase K antigen retrieval.
2.3.4. Validation of Papain Digestion Method and Diluent for use in the
GAG Assay
The assay for determination of sulphated GAGs used in this study had
previously been developed for the determination of GAGs in articular cartilage
from hip and knee tissues (Section 2.2.11.1). As the surface area of the facets
are considerably smaller in comparison to articular surfaces found in the hip and
knee, a smaller amount of cartilage was available for the GAG assay to quantify
the amount of GAGs present. Therefore, for the GAG assay, it was likely that
the sample would not require dilution (Section 2.2.11). However, this in turn
meant that the crude papain, used initially to digest the cartilage, might interfere
with the absorbance readings. In order to determine whether crude papain
interfered with absorbance readings, three standard curves were obtained. The
first curve represented standards diluted in GAG assay buffer, the second were
standards diluted in neat 50 U.ml-1 papain solution and lastly the third curve
represented standards diluted in a 1:10 dilution of 50 U.ml-1 papain solution.
The curves obtained from these studies are shown in Figure 2.21.
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Figure 2.21: Standard curves for chondroitin sulphate B against absorbance at
525 nm. Chondroitin sulphate B was diluted in A: GAG assay buffer, B: neat 50 U.ml-1
papain solution, C: 1:10 50 U.ml-1 papain solution.
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The results from this experiment suggested that neat papain solution had a
significant effect on the absorbance readings as shown in Figure 2.21B. As a
result, standards were diluted in a 1:10 dilution of 50 U.ml-1 papain solution in all
future studies to take into account absorbance that may have resulted from the
presence of papain.
Lastly, in order to ensure all facet cartilage was fully digested in 50 U.ml-1
papain solution, an experiment was carried out using the GAG assay to test
facet cartilage that had been digested using 50 U.ml-1 and 60 U.ml-1 crude
papain. Facet cartilage, previously freeze dried from a T3/T4 left inferior facet of
a three year old sheep, was digested in 50 U.ml-1 and facet cartilage previously
freeze dried from a T3/T4 right inferior facet of a three year old sheep, was
digested in 60 U.ml-1 solution of papain. Both samples were analysed alongside
two controls containing 50 U.ml-1 and 60 U.ml-1 papain only digestion solutions.
The results from this experiment indicated that there was no increase in the
amount of GAGs from the 60 U.ml-1 papain digested cartilage (0.064 mg.mg-1)
in comparison to the 50 U.ml-1 papain digested cartilage (0.071 mg.mg-1). In
addition to this, remaining undigested tissue was tested by staining with Von
Kossa. The staining was positive confirming that any remnants after digestion
were due to calcified tissue rather than undigested cartilage.
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Chapter 3: Anatomical Study of Ovine
FSUs
3.1. Introduction
Previous work has been carried out to compare ovine and human spines (Alini
et al., 2008; Hasler et al., 2010; Sheng et al., 2010; Wang et al., 2010; Bai et al.,
2012). Due to the similarities between these species, as discussed in Section
1.7, the sheep is an ideal animal model for the human spine. Ovine spines can
be obtained from animals of different ages. This offers the potential to ultilise
spines from animals of different ages as models for healthy and degenerate
FSUs and facet cartilage. In addition, a variety of sheep breeds exist which may
exhibit differences in spinal tissues due to variations in size and shape.
The sheep breeds analysed in this study included the breeds which could be
obtained from the local abattoir. These were the Charollais, Suffolk, Texel and
Hebridean breeds as shown in Figure 3.1.
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Figure 3.1: Four different breeds of sheep used in the study. A: Suffolk, B: Texel,
C: Charollais, D: Hebridean (http://www.nationalsheep.org.uk/sheep-breeds.php).
The Suffolk, Texel and Charollais breeds are of similar size weighing between
85-95 kg at maturity. The Texel and Suffolk sheep are bred for meat production
with the Suffolk also being used for wool. The Texel sheep produce lean meat.
The Charollais breed, originating from France, is used primarily for cross
breeding ewes and rams to produce quality meats. The Hebridean breed sheep
are considerably smaller than the Suffolk, Texel and Charollais sheep with an
average weight of 40 kg at maturity. They are not used for their meat but
instead to maintain grassland. For this reason, they are kept longer and are
generally older than the other three breeds.
The initial stage of the study was to determine the age of sheep which would
provide healthy tissue and that which would provide degenerate tissue. This
would enable a detailed characterisation study of healthy ovine facet cartilage
and IVD tissue to be carried out (Chapter 4).
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3.2. Aims and Objectives
The aim of the work described in this chapter was to analyse ovine FSUs of
different ages and breeds to determine whether age and breed have an effect
on the health of facet cartilage, CEP, IVD and bone within FSUs. The ultimate
aim was to determine the age of animal which would provide healthy tissues
and that which would provide degenerated tissues for the future development of
in vitro models.
Specific Objectives:
 Analyse the morphology of FSUs from cervical, thoracic and lumbar
regions of different ages and breeds of sheep including the whole FSU,
IVD and facet joints.
 Analyse and grade degeneration using H&E stained transverse sections
of IVDs from cervical, thoracic and lumbar regions of different ages and
breeds of sheep.
 Analyse and grade degeneration using H&E stained sagittal sections of
IVDs from cervical, thoracic and lumbar regions of different ages and
breeds of sheep.
 Analyse and grade the morphological degeneration of facets from
cervical, thoracic and lumbar regions of different ages and breeds of
sheep.
 Analyse and grade degeneration using H&E stained sections of facet
cartilage from cervical, thoracic and lumbar regions of different ages and
breeds of sheep.
 Scan whole FSUs from cervical, thoracic and lumbar regions of different
ages and breeds of sheep to determine the properties of the bone, IVD
height and facet joint space distance.
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3.3. Experimental Approach
The sheep spines included in this study were limited by the availability of spines
from sheep of different ages and breeds. The sheep spines used in the study
were divided into four age groups. These were 0-1, 3-4, 5-6 and 8-10 years of
age. For each group, other than the three to four year group (n=9), three spines
of the appropriate age were analysed. Various breeds of ovine spines were in
the age groups. In the 0-1 year age group, the spines were all from the
Charollais breed. In the 3-4 year age group, replicates one to three were from
Charollais sheep, replicates four, eight and nine from Suffolk sheep and
replicates five to seven were from Texel sheep. In the 5-6 year age group,
replicate one was a Suffolk, two was a Texel and three was a Suffolk. In the 8-
10 year age group all spines were obtained from Hebridean sheep. For the 3-4
year old age group, the effect of sheep breed was investigated. This involved
analysing three Charollais, Texel and Suffolk spines giving a total of nine for the
group. It was important to determine whether the characteristics of the tissue
changed with breed as well as age.
For each spine, the cervical, thoracic and lumbar regions were analysed. FSUs
C4/C5, T8/T9 and L3/L4 were selected for H&E staining of transverse IVD
sections and photography of the whole FSU, dissected FSU and IVD. These
FSUs were dissected and fixed immediately after obtaining the spine
(approximately one day after slaughter). FSUs C6/C7, T11/T12 and L1/L2 were
selected for µCT scanning, H&E staining of sagittal IVD and facet sections and
photography of the facet surfaces. These FSUs were dissected whole and
immediately stored at -20 ºC until being thawed for µCT scanning. They
underwent another freeze/thaw cycle in order to cut 2 mm sagittal IVD slices
followed by dissection of the left inferior facet to cut 2 mm facet slices. The
grading systems used to grade all histological sections and images of the facets
have been described in Section 2.2.7.8. Details of histology have been
described in Section 2.2.7.1-2.2.7.5 and µCT analysis in Section 2.2.12.
As the grading data was non-parametric and divided into six unmatched groups
(each with n=3), the Kruskal-Wallis test was used to assess whether there was
any significant variation in the data, followed by post hoc testing using Dunn`s
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test to determine individual difference between group means (p< 0.05). If
significant variation was not found in the data for the three breeds in the 3-4
year age group, data from the different breeds of sheep were combined.
Spearman’s rank correlation was chosen to identify the strength of the
relationship between grade and age and whether any correlations were present.
For the parametric µCT data including HA concentration, IVD height and facet
joint space, analysis of variance was used to determine any significant variation
in the data from the different age groups and breeds groups. This was followed
by calculation of the minimum significant difference between means (p<0.05;
p<0.01). For this data correlations between age and the parameter measured
were determined using the Pearson`s moment correlation.
For BV/TV, as this data was a proportion and therefore did not meet the
assumptions of analysis of variance the data was subject to arcsine
transformation and analysis of variance of the transformed data. Since the
BV/TV data was not parametric, correlation with age analysis was by
Spearman`s rank correlation.
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3.4. Results
3.4.1. Morphological Analysis of FSUs using Photography
The FSUs C4/C5, T8/T9 and L3/L4 were photographed intact and separated for
each sheep spine. The facets and IVDs were then photographed separately.
Examples of the images captured from the cervical, thoracic and lumbar regions
of a three year old Texel sheep are shown in Figure 3.2.
Figure 3.2: Images of FSUs from a three year old Texel sheep. A: C4/C5, B: T8/T9,
C: L3/L4, i: Intact FSU, ii: separated FSU, iii: IVD. FSU: Functional spinal unit, IVD:
Intervertebral disc.
In general, differences were observed between cervical, thoracic and lumbar
FSUs from all ages and breeds of sheep. In the cervical region, the FSUs
appeared straight and had no transverse processes. The vertebrae and
surrounding pedicles were bulky and thick. The spinous processes were short.
The facets were round and flat with a large surface area. The cervical IVDs
were curved around the vertebrae and were thick in comparison to both the
A.ii A.iii
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thoracic and lumbar IVDs. The thoracic FSUs were much shorter in vertebral
height and contained long spinous processes. The transverse processes were
replaced with ribs which extended outwards and had been removed from the
tissue during dissection as shown in Figure 3.2.B.ii. The pedicles and laminal
arches were less bulky in comparison to cervical FSUs. The facets appeared
much smaller and had an arch-like shape that was curved. The IVDs appeared
flat, smaller and thinner in appearance in comparison to those in the cervical
FSUs. The lumbar FSUs by comparison were larger containing long, flat
transverse processes. The vertebrae also appeared long and the spinous
processes short but flat and thick. The inferior facets were bulky and appeared
tall and slightly curved. The superior facets were observed to be completely
curved all the way around the inferior facets. As with the thoracic facets there
was no flat surface. The lumbar IVDs were very similar to the thoracic IVDs in
that they were flat but had a larger surface area and were thicker. Lumbar FSUs
of different age groups are shown for comparison in Figure 3.3.
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Figure 3.3: Images of lumbar L3/L4 FSUs from 0-1, 3-4, 5-6 and 8-10 year old
sheep. A: 0-1 year old (Charollais), B: 3-4 years old (Charollais), C: 5-6 years old
(Texel), D: 8-10 years old (Hebridean), i. intact FSU, ii. separated FSU, iii. transverse
IVD. FSU: Functional spinal unit, IVD: Intervertebral disc.
No morphological differences were observed in the intact and separated FSUs
between the ages in the three different regions. However, differences were
observed in the IVDs. In all regions, 0-1 year old IVDs appeared thick enough to
be removed from their vertebral body with the NP white and gelatinous in
appearance. With age, the NP became more fibrous and yellow in colour. At
five to six years of age, the IVD became too thin to be removed from the
vertebral body as an intact tissue.
B.iii.B.ii.B.i.
A.iii.A.ii.A.i.
C.iii.C.ii.C.i.
D.iii.D.ii.D.i.
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3.4.2. Grading of Haematoxylin and Eosin Stained Sections of Transverse
IVDs for Degeneration
Whole intact IVDs were removed from the FSUs C4/C5, T8/T9 and L3/L4.
These were then prepared by fixing, tissue processing, embedding, sectioning
and staining with H&E (Section 2.2.7.5). All transverse sections of each IVD
were observed and graded blindly (Section 2.2.7.8) by two independent trained
graders. The inter-rater reliability (kappa) test was performed on all the data
from both graders. The kappa score was 0.04 (p=0.716), showing there was
slight agreement between the two graders.
The degeneration grading results for the transverse sections of cervical IVD are
shown in Figure 3.4.
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Figure 3.4: The distribution of grading scores for H&E stained sections of ovine
cervical (C4/C5) transverse IVDs in four age groups and three breeds of 3-4 year
old sheep. A: The distribution of grades for each age and breed group (n=3). The
age/breed group data was analysed using the Kruskal-Wallis test (p=0.8814) which
found no significant variation in the data. B: The distribution of grades for each age
group. The data was analysed using Spearman’s rank correlation (r=0.2699) which
found no correlation between the grade and age of sheep. H&E: Haematoxylin and
eosin, IVD: Intervertebral disc.
No variation was found in the degeneration grade of the transverse sections of
the cervical IVDs from sheep of different ages or between the breeds of the 3-4
year age group (Kruskal-Wallis test p=0.88). There was no correlation between
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the degeneration grade and age (r=0.27; Spearman`s rank correlation). The
data was evenly spread and high grades (above 1.5) were assigned to the
degeneration in the transverse sections of the IVDs across the age groups. As a
result, no trend was observed.
The degeneration grading results for the transverse sections of thoracic IVDs
are shown in Figure 3.5.
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Figure 3.5: The distribution of degeneration grading scores for H&E stained
sections of ovine thoracic (T8/T9) transverse IVDs in four age groups and three
3-4 year old breeds of sheep. A: The distribution of grades for each age and breed
group (n=3). The age/breed group data was analysed using the Kruskal-Wallis test
(p=0.9951) which found no significant variation between the age and breed groups. B:
The distribution of grades for each age group. The data was analysed using
Spearman’s rank correlation (r=-0.0495) which found no correlation between grades
and age. H&E: Haematoxylin and eosin, IVD: Intervertebral disc.
No significant variation was found in the degeneration grades of the transverse
sections of the thoracic IVDs between the age groups or between the breeds of
the 3-4 year age group (Kruskal-Wallis test p=0.10). There was no correlation
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between degeneration grade of the histological sections of the transverse
sections of the IVDs (r= -0.05). Similarly to the cervical sagittal IVD sections, the
data was spread relatively evenly across all age groups. The data in the 3-4
year age group was particularly spread across the different grades from 0.75 to
2.00.
The degeneration grading results for the transverse sections of the lumbar IVDs
are shown in Figure 3.6.
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Figure 3.6: The distribution of degeneration grading scores for H&E stained
sections of ovine lumbar (L3/L4) transverse IVDs in all four age groups and three
3-4 year old breeds of sheep. A: The distribution of grades for each age and breed
group (n=3). The age/breed group data was analysed using the Kruskal-Wallis test
(p=0.3211) which found no variation between the age and breed groups B: The
distribution of grades for each age group. The data was analysed using Spearman’s
rank correlation (r=0.4226) which indicated a weak positive correlation between age
and grade. H&E: Haematoxylin and eosin, IVD: Intervertebral disc.
No variation was observed between the degeneration grades of the transverse
sections of the lumbar IVDs of different age groups or between the breeds of
the 3-4 year age group (Kruskal-Wallis test; p=0.32). The grades were generally
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more spread between the grades than those in the cervical and thoracic IVDs
with grades in the 0-1 and 3-4 year age groups as low as 0.25. There was a
weak positive correlation of increasing grade with age (r=0.42; Spearman`s rank
correlation). The grade increased at 5-6 years of age with the lowest grades in
the older age groups increasing from 0.25 to 0.625.
3.4.3. Grading of Haematoxylin and Eosin Stained Sections of Sagittal
IVDs for Degeneration
Sagittal sections (2 mm thick) were obtained from FSUs C6/C7, T11/T12 and
L1/L2 from each age group. These were fixed overnight before being decalcified
in 12.5 % (v/v) EDTA for two weeks. The samples were then tissue processed,
embedded in paraffin wax, sectioned at 5 µm and stained with H&E. Each
section was graded (Section 2.2.7.8) blind by two independent trained graders.
The inter-rater reliability (kappa) test was performed on all the data from both
graders. The kappa score was 0.278 (p=0.007), showing there was fair
agreement between the two graders.
The degeneration grading results for the cervical sagittal IVDs are shown in
Figure 3.7.
Chapter 3
114
0-1
ye
ar
old
3-4
ye
ar
old
Ch
aro
lla
is
3-4
ye
ar
old
Su
ffo
lk
3-4
ye
ar
old
Te
xe
l
5-6
ye
ar
old
8-1
0 y
ea
r o
ld
Figure 3.7: The distribution of degeneration grading scores for H&E stained
ovine cervical (C6/C7) sagittal IVD sections in four age groups and three 3-4 year
old breeds of sheep. A: The distribution of grades for each age and breed group
(n=3). The age/breed group data was analysed using the Kruskal-Wallis test
(p=0.0254) which revealed a significant difference between the 0-1 year and 5-6 year
age group. B: The distribution of grades for each age group. The data was analysed
using Spearman’s rank correlation (r=0.6285) which showed a good positive correlation
between the grades and age. H&E: Haematoxylin and eosin, IVD: Intervertebral disc.
There was a significant difference between the degeneration grade of the 0-1
and 5-6 year old age group sagittal sections of the cervical IVDs (Kruskal-Wallis
test), indicating an increase in grade with age. However, no significant
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differences were found between the 8-10 year old age group and the other five
groups. No significant differences were observed between the three breeds in
the 3-4 year age group. There was a good positive correlation of increasing
grade with age (r=0.63; Spearman`s rank correlation).
The degeneration grading results for the sagittal sections of the thoracic IVDs
are shown in Figure 3.8.
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Figure 3.8: The distribution of degeneration grading scores for H&E stained
ovine thoracic (T11/T12) sagittal IVD sections in four age groups and three 3-4
year old breeds of sheep. A: The distribution of grades for each age and breed group
(n=3). The age/breed group data was analysed using the Kruskal-Wallis test
(p=0.0546) which found no differences between the age and breed groups. B: The
distribution of grades for each age group. The data was analysed using Spearman’s
rank correlation (r=0.3117) which found no correlation between the grades and age
groups. H&E: Haematoxylin and eosin, IVD: Intervertebral disc.
No significant differences were found in the degeneration grading of the sagittal
sections of the thoracic IVDs between the age groups or between the breeds of
the 3-4 year old age group (Kruskal-Wallis test). There were no significant
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differences in the grades of the 3-4 year old age groups of different breeds
Generally, the score appeared to increase with age however no correlation was
found between age and grade (r= 0.31; Spearman`s rank correlation). In
comparison to the sagittal sections of the cervical IVDs, the degeneration
grades were slightly lower particularly for the 5-6 year age group whose lowest
grades decreased from 2.00 in the cervical sagittal sections to 1.00 in the
thoracic sagittal sections. The grades in the 8-10 year age group appeared to
be particularly high in comparison to the other three age groups.
The degeneration grading results for the sagittal sections of the lumbar IVDs
are shown in Figure 3.9.
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Figure 3.9: The distribution of degeneration grading scores for H&E stained
ovine lumbar (L1/L2) sagittal IVD sections in four age groups and three 3-4 year
old breeds of sheep. A: The distribution of grades for each age and breed group
(n=3). The age/breed group data was analysed using the Kruskal-Wallis test
(p=0.0464) which found no differences between the age and breed groups. B: The
distribution of grades for each age group. The data was analysed using Spearman’s
rank correlation (r=0.6775) which found a good positive correlation between the grades
and age groups. H&E: Haematoxylin and eosin, IVD: Intervertebral disc.
There were no significant differences found in the degeneration grading of the
sagittal sections of the thoracic IVDs between the age groups or between the
breeds of the 3-4 year old age group (Kruskal-Wallis test). However, a good
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positive correlation was observed in grade with increasing age (r=0.68;
Spearman`s rank correlation). The grades were in similar ranges to the cervical
and thoracic samples, between 1.00 and 3.00. Similarly to the sagittal sections
of the thoracic IVDs the degeneration grades of the 8-10 year age group
appeared higher in comparison to the other age groups.
The change in tissue morphology with age was most visible in the CEP tissue of
the lumbar sagittal sections. Examples of H&E stained sections in the CEP of
lumbar IVDs from the four age groups is shown in Figure 3.10.
Figure 3.10: H&E stained CEP of lumbar sagittal IVD sections in four different
age groups. A: 0-1 year old (Charollais), B: 3-4 year old (Charollais), C: 5-6 year old
(Suffolk), D: 8-10 year old (Hebridean). H&E: Haematoxylin and eosin, CEP: Cartilage
end plate, IVD: Intervertebral disc.
In sagittal sections of the IVDs of the 0-1 year old age group, the CEP was at its
thickest and had an organised structure with no visible fissures. The cells
appeared randomly dispersed and there were no empty lacunae. No
calcification could be seen. In the sagittal sections of the IVDs of 3-4 year olds,
the structure was similar except for the occasional empty lacunae. For IVDs
A B
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from 5-6 year old sheep, the cartilage was thinner and had a much greater
number of empty lacunae. The CEP showed evidence of calcification. At 8-10
years old, the CEP had lost most of its structure, had no visible cells and was
thinner than that in the 5-6 year old group. Extensive calcification was visible.
3.4.4. Morphological Grading of Facets Using Photography
Left superior and inferior facets from FSUs C6/C7, T11/T12 and L1/L2 were
dissected and photographed. Examples from the cervical, thoracic and lumbar
regions across all four age groups are shown in Figure 3.11.
Figure 3.11: Images of ovine cervical (C6/C7), thoracic (T11/T12) and (L1/L2)
lumbar left superior (S) and inferior (I) facets from one, three to four, five to six
and eight to 10 year old sheep. A: Cervical inferior and superior facets. B: Thoracic
inferior and superior facets. C: Lumbar inferior and superior facets. i. one year, ii. Three
to four years, iii. Five to six years, iv. Eight to 10 years.
Each of the left inferior and superior facets were graded using the degeneration
grading system described (Section 2.2.7.8) by two independent trained graders.
The inter-rater reliability (kappa) test was performed on all the data from both
graders. The kappa score was 0.567 (p<0.0001), showing there was moderate
agreement between the two graders.
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The final grades for the inferior and superior facets were combined by
calculating their mean to give a final score. The mean score from both graders
was determined and plotted for each of the cervical, thoracic and lumbar
regions. The results from the cervical facets degeneration grading is shown in
Figure 3.12.
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Figure 3.12: The distribution of grading scores for the macroscopic left ovine
cervical (C6/C7) facets in four age groups and three 3-4 year old breeds of sheep.
A: The distribution of grades for each age and breed group (n=3). The age/breed group
data was analysed using the Kruskal-Wallis test (p=0.1113) which found no differences
between the age and breed groups. B: The distribution of grades for each age group.
The data was analysed using Spearman’s rank correlation (r=0.6553) which found a
good positive correlation between the grades and age groups.
There were no significant differences found for the morphological grading of the
cervical facets between the age groups and between the different breeds in the
3-4 year old age group (Kruskal-Wallis test). However, a good positive
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correlation was found in grade with increasing age (r=0.66; Spearman`s rank
correlation). The grading scores for the 0-1 year age group were low with all
grades at 1.0 whilst the ranges of grades in the 3-4 and 8-10 year age groups
were similar. The grades in the 5-6 year age group were considerably higher in
comparison to the other three age groups.
The results for the morphological grading of thoracic facets are shown in Figure
3.13.
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Figure 3.13: The distribution of grading scores for the macroscopic left ovine
thoracic (T11/T12) facets in all four age groups and three 3-4 year old breeds of
sheep. A: The distribution of grades for each age and breed group (n=3). The
age/breed group data was analysed using the Kruskal-Wallis test (p=0.1983) which
found no differences between the age and breed groups. B: The distribution of grades
for each age group. The data was analysed using Spearman’s rank correlation
(r=0.3762) which found no correlation between the grades and age groups.
No differences were observed between the age and breed groups of the
macroscopic cervical facet grading scores (Kruskal-Wallis test). There was no
correlation between age and grade (r=0.38; Spearman`s rank correlation).
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Overall, the grades for each group appeared to fluctuate showing no obvious
trend or pattern. The highest grade was in the 5-6 year old group which had a
mean score of 3.08. The grades were higher than those observed for the
cervical facets.
The results for the morphological grading of the lumbar facets are shown in
Figure 3.14.
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Figure 3.14: The distribution of grading scores for the macroscopic left ovine
lumbar (L1/L2) facets in all four age groups and three 3-4 year old breeds of
sheep. A: The distribution of grades for each age and breed group (n=3). The
age/breed group data was analysed using the Kruskal-Wallis test (p=0.3784) which
found no differences between the age and breed groups B: The distribution of grades
for each age group. The data was analysed using Spearman’s Rank Correlation
(r=0.3669) which found no correlation between the grades and age groups.
No differences were observed between the age and breed groups of the
macroscopic lumbar facet grading scores (Kruskal-Wallis test). There was no
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correlation between age and grade (r=0.37; Spearman`s rank correlation). The
range of grades was similar to those of the thoracic facets and fluctuated with
age. The range of grades fell between 1.00-3.50, lower than both the cervical
and thoracic facets.
3.4.5. Grading of Haematoxylin and Eosin Stained Sections of Facets for
Degeneration
Left inferior facets from the FSUs C6/C7, T11/T12 and L1/L2 were fixed in 10 %
(v/v) neutral buffered formalin before being cut at the centre to give rise to 2 mm
thick cross-sections. These were decalcified in 12.5 % (w/v) EDTA for two
weeks, tissue processed (Section 2.2.7.2.), sectioned using a microtome at 5
µm and stained with H&E. A grading system was used (Section 2.2.7.8.) by two
independent graders to grade each stained section blind. The inter-rater
reliability (kappa) test was performed on all the data from both graders. The
kappa score was 0.515 (p<0.0001), showing there was moderate agreement
between the two graders.
The results of the degeneration grading of H&E stained sections of cervical
facet cartilage are shown in Figure 3.15.
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Figure 3.15: The distribution of degeneration grading scores for H&E stained
ovine cervical (C6/C7) left inferior facet cartilage sections in four age groups and
three 3-4 year old breeds of sheep. A: The distribution of grades for each age and
breed group (n=3). The age/breed group data was analysed using the Kruskal-Wallis
test (p=0.0377) which found no differences between the age and breed groups. B: The
distribution of grades for each age group. The data was analysed using Spearman’s
rank correlation (r=0.6744) which found a good positive correlation between the grades
and age groups. H&E: Haematoxylin and eosin.
No differences were observed in the degeneration grade for the cervical facet
cartilage sections between the age and breed groups (Kruskal-Wallis test).
However a good positive correlation was found between grade with increasing
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age (r=0.67; Spearman`s rank correlation). There was an obvious increase in
the range of degeneration grading score from 3-4 years to 5-6 years. The
grades in the 0-4 year old samples were lower in comparison to the 5-10 year
samples.
The results of the degeneration grading of H&E stained sections of thoracic
facet cartilage are shown in Figure 3.16.
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Figure 3.16: The distribution of degeneration grading scores for H&E stained
ovine thoracic (T11/T12) left inferior facet cartilage sections in four age groups
and three 3-4 year old breeds of sheep. A: The distribution of grades for each age
and breed group (n=3). The age/breed group data was analysed using the Kruskal-
Wallis test (p=0.1042) which found no differences between the age and breed groups.
B: The distribution of grades for each age group. The data was analysed using
Spearman’s rank correlation (r=0.7595) which found a good positive correlation
between the grades and age groups. H&E: Haematoxylin and eosin.
No differences were observed in the degeneration grade for the thoracic facet
cartilage sections between the age and breed groups (Kruskal-Wallis test).
However a good positive correlation was found between grade and increasing
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age (r=0.76; Spearman`s rank correlation). The range of grades was generally
lower in comparison to the cervical facet sections. Similarly to the cervical
sections, there was an obvious increase in grades from the 3-4 year to 5-6 year
age groups. The grades in the 0-4 year old samples were lower in comparison
to the 5-10 year samples.
The results of the degeneration grading of H&E stained sections of lumbar facet
cartilage are shown in Figure 3.17.
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Figure 3.17: The distribution of degeneration grading scores for H&E stained
ovine lumbar (L1/L2) left inferior facet cartilage sections in four age groups and
three 3-4 year old breeds of sheep. A: The distribution of grades for each age and
breed group (n=3). The age/breed group data was analysed using the Kruskal-Wallis
test (p=0.5897) which found no differences between the age and breed groups. B: The
distribution of grades for each age group. The data was analysed using Spearman’s
rank correlation (r=0.3731) which found no correlation between the grades and age
groups. H&E: Haematoxylin and eosin.
No differences were observed in the degeneration grade for the lumbar facet
cartilage sections between the age and breed groups (Kruskal-Wallis test). In
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contrast to the cervical and thoracic sections, no correlation was found between
grade and age (r=0.37; Spearman`s rank correlation). In general, the grades
were lower than those in the cervical and thoracic sections but the range of
grades in the 0-1 year age group were more spread reaching as high as 2.75.
The most visible signs of aging were present in the histological sections of
cervical facet cartilage. Examples of this are shown in Figure 3.18.
Figure 3.18: H&E stained sections of ovine cervical (C6/C7) facet cartilage from
four different age groups. A: 0-1 year old (Charollais), B: 3-4 year old (Charollais), C:
5-6 year old (Suffolk), D: 8-10 year old (Hebridean). H&E: Haematoxylin and eosin.
The structure of facet cartilage in the 0-1 year and 3-4 year old samples was
very similar with an organised thick structure and minimal calcification. In both
the 5-6 year and 8-10 year old samples, the cartilage began to lose its structure
with fewer cells, calcification and fissures on its surface.
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3.4.6. Analysis of the Bone in Ovine FSUs
FSUs C6/C7, T11/T12 and L1/L2 from each age and breed of sheep were
scanned whole in a µCT scanner (Section 2.2.12). After scanning was
complete, software was used to calculate BV/TV and hydroxyapatite (HA)
concentration as a measure of BMD (Section 2.2.12).
3.4.6.1. Bone Volume/Total Volume of Ovine FSUs
The results of BV/TV analysis of cervical FSUs are shown in Figure 3.19.
Figure 3.19: The mean BV/TV of ovine cervical (C6/C7) FSUs from four age
groups and three 3-4 year old breeds of sheep. Data was transformed by arcsine
transformation, the means (n=3) and SDs calculated and analysed by one-way ANOVA
which revealed no significant differences between any of the groups (p=0.7340). The
data was then back transformed to proportions for presentation purposes. BV/TV: Bone
volume/total volume, FSU: Functional spinal unit, SD: Standard deviation, ANOVA:
Analysis of variance.
There was no significant variation in the data for the BV/TV of cervical FSUs of
sheep in the different age groups or between the three breeds in the 3-4 year
age group (analysis of variance; p=0.7340) . The BV/TV values were relatively
constant with age and breed lying between 0.2 and 0.3, or 20-30 %. The
Charollais breed in the 3-4 year old age group had lower BV/TV than that of the
Texel and Suffolk breeds. However, this was not significant. The data (age vs
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BV/TV) was therefore analysed using Spearman’s rank correlation which
showed no correlation (r=-0.0206) between the BV/TV and age of the animals
The results of BV/TV analysis of thoracic FSUs are shown in Figure 3.20.
Figure 3.20: The mean BV/TV of ovine thoracic (T11/T12) FSUs from four age
groups and three 3-4 year old breeds of sheep. Data was transformed by arcsine
transformation, the means (n=3) and SDs calculated and analysed by one-way ANOVA
which revealed significant variation amongst the groups (p=0.0301). Calculation of the
minimal significant difference between means showed a significant difference between
the 0-1 and 8-10 year age groups (p < 0.05). The data was then back transformed to
proportions for presentation purposes. *p<0.05. BV/TV: Bone volume/total volume,
FSU: Functional spinal unit, SD: Standard deviation, ANOVA: Analysis of variance.
The BV/TV of FSUs from sheep in the 0-1 age group was significantly lower
than the BV/TV of FSUs in the 8-10 year old age group (p< 0.05; ANOVA).
There were no differences in the BV/TV of the FSUs from the three breeds in
the 3-4 year old age groups. The data (age vs BV/TV) was therefore analysed
using Spearman’s rank correlation which showed a good positive correlation
(r=0.6171) between an increase in BV/TV with age in the thoracic FSUs. The
increase in BV/TV was from 0.18 in 0-1 year old samples to 0.30 in the 8-10
year old samples. The samples from the four other age/breed groups had mean
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values which lay within this range. In comparison to the cervical FSUs, all
BV/TV values lay in a similar range (0.2-0.3) with the exception of the 0-1 year
age group (0.18).
The results of BV/TV analysis of lumbar FSUs are shown in Figure 3.21.
Figure 3.21: The mean BV/TV of ovine lumbar (L1/L2) FSUs from four age groups
and three 3-4 year old breeds of sheep. Data was transformed by arcsine
transformation, the means (n=3) and SDs calculated and analysed by one-way ANOVA
which revealed no significant differences between any of the groups (p=0.1146). The
data was then back transformed to proportions for presentation purposes. BV/TV: Bone
volume/total volume, FSU: Functional spinal unit, SD: Standard deviation, ANOVA:
Analysis of variance.
There was no significant variation in the data for the BV/TV values of the lumbar
FSUs of sheep of different ages or breeds (analysis of variance; p=0.12). The
data (BV/TV vs age) was therefore analysed using Spearman’s rank correlation
which showed no correlation between BV/TV and age (r=0.2162). The values
appeared to fluctuate with age and breed. In comparison to the cervical and
thoracic samples, the range of BV/TV values was higher lying between 0.20 and
0.34.
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
0.5
0-1 year olds 3-4 year old
charollais
3-4 year old
suffolks
3-4 year old
texels
5-6 year olds 8-10 year
olds
BV
/T
V
Age/breed groups
Chapter 3
137
3.4.6.2. Hydroxyapatite Concentration
The results of HA concentrations in the bone from cervical FSUs are shown in
Figure 3.22.
Figure 3.22: The mean HA concentration in ovine cervical (C6/C7) FSUs from four
age groups and three 3-4 year old breeds of sheep. Data is presented as the mean
(n=3) ± SD. Data was analysed by one-way ANOVA which revealed no significant
variation between the groups (p=0.3424). HA: Hydroxyapatite concentration, FSU:
Functional spinal unit, SD: Standard deviation, ANOVA: Analysis of variance.
The mean HA concentration in the ovine cervical FSUs showed no variation
between the different age groups or breed of sheep (analysis of variance;
p=0.34). The data (HA concentration vs age) was therefore analysed using the
Pearson’s moment correlation which showed no correlation between HA
concentration of the FSUs and age (r=0.2574). The range of values was fairly
constant amongst all ages and breeds of sheep. The mean values ranged from
250 mg HA/ccm (3-4 year old Charollais) to 312 mg HA/ccm (3-4 year old
Suffolk).
The results of HA concentrations in the bone of thoracic FSUs are shown in
Figure 3.23.
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Figure 3.23: The mean HA concentration in ovine thoracic (T11/T12) FSUs from
four age groups and three 3-4 year old breeds of sheep. Data is presented as the
mean (n=3) ± SD. Data was analysed by one-way ANOVA which revealed no
significant variation between the groups (p=0.0592). HA: Hydroxyapatite concentration,
FSU: Functional spinal unit, SD: Standard deviation, ANOVA: Analysis of variance.
There was no significant variation in the concentrations of HA in the bone of
thoracic FSUs from sheep of different ages or breeds (analysis of variance;
p=0.06). The values fluctuated between age and breed groups. The data (HA
concentration vs age) was therefore analysed using the Pearson’s moment
correlation which showed no correlation between age and HA concentration in
the bone of the thoracic FSUs (r=0.2799). In comparison to the cervical FSUs,
the range of values was wider lying between 212 mg HA/ccm (3-4 year old
Charollais) and 321 mg HA/ccm (3-4 year old Suffolk). As with the cervical
FSUs the Charollais breed showed the lowest values with the Suffolk breed
showing the highest values. However, this was not statistically significant.
The results of HA concentrations in the bone of lumbar FSUs are shown in
Figure 3.24.
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Figure 3.24: The mean HA concentration in ovine lumbar (L1/L2) FSUs from four
age groups and three 3-4 year old breeds of sheep. Data is presented as the mean
(n=3) ± SD. Data was analysed by one-way ANOVA which revealed no significant
variation in the data between the groups (p=0.0563). HA: Hydroxyapatite
concentration, FSU: Functional spinal unit, SD: Standard deviation, ANOVA: Analysis
of variance.
No significant variation was found in the HA concentration in the bone of lumbar
FSUs from the different age groups or breeds of the lumbar FSUs. The values
fluctuated between all age and breed groups. The data (HA concentration vs
age) was therefore analysed using the Pearson’s moment correlation which
showed no correlation between HA concentration and age (r=0.3015). In
comparison to the cervical and thoracic FSUs, the values lay in a similar range
from 212 mg HA/ccm (3-4 year old Charollais) and 309 mg HA/ccm (3-4 year
old Suffolk). As with both the cervical and thoracic FSUs the Charollais breed
showed the lowest values with the Suffolk breed showing the highest values.
However, this was not statistically significant.
3.4.7. IVD Height and Facet Spacing Measurements of Ovine FSUs
The µCT scans were used to measure the thickness of the IVD (including the
CEP). Three equally spaced points along the IVD were chosen to take
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measurements from (Section 2.2.12). The µCT scans were also used to
measure the space between the facet joints in the FSU as a measure of
cartilage thickness. Three equally spaced points were chosen along both the
left and right facet joint. Three measurements were taken along each facet at
three equally spaced depths which were averaged out to give one
measurement along each facet and averaged out again to give one
measurement for both inferior and superior facets (Section 2.2.12).
3.4.7.1. IVD Height
The results of IVD height in cervical FSUs of sheep of different ages and breeds
are shown in Figure 3.25.
Chapter 3
141
Figure 3.25: The IVD height in ovine cervical (C6/C7) FSUs from four age groups
and three 3-4 year old breeds of sheep. Data is presented as the mean (n=3) ± SD.
Data was analysed by one-way ANOVA which revealed significant variation in the data
(p= 0.0004). Calculation of the minimum significant difference revealed significant
differences between the 0-1 and 8-10 year age groups, 3-4 Charollais and 8-10 year
age groups, 3-4 Suffolk and 3-4 year old Texel groups, 3-4 Suffolk and 8-10 year age
groups and 5-6 and 8-10 year age groups (p=0.0004).*p<0.05, ***p<0.001. IVD:
Intervertebral disc, FSU: Functional spinal unit, SD: Standard deviation, ANOVA:
Analysis of variance.
Significant differences in cervical IVD height were found between 0-1 and 8-10
year age groups, 3-4 Charollais and 8-10 year age groups, 3-4 Suffolk and 8-10
year age groups and 5-6 and 8-10 year age groups. A significant difference was
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also found between the 3-4 year old Suffolk and Texel breeds with the Suffolks
having a greater cervical IVD height. Analysis of the data using Pearson’s
moment correlation showed a weak negative correlation between age and IVD
height (r=0.3015). This showed that the IVD height within cervical FSUs
decreased with age.
The results of IVD height in thoracic FSUs are shown in Figure 3.26.
Figure 3.26: The mean IVD height in ovine thoracic (T11/T12) FSUs from four age
groups and three 3-4 year old breeds of sheep. Data is presented as the mean
(n=3) ± SD. Data was analysed by one-way ANOVA which revealed no significant
variation between the age and breed groups (p=0.1188. IVD: Intervertebral disc, FSU:
Functional spinal unit, SD: Standard deviation, ANOVA: Analysis of variance.
There was no significant variation in the data for thoracic FSU IVD height
between the age groups and breeds of sheep (analysis of variance; p= 0.1188).
Although the mean IVD height in the 8-10 year old age group appeared to be
lower than in the other five groups, this was not significant. No differences were
found between the three different breeds in the 3-4 year old age group. The
data (IVD height vs age) was analysed using the Pearson’s moment correlation
which revealed a good negative correlation (r=-0.65) indicating a decrease in
IVD height with age. In comparison to the cervical FSU disc height which
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ranged from 3.8 mm to 6.9 mm, the thoracic values were much lower ranging
from 1.8 mm to 2.7 mm.
The results for IVD height in lumbar FSUs are shown in Figure 3.27.
Figure 3.27: The mean IVD height in ovine lumbar (L1/L2) FSUs from four age
groups and three 3-4 year old breeds of sheep. Data is presented as the mean
(n=3) ± SD. Data was analysed by one-way ANOVA which revealed no significant
variation between the age and breed groups (p=0.1241). IVD: Intervertebral disc, FSU:
Functional spinal unit, SD: Standard deviation, ANOVA: Analysis of variance.
There was no significant variation in the lumbar FSU IVD height between the
age groups or breed of sheep (analysis of variance; p=0.1241). Although the
mean IVD height in the 8-10 year old age group appeared to be lower than in
the other five groups, this was not significant. No differences were found
between the three different breeds in the 3-4 year old age group. The data (IVD
height vs age) was analysed by Pearson`s moment correlation which revealed a
good negative correlation indicating a decrease in IVD height with age. In
comparison to both the cervical and thoracic IVD height, the lumbar IVD height
was higher (2.48-3.88 mm) than that of the thoracic samples (1.81-2.70 mm)
but lower than the cervical samples (3.81-6.85 mm).
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
0-1 year olds 3-4 year old
charollais
3-4 year old
suffolks
3-4 year old
texels
5-6 year olds 8-10 year
olds
Di
sc
He
ig
ht
(m
m
)
Age/breed Group
Chapter 3
144
3.4.7.2. Facet Joint Spacing Measurements
The results of facet joint spacing in cervical FSUs of sheep of various ages and
breeds are shown in Figure 3.28.
Figure 3.28: The mean facet joint spacing in ovine cervical (C6/C7) FSUs from
four age groups and three 3-4 year old breeds of sheep. Data is presented as the
mean (n=3) ± SD. Data was analysed by one-way ANOVA which revealed no
significant variation between the data for the different age and breed groups
(p=0.0895). FSU: Functional spinal unit, SD: Standard deviation, ANOVA: Analysis of
variance.
There was no significant variation in the data for the facet joint spacing
measurements in the cervical FSUs from sheep of different ages or breed
(analysis of variance; p=0.09). No differences in facet joint spacing were found
between the age groups in the cervical FSUs. No differences were present
between the three breeds in the 3-4 year old age group. The data (facet joint
space vs age) was analysed using Pearson`s moment correlation which
showed no correlation with age.
The results of facet joint spacing in thoracic FSUs are shown in Figure 3.29.
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Figure 3.29: The mean facet joint spacing in ovine thoracic (T11/T12) FSUs from
four age groups and three 3-4 year old breeds of sheep. Data is presented as the
mean (n=3) ± SD. Data was analysed by one-way ANOVA which revealed significant
variation amongst the data. The minimum significant difference between means was
therefore calculated and this revealed a significant difference between the 5-6 year and
8-10 year age groups (p < 0.05). *p<0.05. FSU: Functional spinal unit, SD: Standard
deviation, ANOVA: Analysis of variance.
Analysis of the data using ANOVA revealed significant variation in the data and
this was found to be due to a significantly smaller facet joint spacing (p<0.05) in
thoracic FSU`s in the 8-10 years age group compared to the 5-6 year old group.
This showed that the facet joint space decreased with age after 5-6 years. No
difference was found in facet joint space between the three breeds in the 3-4
year old age group. The data (facet joint spacing vs. age) was analysed using
Pearson`s moment correlation which revealed no correlation between facet joint
space and age (r= 0.22). In comparison to the facet joint space in the cervical
FSUs, the space between the facet joints was smaller.
The results of facet joint spacing in lumbar FSUs are shown in Figure 3.30.
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Figure 3.30: The mean facet joint spacing in ovine lumbar (L1/L2) FSUs from four
age groups and three 3-4 year old breeds of sheep. Data is presented as the mean
(n=3) ± SD. Data was analysed by one-way ANOVA which revealed no significant
variation in the data for the different age and breed groups (p=0.4130). FSU:
Functional spinal unit, SD: Standard deviation, ANOVA: Analysis of variance.
There was no significant variation in the data for the facet joint spacing between
the age groups and breeds of the lumbar FSUs. The facet joint space in the 8-
10 year old age group appeared to be smaller in comparison to the other age
groups however this was not significant. No differences were present in facet
joint space between the three breeds in the 3-4 year old age group. The data
(facet joint space vs age) was analysed using Pearson`s moment correlation
which showed a weak negative correlation between facet joint space in lumbar
FSUs and age (r= -0. 4). In comparison to both the cervical (0.83-2.21) and
thoracic (0.65-1.19) mean values, the facet joint space in the lumbar FSUs
(0.29-0.60) was smaller.
A summary of all the data collected in this part of the study is presented in
Tables 3.1-3.3.
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Table 3.1: A summary of the data for the cervical FSUs. Each value for the grading data represents the median and each value for the
measurement data represents the mean (n=3). Grading data were analysed using the Kruskal-Wallis test and Spearman’s rank correlation.
BV/TV data were calculated using one-way ANOVA on arcsine transformed data. HA concentration, IVD height and facet joint height data
were analysed using one-way ANOVA and determination of the minimal significant difference between group means and Pearson`s
moment correlation coefficient. *p<0.05, **p<0.005. BV/TV: Bone volume/total volume, HA: Hydroxyapatite, IVD: Intervertebral disc,
ANOVA: Analysis of variance.
0-1 year
old
3-4 year
old
Charollais
3-4 year
old
Suffolk
3-4 year
old Texel
5-6 year
old
8-10 year
old
Significant
difference
between
breeds?
Significant
difference
between
age
groups?
Correlation?
Transverse IVD
grading
1.38 1.13 1.63 1.50 1.50 1.75 No No
(p=0.8814)
No
(r=0.2699)
Sagittal IVD
grading
1.25* 1.25 1.88 1.50 2.38* 2.38 No Yes*
(0-1 & 5-6)
Good
(r=0.6285)
Morphological
facet grading
1.00 1.00 1.50 1.25 2.00 2.00 No No
(p=0.1113)
Good
(r=0.6553)
Facet section
grading
1.13 2.38 1.14 1.50 3.13 2.50 No No
(p=0.0377)
Good
(r=0.6744)
BV/TV 0.2277 0.2146 0.2903 0.2746 0.2455 0.2146 No No
(p=0.7340)
No
(r=-0.0206)
HA
concentration
265.10 250.55 312.32 305.34 278.29 306.29 No No
(p=0.3424)
No
(r=0.2574)
IVD height 5.66*
(8-10)
6.60***
(8-10)
6.85***
(8-10)
5.01*
(3-4suffolk)
5.68*
(8-10)
3.81*** Yes* Yes*** Weak
(r=-0.5718)
Facet joint
space
1.53 1.76 1.64 1.10 2.21 0.827 No No
(p=0.0895)
No
(r=-0.2489)
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Table 3.2: A summary of the data for the thoracic FSUs. Each value for the grading data represents the median and each value for the
measurement data represents the mean (n=3). Grading data were analysed using the Kruskal-Wallis test and Spearman’s rank correlation.
BV/TV data were analysed using one-way ANOVA on arcsine transformed data. HA concentration, IVD height and facet joint height data
were analysed using one-way ANOVA followed by determination of the minimum significant difference between group means and
Pearson's moment correlation coefficient. *p<0.05. BV/TV: Bone volume/total volume, HA: Hydroxyapatite, IVD: Intervertebral disc,
ANOVA: Analysis of variance.
0-1 year
old
3-4 year
old
Charollais
3-4 year
old
Suffolk
3-4 year
old Texel
5-6 year
old
8-10 year
old
Significant
difference
between
breeds?
Significant
difference
between
age
groups?
Correlation?
Transverse IVD
grading
1.13 1.63 1.13 1.13 1.50 1.25 No No
(p=0.9951)
No
(r=-0.0495)
Sagittal IVD
grading
1.50 1.25 2.25 1.75 1.63 2.50 No No
(p=0.0546)
No
(r=0.3117)
Morphological
facet grading
1.50 2.75 1.00 1.00 3.25 2.00 No No
(p=0.1983)
No
(r=0.3762)
Facet section
grading
1.25 2.13 1.88 1.50 2.75 3.25 No No
(p=0.1042)
Good
(r=0.7595)
BV/TV 0.1773* 0.2019 0.2576 0.2380 0.2233 0.2982* No Yes*
0-1 & 8-10
Good
(0.6171)
HA
concentration
242.21 212.06 321.42 305.69 246.04 310.28 No No
(p=0.0592)
No
(r=0.2799)
IVD height 2.70 2.65 2.60 2.63 2.39 1.81 No No
(p=0.1188)
Good
(r=-0.6484)
Facet joint
space
0.933 0.733 0.753 1.00 1.19* 0.645* No Yes*
5-6 & 8-10
No
(r=-0.2217)
Chapter 3
149
Table 3.3: A summary of the data for the lumbar FSUs. Each value for the grading data represents the median and each value for the
measurement data represents the mean (n=3). Grading data were analysed using the Kruskal-Wallis test and Spearman’s rank correlation.
BV/TV data were analysed using one-way ANOVA on arcsine transformed data. Data on HA concentration, IVD height and facet joint
height were analysed using one-way ANOVA and Pearson`s moment correlation coefficient. BV/TV: Bone volume/total volume, HA:
Hydroxyapatite, IVD: Intervertebral disc, ANOVA: Analysis of variance.
0-1 year
old
3-4 year
old
Charollais
3-4 year
old
Suffolk
3-4 year
old Texel
5-6 year
old
8-10 year
old
Significant
difference
between
breeds?
Significant
difference
between
age
groups?
Correlation?
Transverse IVD
grading
1 0.63 1.63 0.50 1.00 1.75 No No
(p=0.3211)
Weak
(r=0.4226)
Sagittal IVD
grading
1.38 1.75 1.75 1.63 1.88 2.38 No No
(p=0.0464)
Good
(r=0.6775)
Morphological
facet grading
1.75 2.75 1.25 1.25 2.00 2.25 No No
(p=0.3784)
No
(r=0.3669)
Facet section
grading
1.88 2.25 1.88 1.75 2.38 2.38 No No
(p=0.5897)
No
(r=0.3731)
BV/TV 0.2262 0.1977 0.2591 0.3438 0.2653 0.2470 No No
(p=0.1146)
No
(r=0.2162)
HA
concentration
239.97 211.90 308.65 299.49 258.92 297.48 No No
(p=0.0563)
No
(r=0.3015)
IVD height 3.88 3.39 3.47 3.31 3.44 2.48 No No
(p=0.1241)
Good
(r=-0.6460)
Facet joint
space
0.550 0.497 0.522 0.591 0.600 0.291 No No
(p=0.4130)
Weak
(r=-0.3960)
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3.5. Discussion and Conclusions
The aim of this part of the study was to analyse ovine FSUs from cervical,
thoracic and lumbar regions to determine at what age the ovine spine begins to
show signs of degeneration. This included analysing the morphology of the
FSUs and facet surfaces, the micro-detail of the facet cartilage and IVD whilst
also determining some bone properties of the vertebral body, IVD height and
space between the facet joints. As aging has been frequently reported in the
literature to be linked to the degeneration of the IVD, facet joint and bone
structure, the analyses focused on these tissues (Miller et al., 1988; Gong et al.,
2005; Tischer et al., 2006; Urban and Roberts, 2006; Melrose et al., 2009;
Varlotta et al., 2011A). In addition, due to the difficulties in obtaining ovine
spines from a single breed, three breeds were analysed using the same
methods to determine whether there were differences between different breeds
and therefore whether the study was valid using a range of breeds. Currently,
no such study exists in the literature.
The results with regard to the different breeds in the 3-4 year old age range
showed only one significant difference between the Suffolk and Texel breeds in
the cervical FSU and this was for the IVD height. No significant differences were
observed between thoracic and lumbar FSUs in IVD height. In addition there
were no significant differences in cervical, thoracic and lumbar FSUs between
the three breeds in the histological grading of the transverse IVD sections,
sagittal IVD sections, facet photography and facet histology grading or the other
µCT measurements. As a result, the breed of sheep within an age group, with
the exception of the Hebridean breed in the 8-10 year age group, was not
relevant and was not considered to be important and taken into consideration
whilst discussing the results.
The FSU morphology results showed changes in the macrostructure of the IVD
with age. The common features observed within an aging IVD were observed
including loss of water within the NP and loss of demarcation. However, the
results from the grading of the histological sections of the transverse IVD
showed no significant differences between the age groups and only one weak
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correlation of increasing grade with age in the lumbar sections. This did not
reflect the macroscopic appearance. This may have been due to the other
factors in the transverse IVD grading system that was not visible to the naked
eye. These included both the presence of cell clusters and fissures. As a result,
this meant that although the loss of demarcation and haematoxophilia increased
with age, the presence of cell clusters and fissures within these samples did
not. The results showed that a great deal of variation existed between samples
within the age groups. This may explain the absence of correlations in the
grading of the cervical and thoracic transverse IVD sections. The results of the
grading of the histological sections of the lumbar transverse IVD did not show
any significant differences between the age groups; however, there was a
noticeable trend with the grade for the 0-1 year age group being lower than that
of the 8-10 year age group and the overall data showing a weak correlation
between age and grade. Previous studies have found that the disc degenerates
with age (Urban and Roberts, 2003; An et al., 2006). Despite the absence of
differences in degeneration with age in the transverse histological sections,
significant differences were observed in the grades of the cervical sagittal IVD
sections. This was between the 0-1 year and 5-6 year old samples. In addition a
good positive correlation was present in cervical and lumbar sagittal sections
showing increasing grade with age. These results showed that generally the
grades given to histological sections increased with age. This difference
between the sagittal and transverse section histological grading systems may
have been due to the fact that the CEP and subchondral bone were taken into
consideration when analysing the sagittal sections as well as the IVD itself. In
addition, the grading of the sagittal IVD sections involved closer examination of
both the AF and NP. This included not only analysing fissures but detail of
widening of the matrix, vessels, disorganisation of attachment, cystic
degeneration and chondrone formation. For this reason it was apparent that the
grading system for the sagittal IVD sections was more reliable than that of the
grading system for the transverse IVD sections. No significant difference in
grades were observed between the 0-1 year and 3-4 year age groups
suggesting that degeneration had not yet begun at this age and therefore began
at 5-6 years of age in the IVD.
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The grading data for the facet cartilage grading from both photographs and H&E
stained sections, showed no statistical differences between the age and breed
groups. However, good correlations between degeneration and age were
observed in grading of both the morphology and histological sections of cervical
facets. In addition, a good correlation was present between degeneration and
age in the grading of thoracic facet histological sections. More correlations
between age and degeneration were observed for the facet histology sections
than for the photographs. This may have been because the facet histology
grading system was more detailed than that for the facet photographs. Previous
work to investigate the changes in facet cartilage with age was restricted to
human samples rather than ovine (Taylor and Twomey, 1986; Gries et al.,
2000; Tischer et al., 2006; Kettler et al., 2007). In comparison to the
macroscopic appearance of degenerated human facets shown in the literature,
the ovine facets analysed here were in general much healthier. Most of the
samples, including those in the 8-10 year age group, did not show major signs
of degeneration such as eburnation of cartilage from the underlying bone. This
may have explained the lack of significant differences between the age groups.
It may be that more extensive features exist in older sheep.
Only one significant difference was observed for BV/TV in the bone of all FSU
samples. This was between the 0-1 year and 8-10 year age group in the
thoracic FSUs. A correlation was also found showing an increase in BV/TV with
age for thoracic FSUs. It is not known whether this was due to variations in the
Hebridean breed of sheep or their older age. However, despite the lack of
statistical differences and correlations for the cervical and lumbar FSUs, it was
observed that BV/TV generally increased with age in some FSUs. Some studies
have previously reported this for human vertebrae (Simpson et al., 2001; Briggs
et al., 2004). However, other studies since have found that BV/TV decreases
with age in human vertebrae due to increased bone resorption (Gong et al.,
2005; Chen et al., 2008; Wilke et al., 2012). The change in BV/TV with age in
ovine vertebrae has not previously been reported. The findings here were most
likely due to the lack of biomechanical support within the IVDs as the amount of
GAGs decreased affecting resistance to axial loads. As a result, the bone within
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the vertebral body may have restructured to deal with this increase loading
force by synthesising bone.
No significant differences or correlations were observed in HA concentration
between age groups. HA deposition in the degenerated human lumbar IVD has
previously been reported (Feinberg et al., 1990). Another study found calcium
deposits present in the IVDs of 11 year old sheep which contained a reduced
amount of PGs in the absence of any morphological signs of degeneration
(Melrose et al., 2009). Further studies will need to be carried out to determine
whether there is a link between HA concentration and age. This may involve
using a larger sample size.
In the cervical FSUs the IVD height in the 8-10 year old group was significantly
smaller than all other age groups. Although, there were no significant
differences in the IVD heights of FSUs from the thoracic and lumbar regions
between the different age groups and breeds, negative correlations were found
in cervical, thoracic and lumbar FSUs indicating a decrease in IVD height with
age. As the Hebridean breed were considerably smaller than the other breeds
used in this study, it is likely that this change in IVD height was due to the
smaller animal and therefore smaller spine. Due to the limitations in obtaining 8-
10 year old tissue of Charollais, Suffolk or Texel breed it was not possible to
investigate this further. Therefore, whether IVD height decreases with age is not
known.
A major limitation of this study was the number of replicates. For each age
group, with the exception of the 3-4 year age group, there were only three
replicates. A greater n value could have resulted in more evident trends,
correlations and significant differences. However, overall, the results from this
study showed that in comparison to 0-1 year old samples which did not show
signs of degeneration, 3-4 year old FSU samples also did not show significant
signs of degeneration. Significant changes were observed in 5-6 and 8-10 year
old samples with regards to degeneration and therefore it was concluded from
this work that degeneration began at 5 years of age. As issues may arise from
using 0-1 year old samples for characterisation as bone does not mature in
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sheep until approximately 15-18 months (Hasler et al., 2010), tissue from 3-4
year old sheep was regarded as “healthy” tissue and used for characterisation
studies. As the most easily obtained sheep breed was the Texel and would
most likely be used in future studies, this breed was used in the characterisation
studies reported in the following chapter.
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Chapter 4: Biological Characterisation
of the Ovine Functional Spinal Unit and
Biomechanical Evaluation of the Facet
Joint Cartilage
4.1 Introduction
The results presented in Chapter 3 demonstrated that healthy ovine FSU tissue
suitable for histological, immunohistochemical, biochemical and biomechanical
characterisation could be obtained from sheep aged three to four years. Tissue
from sheep of this age was therefore used for characterisation. The longer term
aim was to enable direct comparison with normal and pathological human tissue
and allow for similarities and differences to be identified.
The approach taken was to firstly determine the biological characteristics of the
three to four year old ovine tissue from the IVD, including the outer AF, inner AF
and NP, and facet cartilage. This was carried out by histology and
immunohistological evaluation of key extracellular matrix components and
cellular markers. In order to determine the phenotype of the cells from the
different FSU tissues the cells were isolated and phenotyped in primary cell
culture.
In addition to the major collagens (types I, II, III, V, VI and X; Section 1.2.1.) and
aggrecan (Section 1.2.1.), which have been widely documented in the FSU
tissues, other key cellular markers and extracellular markers including SOX-9,
CD44 and fibronectin were included in the study due to their reported
expression by the tissues/cells as outlined below.
Immunohistochemical staining for aggrecan within tissues/cells is problematic
due to the epitopes of the protein being masked by the associated GAGs. It was
Chapter 4
157
therefore decided to determine the presence of chondroitin sulphate in
tissues/cells as an indication of proteoglycan/GAG content/expression.
Chondroitin sulphate is a naturally sulphated GAG (Section 1.2.1.2.). It is
commonly sulphated at the fourth and sixth position making chondroitin-4-
sulphate and chondroitin-6-sulphate the most common forms. It is highly anionic
and forms a major part of aggrecan which binds to collagen. Its main functions
when covalently linked to the aggrecan core protein are to maintain structural
integrity of cartilage as well as providing resistance to compression (Henrotin,
2010). In addition, by affecting matrix integrity and bone mineralisation,
chondroitin sulphate has also been reported to play a role in articular and bone
metabolism (Bali et al., 2001).
Sox9 is a gene that regulates chondrogenesis in mammals. This process
involves mesenchymal cells which condense and differentiate to form
chondrocytes initiating endochondral bone formation during the development of
the vertebrate skeleton. The process of skeletal development is regulated and
controlled by many factors such as signalling molecules and transcription
factors including SOX-9 (Ng et al., 1997).
SOX-9 is a transcription factor involved in regulating developmental events
including cartilage development. The gene is highly expressed in proliferating
and prehypertrophic chondrocytes but this decreases greatly in hypertrophic
chondrocytes. It has also been found to be a negative regulator of cartilage
vascularisation, cartilage resorption and formation of trabecular bone in the
growth plate (Hattori et al., 2010).
CD44 is a single-pass transmembrane receptor expressed by chondrocytes and
other cell types. It is the primary receptor that allows hyaluronan binding. As
hyaluronan is associated with many PG monomers attached non-covalently via
link proteins, CD44 allows the highly charged protein aggregates to be present
at the chondrocyte surface as illustrated in Figure 4.1 (Knudson and Loeser,
2002).
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Figure 4.1: A human chondrocyte making multiple interactions with different
macromolecules. The image shows the attachment of a large hyaluronan/PG
aggregate at the surface of a chondrocyte. PG: Proteoglycan (Knudson and Loeser,
2002).
As well as providing attachment of hyaluronan to the chondrocyte, CD44 has
also been shown to be involved in the internalisation of hyaluronan resulting in
its catabolism (Hua et al., 1993). CD44 expression by chondrocytes is believed
to be essential for maintaining healthy cartilage metabolism (Knudson and
Loeser, 2002).
Fibronectin is a multifunctional glycoprotein within the ECM of articular cartilage.
Its main function is to provide a site for the attachment of chondrocytes via
integrins (Figure 4.1) which is important to allow cellular responses to physical
forces in the ECM. It also binds to other components of the ECM. Fibronectin
has been shown to be present at low levels in normal articular cartilage.
However, it is expressed at higher levels in osteoarthritic cartilage (Chevalier,
1993).
Several potential roles for fibronectin in healthy cartilage have been suggested.
The first possibility is that it is part of a cell substrate-adhesion complex
alongside cell surface proteoglycans. Chondrocytes are capable of binding
fibronectin and fibronectin has been shown to bind to chondroitin sulphate and
dermatan sulphate (Ruoslahti, 1988). Another role involves regulating the
organisation of the ECM. This is due to the common multiple binding sites that
are shared between fibronectin and other ECM molecules. This would suggest
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an important role in organising the collagen and aggrecan network (Brown and
Jones, 1990). In addition to this, fibronectin has been shown to protect collagen
from collagenases (Menzel and Borth, 1983).
Osteocalcin is a non-collagenous protein expressed in bone and is thought to
regulate bone matrix formation (Ducy et al., 1996). It is involved in the
mineralisation process of bone via its three γ-carboxyglutamic acid residues 
which bind to calcium and hydroxyapetite (Hauschka and Reid, 1978; Poser et
al., 1980). Osteocalcin can be used as a marker for mature and fully
differentiated osteoblasts. Osteocalcin mRNA has been identified in
osteoarthritic articular cartilage from human knees (Pullig et al., 2000).
Since a major focus of this study was to characterise the facet joint cartilage,
which has received little attention in the literature, additional characterisation of
this tissue was carried out. This was mainly to assess the biomechanical
properties of the cartilage using unconfined indentation testing. The
compressive behaviour of cartilage is determined mainly by physical
interactions between solid and fluid phases of the tissue during loading. This is
mainly controlled by the GAG content of the tissue (Katta et al., 2008A). Hence
the GAG content was determined using the DMB assay.
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4.2. Aims and Objectives
The aim of this chapter was to analyse cells and tissue of the three year old
ovine FSU including inner AF, outer AF, NP and facet cartilage to determine the
biological characteristics. In addition, the biomechanical properties of the facet
cartilage was investigated and the total GAG content.
Specific objectives:
 Isolate outer AF, inner AF, NP and facet cartilage cells from cervical,
thoracic and lumbar FSUs of a three year old sheep.
 Culture the cells in monolayer culture.
 Phenotype the cells using a panel of selected antibodies.
 Analyse three year old ovine facet cartilage and IVD tissue from cervical,
thoracic and lumbar regions histologically.
 Analyse three year old ovine facet cartilage and IVD tissue from cervical,
thoracic and lumbar regions immunohistochemically.
 Determine the indentation properties of three year old ovine cervical
facet cartilage.
 Quantify the amounts of GAGs in three year old ovine facet cartilage
from the thoracic region.
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4.3. Experimental Approach
A three year old Charollais sheep (third replicate of the three to four year old
age group in the anatomical study (Figure 4.2)) was dissected as previously
described (Section 2.2.5.3.) Tissue from the outer AF, inner AF, NP and facet
cartilage (from all facets) from the FSUs C2/C3, T5-T7 and L5/L6 were removed
for cell isolation (Section 2.2.8). The isolated cells were transferred to
monolayer culture to establish 12 primary cell cultures including outer and inner
AF, NP and facet cartilage from cervical, thoracic and lumbar regions. After two
passages each cell type was transferred to multispot slides at a density of
approximately 800 cells per spot. Cells from the CEP were excluded due to the
technical difficulties in isolating the tissue.
In order to determine the phenotype of the FSU cells, indirect
immunofluorescence was carried out. This technique made it possible to identify
which chondrocyte-specific markers were being expressed and allowed a
qualitative assessment by the level of intensity of the fluorescent signal (Section
2.2.9.1.). Primary antibodies to the following markers (Section 2.1.3.1.) were
used:
 Collagen I
 Collagen II
 Collagen III
 Collagen V
 Collagen VI
 Collagen X
 Chondroitin-6-sulphate
 CD44
 Fibronectin
 SOX-9
The tissues of the ovine FSU including the left inferior facet cartilage, IVD and
CEP were analysed using the DAKO Envision method of immunohistochemistry
(Section 2.2.10.1) and histology (Section 2.2.7). This was carried out on the
FSUs C6/C7, T11/T12 and L1/L2 of replicates five, six and seven from the three
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to four year old age group in the natural history study (Figure 4.2). These were
used because the sheep were all of the Texel breed which is the most
accessible breed and thus available for use as a pre-clinical model. Antibodies
to the following markers were used for immunohistochemistry:
 Collagen I
 Collagen II
 Collagen III
 Collagen VI
 Chondroitin Sulphate
 Fibronectin
 Osteocalcin
For histological analysis, H&E, alcian blue, picro-sirius red and Miller’s elastin
stains were used to determine the structure and distribution of GAGs, collagen
and elastic fibres in facet cartilage, CEP and the IVD.
In order to explore some biomechanical properties of ovine facet cartilage,
indentation studies were carried out (Section 2.2.13). This was performed on 4
mm pins from the C6/C7 facets of a three year old Texel sheep including the left
and right of both superior and inferior facets.
The GAG content of ovine facet cartilage was quantified using the DMB assay
(Section 2.2.11.1). This was carried out on ovine facet cartilage from the T2/T3
facets remaining from the natural history study. This included the second
replicate of the one year old age group; replicates one, four, five, six, seven,
eight and nine from the three to four year old age group; the second replicate
from the five to six year age group; and the second and third replicates of the
eight to 10 year old age group (Figure 4.2). The focus was on the three year old
samples and the samples from the 0-1, 5-6 and 8-10 year age groups were
analysed for comparative purposes only. Cartilage from the left inferior facet of
T2/T3 was used for the GAG assay.
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GAG Assay GAG Assay GAG Assay GAG Assay
Cell Isolation Histology
Immunocytochemistry Immunohistochemistry
Figure 4.2: The allocation of tissue for each analysis. Tissue from the natural history study in Chapter 3 was used (Section 3.3). Each
number represents the replicate spine number for each age group.
3-4 year olds 5-6 year olds0-1 year olds 8-10 year
olds
1 2 2 198 1713 6543 32 2 3
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4.4 Results
4.4.1. Growth Characteristics of Isolated Cells
Outer AF, inner AF, NP and facet cartilage cells were isolated from C2/C3, T5-
T7 and L5/L6 of a three year old Charollais sheep and were cultured in
monolayer (Section 2.2.9). All cells appeared to grow at different rates. Facet
cartilage cells from the cervical region grew the fastest reaching confluency
after 12 days in culture. The outer AF cells from both cervical and lumbar
regions grew at the slowest rate. Images of the cells in monolayer culture 12
days after isolation are shown in Figure 4.3.
Figure 4.3: Light microscope images of FSU cells growing 12 days after isolation
and before passage. A: i. Outer AF cells (cervical) 10x magnification, ii: NP cells
(thoracic) 10x magnification. B: i. NP cells (cervical) 4x magnification, ii: Facet cells
(lumbar) 4x magnification. FSU: functional spinal unit, AF: annulus fibrosus, NP:
nucleus pulposus.
The cells appeared rounded during the initial stages. As the cells divided and
became more confluent they formed colonies. The cells also became elongated
and spindle shaped as they adhered to the plastic of the culture flask.
A.i
.
B.iiB.i
.
A.ii
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4.4.2. Phenotype of FSU cells
Once the cells had reached confluency after approximately three weeks, they
were passaged and split into two flasks. Once the cells had reached confluency
for a second time they were transferred to multispot slides and phenotyped at
passage two (Section 2.2.9.2).
The cells were analysed for their expression of collagen types I, II, III, V, VI and
X, chondroitin-6-sulphate, CD44, fibronectin and SOX-9 in outer and inner AF,
NP and facet cartilage cells. The level of expression was measured as a level of
intensity of the immunofluorescent stain. The following system was used to
describe the levels of marker expression:
 - No expression
 + Positive expression
 ++ Good expression
 +++ Very good expression
Each cell and antibody combination was assessed. Across the different cell
types the expression of the different markers appeared to be relatively similar.
The markers which were highly expressed in the FSU cells were collagen types
II, III and VI, CD44, chondroitin-6-sulphate, fibronectin and SOX-9. Markers
which were not expressed or expressed at a low level by the ovine FSU cells
were collagen types I, V and X. The results obtained using antibodies to
collagens are shown in Table 4.1 and results for the other antibodies are shown
in Table 4.2.
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Cell Type Collagen
I
Collagen
II
Collagen
III
Collagen
V
Collagen
VI
Collagen
X
C.F ++ ++ ++ - ++ +
C.NP + ++ +++ - ++ +
C.IAF + +++ +++ - ++ -
C.OAF + + + - + +
T.F + + - - +++ +
T.NP + ++ + - +++ +
T.IA + ++ + - + -
T.OA + +++ ++ - + -
L.F ++ ++ ++ - ++ -
L.NP + ++ - - +++ -
L.IAF + +++ ++ - ++ -
L.OAF - + - - +++ +
Table 4.1: Expression of collagens and levels of collagen expression in FSU cell
types at passage two. C: Cervical, T: Thoracic, L: Lumbar cells, F: Facet, IAF: inner
AF, OAF: outer AF, AF: annulus fibrosus, NP: nucleus pulposus, FSU: Functional
spinal unit. -: No expression, +: positive expression, ++: good expression, +++: very
good expression.
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Cell Type CD44 Chondroitin-6-
sulphate
Fibronectin SOX-9
C.F + ++ ++ +
C.NP +++ ++ +++ ++
C.IAF +++ ++ +++ +++
C.OAF + + + +++
T.F ++ ++ +++ +++
T.NP + ++ +++ ++
T.IA + ++ ++ +
T.OA ++ ++ ++ +++
L.F + ++ ++ ++
L.NP ++ ++ ++ ++
L.IAF ++ +++ +++ ++
L.OAF ++ ++ + +
Table 4.2: The expression of non-collagenous markers and the level of
expression in FSU cell types at passage two. C: cervical, T: thoracic, L: lumbar
cells. F: Facet, IAF: inner AF, OAF: outer AF, AF: annulus fibrosus, NP: nucleus
pulposus, FSU: Functional spinal unit. -: No expression, +: positive expression, ++:
good expression, +++: very good expression.
4.4.2.1. Collagen Type I
Collagen I expression was found to vary with cell type. For the cervical region,
staining was positive in cells from all regions of the FSU but particularly good in
the facet cartilage cells where it was present in the cytoplasm and nucleus and
appeared granular. In the inner AF and NP cells most of the staining was
nuclear. In the outer AF, the staining was largely cytoplasmic. For the thoracic
region the facet cartilage and NP cells showed little expression. In both the
inner and outer AF however there was good positive expression. This is
illustrated in Figure 4.4. The majority of the positive staining was found in the
cytoplasm but some was present within the nucleus. The staining was generally
uniform within the cells. Lastly in the lumbar region, the facet cartilage cells
displayed the most staining. This was found uniformly throughout the cytoplasm
and nucleus and appeared granular. The NP and inner AF cells showed positive
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staining of less intensity which was largely present as granular staining in the
nucleus. No staining was observed in the outer AF cells.
Figure 4.4: Ovine thoracic (T5-T7) facet cartilage (A) and outer AF (B) cells
stained with mouse anti-sheep collagen type I monoclonal antibody (i) and
mouse IgG1 isotype control (ii) together with rabbit anti-mouse FITC-conjugated
secondary antibodies. 40x magnification. AF: Annulus fibrosus.
4.4.2.2. Collagen Type II
Collagen II expression varied between different cell types. For the cervical
region, the greatest staining intensity was seen in the inner AF cells (Figure
4.5B). The staining was located within the cytoplasm and was granular. There
were some areas within the nucleus which also contained granular staining. The
staining was less intensive but evidently positive within the facet cartilage cells
(Figure 4.5A). The pattern of staining was similar to the inner AF cells. The
same was observed for the NP cells. The outer AF cells in the cervical region
had the lowest intensity of collagen II staining.
B.ii.B.i.
A.ii.A.i.
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Figure 4.5: Ovine cervical (C2/C3) facet cartilage (A) and inner AF (B) cells
stained with mouse anti-sheep collagen type II monoclonal antibody (i) and
mouse IgG1 isotype control (ii) together with rabbit anti-mouse FITC-conjugated
secondary antibodies. 40x magnification. AF: Annulus fibrosus.
In the thoracic region, a different pattern of staining was observed between the
cells. Very little staining was observed in the facet cartilage cells. The difference
between the collagen II staining and the isotype control was the presence of
small concentrated granules in the cytoplasm. The outer AF cells showed the
highest level of staining which appeared as concentrated granules similar to
that seen in the cervical facet cartilage cells but of greater intensity. The
staining was mainly in the cytoplasm but was also observed in the nucleus.
4.4.2.3. Collagen Type III
Collagen III staining varied between different cell types. In the cervical region,
the most intense staining was found in the NP and inner AF cells in comparison
to the isotype control. The facet cartilage cells showed good staining intensity
whilst the outer AF cells stained positive. The staining was present in the
cytoplasm and was generally uniform in the different cell types. No staining was
A.i. A.ii.
B.i. B.ii.
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found in the nucleus. An example of collagen III staining within the inner AF and
outer AF cells in the cervical region is shown in Figure 4.6.
Figure 4.6: Ovine cervical (C2/C3) inner AF (A) and outer AF (B) cells stained with
rabbit anti-sheep collagen type III rabbit polyclonal antibody (i) and rabbit IgG
isotype control (ii) together with Goat anti-rabbit FITC-conjugated secondary
antibodies. 40x magnification. AF: Annulus fibrosus.
In the thoracic region, the facet cartilage cells did not express collagen III. The
NP and inner AF cells showed positive expression and the outer AF cells
showed good expression. As with the cervical region, the staining was limited to
the cytoplasm and no staining was present within the nucleus. In the lumbar
region, the staining was good in the facet cartilage cells and inner AF cells but
negative in the NP and outer AF cells. The staining patterns were the same as
observed in the cervical and thoracic cells.
A.i. A.ii.
B.i. B.ii.
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4.4.2.4. Collagen Type V
Collagen type V staining was absent in all cell types. An example of cervical
and lumbar outer AF cells stained with antibodies to collagen type V is shown in
Figure 4.7.
Figure 4.7: Ovine cervical (C2/C3) outer AF (A) and lumbar (L5/6) outer AF (B)
cells stained with mouse anti-sheep collagen type V monoclonal antibody (i) and
mouse IgG2a isotype control (ii) together with Goat anti-mouse FITC-conjugated
secondary antibodies. 40x magnification. AF: Annulus fibrosus.
4.4.2.5. Collagen Type VI
Collagen type VI staining varied amongst the different cells types. In the cervical
region, good staining was observed for the facet cartilage, NP and inner AF
cells. Staining in the outer AF cells was just positive. In the thoracic region,
good staining was found in the facet cartilage and NP cells but only positive in
the inner and outer AF cells. In the lumbar region, very good staining was
observed in the NP and outer AF cells and good staining in the facet cartilage
and inner AF cells. An example of the staining in lumbar outer AF cells and
thoracic inner AF cells is shown in Figure 4.8.
B.i.
A.ii.
B.ii.
A.i.
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Figure 4.8: Ovine lumbar (L5/L6) outer AF (A) and thoracic (T5-T7) inner AF (B)
cells stained with rabbit anti-sheep collagen type VI polyclonal antibody (i) and
rabbit IgG isotype control (ii) together with Goat anti-rabbit FITC-conjugated
secondary antibodies. 40x magnification. AF: Annulus fibrosus.
The staining distribution patterns within the cells were the same across all
cervical, thoracic and lumbar regions. The staining was within the cytoplasm
outside the nucleus and was uniform without any accumulation in particular
areas.
4.4.2.6. Collagen Type X
The staining intensities of collagen type X in the FSU cells were either positive
or negative. In the cervical region, the cells of the inner AF were negative whilst
the cells in the facet cartilage, NP and outer AF were positive in comparison to
the isotype controls. The staining distribution within the positive cells was
confined to the cytoplasm with no staining in the nucleus. The staining was not
uniform and appeared more intense in some areas than others giving a
speckled appearance. In the FSU cells from the thoracic region, facet cartilage
and NP cells stained positively whilst AF cells, both in the inner and outer
A.i.
B.ii.B.i.
A.ii.
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regions were negative. In the lumbar region, all cells were negative for collagen
type X with the exception of the outer AF cells which were positive. An example
of the immunofluorescence in cervical outer AF cells and thoracic facet cartilage
cells is shown in Figure 4.9.
Figure 4.9: Ovine cervical (C2/C3) outer AF (A) and thoracic (T5-T7) facet (B) cells
stained with mouse anti-sheep collagen type X monoclonal antibody (i) and
mouse IgM isotype control (ii) together with Goat anti-mouse FITC-conjugated
secondary antibodies. 40x magnification. AF: Annulus fibrosus.
The staining distributions in the thoracic and lumbar cells were the same as
observed in the cervical FSU cells.
4.4.2.7. Chondroitin-6-sulphate
FSU cells in all regions were positive for chondroitin-6-sulphate with staining
intensity ranging from good to very good in comparison to the isotype control. In
the cervical region, facet cartilage, NP and inner AF cells showed good staining
patterns with outer AF cells showing just a positive result. In the thoracic region,
all FSU cells showed good staining. In the lumbar region, facet cartilage, NP
and outer AF cells showed good staining and inner AF cells showed very good
A.i. A.ii.
B.ii.B.i.
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staining. An example of chondroitin-6-sulphate staining in thoracic facet
cartilage cells and lumbar inner AF cells is shown in Figure 4.10.
Figure 4.10: Ovine thoracic (T5-T7) facet cartilage (A) and lumbar (L5/L6) inner
AF (B) cells stained with mouse anti-sheep chondroitin-6-sulphate monoclonal
antibody (i) and mouse IgG1 isotype control (ii) together with goat anti-mouse
FITC-conjugated secondary antibodies. 40x magnification. AF: Annulus fibrosus.
The staining patterns within the FSU cells immunofluorescently stained with
antibodies to chondroitin-6-sulphate were both cytoplasmic and nuclear. Most
areas of staining were granular in appearance with intensely stained regions
showing more uniform staining. Most intense staining appeared to be located
near the nucleus of the cells. In the nucleus, the staining was randomly
distributed and granular.
4.4.8. CD44
CD44 staining was positive in all the FSU cells from different regions and
intensities varied. In the cervical region, the NP and inner AF cells showed very
good staining whilst the facet cartilage and outer AF cells were only positively
stained. In the thoracic region, the facet cartilage and outer AF cells showed
A.i. A.ii.
B.i. B.ii.
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good staining and the NP and inner AF cells were only positive. In the lumbar
region, the facet cartilage cells showed positive staining whilst the NP, inner
and outer AF cells showed good staining. An example of the staining patterns in
cervical inner AF cells and lumbar facet cartilage cells is shown in Figure 4.11.
Figure 4.11: Ovine cervical (C2/C3) inner AF (A) and lumbar (L5/L6) facet
cartilage (B) cells stained with rat anti-sheep CD44 monoclonal antibody (i) and
rat IgG1 isotype control (ii) together with rabbit anti-rat FITC-conjugated
secondary antibodies. 40x magnification. AF: Annulus fibrosus.
The staining patterns within the FSU cells appeared to be mainly cytoplasmic
and slightly nuclear. Most of the expression appeared more intense around the
nucleus of the cell and around the membrane. Staining within the nucleus was
generally uniform; however, in some areas the staining was slightly speckled
evenly throughout the nucleus.
4.4.2.9. Fibronectin
All the FSU cells stained positively for fibronectin and the level of intensities
varied amongst the cells across the different regions. In the cervical region, the
NP and inner AF cells showed very good expression whilst the facet cartilage
A.i.
B.i. B.ii.
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cells showed good expression and outer AF cells stained positively. In the
thoracic region, facet cartilage and NP cells had very good expression of
fibronectin whilst inner and outer AF cells showed good expression. In the
lumbar region, the inner AF cells showed very good expression. The facet
cartilage and NP cells showed good expression and the outer AF cells gave a
positive result. An example of fibronectin staining in lumbar facet cells and
cervical NP cells is shown in Figure 4.12.
Figure 4.12: Ovine lumbar (L5/L6) facet (A) and cervical (C2/C3) NP cartilage (B)
cells stained with mouse anti-sheep fibronectin monoclonal antibody (i) and
mouse IgG1 isotype control (ii) together with goat anti-mouse FITC-conjugated
secondary antibodies. 40x magnification. NP: Nucleus pulposus.
The staining patterns of the cells were largely pericellular and cytoplasmic with
slight staining in the nucleus. Long, thin patterns were seen distributed in the
intercellular space and pericellular. The highest level of intensities was seen in
these regions. The cells appeared to make connections to one another through
these thin projections. Some staining was observed in the nuclear space and
this appeared mostly diffuse and random with few speckled regions.
A.i. A.ii.
B.ii.B.i.
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4.4.2.10. SOX-9
All FSU cells across the different regions expressed different levels of SOX-9. In
the cervical region, facet cartilage cells showed positive expression and NP
cells showed good expression. Both inner and outer AF cells showed very good
expression. In the thoracic region, both facet and outer inner AF cells showed
very good expression. NP cells showed good expression whilst inner AF cells
showed only positive expression. In the lumbar region, facet cartilage, NP and
inner AF cells showed good expression whilst the outer AF cells only showed
positive expression. Examples of SOX-9 staining in cervical outer AF cells and
lumbar facet cartilage cells are shown in Figure 4.13.
Figure 4.13: Ovine cervical (C2/C3) outer AF (A) and lumbar (L5/L6) facet
cartilage (B) cells stained with rabbit anti-sheep SOX-9 polyclonal antibody (i)
and rabbit IgG isotype control (ii) together with goat anti-rabbit FITC-conjugated
secondary antibodies. 40x magnification. AF: Annulus fibrosus.
In comparison to the isotype controls, the staining in all cell types was confined
to the nucleus. The staining was diffuse and covered all parts of the nucleus
with some speckled areas containing a higher concentration of the
fluorescence.
A B CD E FJ
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4.4.3. Characterisation of the IVD and Facet Cartilage using H&E Stained
Histological Sections of Ovine FSU tissue
H&E was used to stain ovine facet cartilage and IVD tissues to determine the
organisation and distribution of the cells and ECM in cervical, thoracic and
lumbar regions.
The cervical AF tissue in all three replicates of the three to four year old age
group showed intact lamellae with minimal fissures. The cells were randomly
distributed. The thickness of the lamellae layers varied across the section of the
AF. Dense fibrous tissue was present in between the layers and occasionally
passed across them. The NP tissue in the three cervical replicates appeared
homogenous. The colour of the eosin stain was light pink and no dense fibrous
tissue or fissures were present. The cells were contained within their lacunae
and the haematoxylin stain was confined to the nuclei. The cells were randomly
distributed and no clusters were present. The cervical CEPs were relatively
thick in comparison to the thoracic and lumbar regions and contained randomly
distributed cells confined within lacunae. The eosin stain became darker
towards the deeper layers of the CEP where it met the subchondral bone. The
thickness of the CEP remained constant along the length of the AF/NP section.
The CEP followed a curved path along the length of the AF/NP section in
comparison to the thoracic and lumbar CEPs which were relatively straight.
The cervical facet sections showed articular cartilage which was thicker in
comparison to the thoracic and lumbar regions. The cartilage was divided into
four zones. The top superficial layers contained flat chondrocytes randomly
distributed. The middle and deep zones were comparably thicker and contained
chondrocytes randomly arranged in groups within lacunae of approximately four
cells. The deep zone contained chondrocytes which were stacked on top of
each other. Each zone within the articular cartilage was thicker than that of the
thoracic and lumbar regions. The calcified zone was present near the
subchondral bone and was stained more darkly with eosin than the upper layers
particularly around the lacunae. The thickness of the calcified zone was
relatively constant along the length of the cartilage. The cells that were present
within the calcified zone appeared more stacked in comparison to the upper
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zones. The subchondral bone within cervical facet cartilage was relatively
uniform and budded into the calcified zone. The middle zone of cervical facet
cartilage was less intensely stained by eosin in comparison to the other zones.
Examples of H&E stained sections of cervical AF, NP, CEP and facet cartilage
are shown in Figure 4.14.
Figure 4.14: H&E stained facet cartilage and IVD sagittal sections from C6/C7. A:
AF, B: NP, C: CEP, D: Facet cartilage. H&E: Haematoxylin and eosin, AF: Annulus
fibrosus, NP: Nucleus pulposus, CEP: Cartilage end plate.
The thoracic AF tissue showed dense tissue arranged in lamellae as in the
cervical and lumbar regions. The thickness of the lamellae layers appeared to
differ throughout the length of the AF section, similar to that of the cervical AF.
The layers appeared thin in comparison to the cervical lamellae. The colour of
the eosin stain within the lamellae was constant; however, the colour in
between in the layers was much lighter in comparison. Small amounts of fibrous
tissue ran between the layers and occasionally across the lamellae layers as
seen in the cervical AF. The cells within the AF were randomly distributed and
minimal cell clustering was observed. The haematoxylin stain was confined to
the nuclei and did not extend to the lacunae. The thoracic NP tissue appeared
A
DC
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similar to that of the cervical NP and was homogenous. The eosin stain was a
light pink colour and occasional deepening of the colour was observed
indicating the presence of a few fibres. The cells were randomly distributed and
no cell clustering was observed. The thoracic CEP appeared thin in comparison
to the cervical CEP and its thickness was constant along the AF/NP section.
Eosin stained the CEP darker pink in comparison to the IVD tissue. The cells
were randomly distributed within the CEP and contained within lacunae.
Occasional lacunae were observed which contained no cells. The haematoxylin
stain appeared to spread from some of the cells to the surrounding lacunae.
The boundary between the CEP and subchondral bone was relatively flat.
Some small, transverse fissures were present.
The histology sections of the facet cartilage in the three thoracic replicates
showed that the cartilage was arranged into four zones similar to the cervical
facet cartilage but had less depth. Few cells were seen in the superficial layer
but the ones that were observed were flat and randomly distributed over a small
depth. The cells in the middle and deep zones were stacked on top of one
another and arranged in lacunae of approximately three cells. Many lacunae
were present in the calcified zone with some containing no cells. The boundary
between the calcified zone and subchondral bone was relatively constant along
the length of the cartilage. The cells in the subchondral bone were randomly
distributed. The darkness of the eosin stain appeared to vary along the depth of
the cartilage. The superficial, deep and calcified zones were more intensely
stained in comparison to the middle zone. The same was observed for cervical
facet cartilage. Examples of some H&E stained FSU tissue sections from the
thoracic region are shown in Figure 4.15.
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Figure 4.15: H&E stained facet cartilage and IVD sagittal sections from T11/T12.
A: AF, B: NP, C: CEP, D: Facet cartilage. H&E: Haematoxylin and eosin, AF: Annulus
fibrosus, NP: Nucleus pulposus, CEP: Cartilage end plate.
The lumbar AF showed many similarities to both the cervical and thoracic AF.
Dense fibrous tissue was arranged into lamellae. The lamellae layers were
slightly thinner in comparison to the cervical lamellae. The thickness of the
layers across the section of AF appeared to vary. Again as with the thoracic AF,
the colour of the eosin stain within the lamellae was constant; however, the
colour in between in the layers was much lighter in comparison. Thin fibrous
tissue lined the lamellae layers and also passed through them occasionally
throughout the AF structure. The cells within the lumbar AF showed similar
characteristics to that of the cervical and thoracic AF and were randomly
distributed. The haematoxylin stain was confined to the nuclei and did not
spread to the lacunae. The lumbar NP tissue showed the same characteristics
as that of both cervical and thoracic NPs. The NP tissue was homogenous and
was stained a light pink colour by eosin. The cells were randomly distributed
and contained within their lacunae. No cell clusters were present. The
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haematoxylin stain of the NP cells was confined to the nuclei and did not spread
to the lacunae. There were occasional areas of darkening indicating the
presence of few fibres. The lumbar CEP had similar features of that of the
thoracic region. The CEP was thin and constant along the length of the AF/NP
section. The colour of the eosin stain was darker in comparison to the IVD
tissue. There were many randomly distributed lacunae some containing no
cells. The subchondral bone was more darkly stained with eosin and budded
into the CEP but at a constant level and thickness throughout the length of the
CEP. Very few fissures were present.
The three lumbar facet cartilages were not as thick in comparison to the cervical
and thoracic cartilage. The cartilage was still divided into four zones; however,
these had less depth in comparison to those of the cervical and thoracic facet
cartilage. Few cells were seen in the superficial zone and these were not as flat
as those seen in the cervical and thoracic sections. The cells in the middle and
deep zones contained stacked cells in lacunae containing approximately two
cells, less than both the cervical and thoracic sections. The calcified zone
contained similar stacking patterns of chondrocytes in lacunae. The
haematoxylin stain around the cells appeared to spread into the lacunae in this
zone. The subchondral bone showed similar patterns to that of the cervical and
thoracic region and remained relatively constant along the length of the
cartilage in the three lumbar replicates. The colour of the eosin stain varied
across the depth of the cartilage with the superficial and calcified zones
appearing more intensely stained compared to the middle and deep zones.
Similar patterns were observed in both the cervical and thoracic sections. An
example of some H&E stained FSU tissue sections from the thoracic region are
shown in Figure 4.16.
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Figure 4.16: H&E stained facet cartilage IVD sagittal sections from L1/L2. A: AF,
B: NP, C: CEP, D: Facet cartilage. H&E: Haematoxylin and eosin, AF: Annulus
fibrosus, NP: Nucleus pulposus, CEP: Cartilage end plate.
4.4.4. Characterisation of the IVD and Facet Cartilage using Alcian Blue
Stained Histological Sections of Ovine FSU tissue
Alcian blue was used to stain sections of all three replicates of cervical, thoracic
and lumbar facet cartilage and IVD tissue to determine the distribution of GAGs.
The cervical AF was deeply stained with alcian blue in all three replicates. The
intensity of the stain was found to increase from the outer AF to the inner AF.
The fibres running in between the lamellae layers stained more intensely than
the fibres within the lamellae. The cells and surrounding lacunae of the AF did
not stain. The NP tissue was less intensely stained than the AF but varied in the
three replicates. The stain was distributed in patches throughout the ECM with
the cells appearing to capture more of the stain than the ECM. Alcian blue
intensely stained the cells within the NP and this appeared to spread out to the
surrounding lacunae. The CEP appeared to capture more of the stain than the
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NP. The distribution of the stain throughout the CEP appeared constant and
stopped at the subchondral bone where the colour became a lighter blue/pink.
The staining intensity within the cells and surrounding lacunae appeared the
same as that of the ECM. However, in one of the three replicates the stain was
less intense with areas of light blue/pink stain distributed randomly.
The facet cartilage in all three cervical samples was intensely stained with
alcian blue. This appeared relatively constant throughout most of the cartilage
with the superficial layer being the most intense. The stain became lighter in
some parts of the calcified region. The stain became light blue/pink at the
subchondral bone. Examples of alcian blue stained sections of the cervical AF,
NP, CEP and facet cartilage is shown in Figure 4.17.
Figure 4.17: Alcian blue stained facet cartilage and IVD sagittal sections from
C6/C7. A: AF, B: NP, C: CEP, D: Facet cartilage. IVD: Intervertebral disc, AF: Annulus
fibrosus, NP: Nucleus pulposus, CEP: Cartilage end plate.
Alcian blue stained sections of the thoracic AF showed similar patterns to that of
the cervical AF. The intensity of the stain increased from the outer AF to the
inner AF. The stain intensity was greater in between the lamellae layers than
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within them. This was true for all three replicates. The staining patterns within
the NP were similar to that in the cervical region. The stain was less intense
than the AF and distributed randomly in patches. Alcian blue intensely stained
the NP cells and the surrounding lacunae. This was observed for all three
replicates. The staining within the thoracic CEP varied with some parts showing
a pink/purple colour within the ECM. These variations were seen in all three
replicates. The cells and their surrounding lacunae also took up the stain and
appeared bluer in comparison to the ECM. The blue colour was absent in the
subchondral bone with the colour becoming light pink.
The facet cartilage in all thoracic samples did not show as much intensity as the
cervical samples. The superficial layer showed the deepest blue staining and
both the middle and deep zones were more lightly stained in comparison. The
distribution of colour within the middle and deep zones was random with some
parts more deeply stained than others. The colour in the calcified zone was
pink/purple however, the cells and their lacunae were deeply stained blue. Less
intense staining was observed in the calcified zone in comparison to the cervical
samples. The colour was lighter in the subchondral bone. The same
observations were recorded for all replicates in the thoracic region. Examples of
alcian blue stained sections of the AF, NP, CEP and facet cartilage in the
thoracic region are shown in Figure 4.18.
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Figure 4.18: Alcian blue stained facet cartilage and IVD sagittal sections from
T11/T12. A: AF, B: NP, C: CEP, D: Facet cartilage. IVD: Intervertebral disc, AF:
Annulus fibrosus, NP: Nucleus pulposus, CEP: Cartilage end plate.
The sections of the lumbar AF showed similar alcian blue staining patterns to
that of the cervical and thoracic sections. The intensity of the stain increased
from the outer to inner AF and greater staining was observed between the
lamellae layers rather than within them. Similar trends were seen in all three
replicates. The lumbar NP also showed similar patterns to that of the cervical
and thoracic samples. The stain was less intense than that in the AF and was
distributed randomly in patches. The cells of the NP had taken up the stain and
were found to spread to the surrounding lacunae. Similar to the thoracic CEP,
the distribution of the alcian blue stain in the lumbar CEP varied throughout the
length of the AF/NP section with some patches of pink/purple staining. The
colour of the stain abruptly changed from a deep blue colour to light pink at the
subchondral bone. The lacunae of the cells appeared more intensely stained
than the surrounding ECM. In general, the colour of the CEP was bluer in
comparison to the IVD tissue surrounding it. The lumbar CEP samples showed
similar features to that of the thoracic samples. The most intense staining was
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observed in the superficial layer. This intensity decreased but was still strong in
the middle and deep zones. In the calcified zone, the ECM stained pink/purple
with only the cells and their lacunae staining a deep blue colour. The colour of
the subchondral bone was light pink.
Similarly to the thoracic facet cartilage sections, the distribution of the stain
within the middle and deep zones appeared patchy with some areas more
intense than others. The lacunae in these zones were less intensely stained
than those in the calcified zones. These observations were present in all three
replicate samples. Examples of alcian blue stained sections of the AF, NP, CEP
and facet cartilage are shown in Figure 4.19.
Figure 4.19: Alcian blue stained facet cartilage and IVD sagittal sections from
L1/L2. A: AF, B: NP, C: CEP, D: Facet cartilage. IVD: Intervertebral disc, AF: Annulus
fibrosus, NP: Nucleus pulposus, CEP: Cartilage end plate.
4.4.5. Characterisation of the IVD and Facet Cartilage using Sirius Red
Stained Histological Sections of Ovine FSU tissue
Sirius red staining was viewed under polarised light and was used to stain FSU
tissue to determine the distribution of collagen. The cervical AF stained
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positively for Sirius red throughout all the sections of all three replicates. The
colour of the stain within the AF was red and orange indicating the presence of
large mature collagen fibres. The staining intensity between different lamellae
layers appeared to alternate throughout the length of the AF. The most intense
staining appeared to be within the lamellae layers rather than between them.
These collagen staining patterns appeared constant throughout the length of
the AF in the section and did not vary. No staining was observed in the cervical
NPs. The staining within the cervical CEP appeared random but consistent
throughout the AF/NP sections in all three replicates. The colour of the staining
in the CEP was largely red/orange indicating the presence of large mature
collagen fibres. The staining became greener in colour towards the surface of
the CEP. Gaps in the staining were seen where the cells were situated.
In the cervical facet cartilage, the collagen distribution appeared organised. The
collagen was confined to the superficial, deep and calcified zones. The staining
within these regions was patchy with some parts showing more intensity than
others. The colour of the staining was largely red/orange in most parts but
green in the upper deep zone. The staining intensity was greatest in the
calcified zone. The staining was visible within the lacunae of cells. There was
no staining in the middle zones. Examples of Sirius red stained sections of the
cervical AF, NP, CEP and facet cartilage are shown in Figure 4.20.
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Figure 4.20: Sirius Red stained facet cartilage and IVD sagittal sections from
C6/C7. A: AF, B: NP, C: CEP, D: Facet cartilage. IVD: Intervertebral disc, AF: Annulus
fibrosus, NP: Nucleus pulposus, CEP: Cartilage end plate.
The staining within the thoracic AF showed similar characteristics to that of the
cervical AF. The intensity of the stain remained constant throughout the length
of the AF. The lamellae layers themselves were highly stained rather than the
tissue in between them as is seen in the cervical AF. The colour of stain was
red and orange. Small traces of stain were observed in the thoracic NP and this
was white/green in colour indicating the presence of thin, perhaps newly formed
collagen fibres. Very little staining was observed in the thoracic CEP in
comparison to the cervical CEP. As with the cervical CEP the staining within the
tissue was random and patchy with some areas showing more intensity than
others. The intensity of the staining was much higher in the underlying
subchondral bone. The colour of the staining in the CEP was largely red and
orange.
The thoracic facet cartilage showed similar patterns to the cervical facet
cartilage with the superficial, deep and calcified zones staining positively for
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collagen. The staining within these zones varied between samples and was
patchy. The colour of the staining was red and orange. Very little staining was
observed in the middle zone. In some replicates, the superficial zone was less
intensely stained in comparison to that in the cervical facet cartilage. Examples
of Sirius red stained sections of the AF, NP, CEP and facet cartilage are shown
in Figure 4.21.
Figure 4.21: Sirius Red stained facet cartilage and IVD sagittal sections from
T11/T12. A: AF, B: NP, C: CEP, D: Facet cartilage. IVD: Intervertebral disc, AF:
Annulus fibrosus, NP: Nucleus pulposus, CEP: Cartilage end plate.
The staining of Sirius red within the lumbar AF showed similar staining patterns
to that in both the cervical and thoracic AF. The level of staining throughout the
structure from the outer to inner AF remained constant. The stain was confined
to within the densely packed lamellae layers and not in between them. The
colour of the staining was red/orange. No staining was observed in the NP
samples. The staining in the lumbar CEP was similar to that observed in the
cervical and thoracic CEPs. Along the depth and length of the AF/NP it was
constant. The collagen fibres appeared to be randomly orientated in all three
replicates. The intensity of the stain greatly increased at the subchondral bone.
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The colour of the staining was red/orange but green above its surface, similar to
the thoracic sections. The staining patterns in the facet cartilage were similar to
those observed in the cervical and thoracic samples. The most intensely stained
zones were the superficial, deep and calcified zones. As with the cervical and
thoracic samples, the staining in these regions was distributed randomly. Some
staining in the middle zones was observed in some of the replicates. The colour
of the staining in the lumbar facet cartilage was similar to that in the thoracic
samples with large amounts of red/orange stain with no green staining as seen
in the cervical samples. Examples of Sirius red stained sections of the lumbar
AF, NP, CEP and facet cartilage are shown in Figure 4.22.
Figure 4.22: Sirius red staining of facet cartilage and IVD sagittal sections from
L1/L2. The AF, NP and CEP in cervical, thoracic and lumbar regions were stained. A:
C6/C7, B: T11/T12, C: L1/L2. IVD: Intervertebral disc, AF: annulus fibrosus, NP:
nucleus pulposus, CEP: cartilage end plate.
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4.4.6. Characterisation of the IVD and Facet Cartilage using Miller`s Elastin
Stained Histological Sections of Ovine FSU tissue
Miller’s elastin staining was used to stain FSU tissue sections to determine the
distribution of elastin. The cervical AF appeared to stain positively for elastin
within and between the lamellae layers. Elastin fibres were observed passing in
between the red lamellae layers of the AF and were thin and blue in colour. This
was found along the whole length of the AF and in all three replicates. In the
cervical NP, blue staining was found to be present within the cells and the
surrounding lacunae. The ECM was very faintly stained red. Small traces of
blue stain were found randomly distributed in the ECM. The sections of the
cervical CEP showed positive staining around the lacunae of the cells with the
presence of blue staining. The ECM was largely stained red. Some positive
blue/black staining was also observed randomly throughout the ECM. This was
found along the length of the CEP in all three replicate samples. The staining
within the ECM of the CEP was random. The facet cartilage was largely stained
red. Some positive blue staining was observed around the lacunae of cells.
Examples of Miller’s elastin stained sections of the cervical AF, NP, CEP and
facet cartilage are shown in Figure 4.23.
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Figure 4.23: Miller’s elastin stained facet cartilage and IVD sagittal sections from
C6/C7. The AF, NP and CEP in cervical, thoracic and lumbar regions were stained. A:
C6/C7, B: T11/T12, C: L1/L2. IVD: Intervertebral disc, AF: annulus fibrosus, NP:
nucleus pulposus, CEP: cartilage end plate.
Miller’s elastin staining within the thoracic tissues was the same as that
observed in the cervical AF. Red/blue staining was observed in between the red
lamellae layers and in fibrous tissues crossing over between the layers. The
red/blue fibres in between the lamellae were thin in appearance. This was
consistent along the entire length of the AF section in all three replicates.
Staining in the thoracic NP was also similar to that observed in the cervical NP.
Most of the blue staining was found to be located around the lacunae of the
cells. Some traces of positive blue staining was also found randomly distributed
in the ECM. Much of the faint staining within the ECM however was red. This
was observed in all three replicate samples. Staining of the thoracic CEP varied
between the three replicate samples. In two of the replicates, the staining was
found to be random and located largely around the lacunae of the cells with
small amounts distributed in the ECM. In one of the replicates, a band of
positive blue staining was observed in the upper half of the CEP structure and a
A B
C D
Chapter 4
194
band of red staining was found in the lower half (Figure 4.24C). The staining
here was found to be largely red but with some trace of blue staining throughout
the ECM and around the lacunae of the cells. Some small amounts of positive
blue staining were observed in the lacunae of facet cartilage in all replicate
samples as was observed in the cervical samples however the staining here
was largely red. Examples of Miller’s elastin stained sections of the thoracic AF,
NP, CEP and facet cartilage are shown in Figure 4.24.
Figure 4.24: Miller’s elastin stained facet cartilage and IVD sagittal sections from
T11/T12. The AF, NP and CEP in cervical, thoracic and lumbar regions were stained.
A: C6/C7, B: T11/T12, C: L1/L2. IVD: Intervertebral disc, AF: annulus fibrosus, NP:
nucleus pulposus, CEP: cartilage end plate.
Miller’s elastin staining within the lumbar AF showed the same characteristics
as that of the cervical and thoracic samples. Positive blue staining was
observed between the layers of the lamellae, which stained red, and in fibres
crossing between the layers. The blue fibres were thin in appearance. This was
observed along the entire length of the AF and in all three replicates. The NP
cells in the lumbar sections did not contain as much blue stain as those in the
cervical and thoracic NP sections. This was an observation for all three replicate
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samples. Some traces of blue staining were observed in the ECM of the lumbar
NP samples however it was mostly red in colour. The lumbar CEP showed the
same characteristics as those observed in the cervical and thoracic samples.
The stain, which was largely red in colour, was found randomly distributed in the
ECM and around the lacunae of cells. Blue staining was also present around
some lacunae. Similarly to the cervical and thoracic facet cartilage samples,
minimal blue staining was observed around the lacunae of cells in the lumbar
facet cartilage which was largely stained red. A band of dark red staining was
observed in the deep zone in one of the replicates (Figure 4.25D). Examples of
Miller’s Elastin stained sections of the lumbar AF, NP, CEP and facet cartilage
are shown in Figure 4.25.
Figure 4.25: Miller’s elastin stained facet cartilage and IVD sagittal sections from
L1/L2. The AF, NP and CEP in cervical, thoracic and lumbar regions were stained. A:
C6/C7, B: T11/T12, C: L1/L2. IVD: Intervertebral disc, AF: annulus fibrosus, NP:
nucleus pulposus, CEP: cartilage end plate.
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4.4.7. Localisation of Specific Markers within the Ovine IVD and Facet
Cartilage
A selection of antibodies used to phenotype the FSU cells were also used to
identify the location of specific markers in three year old Texel ovine FSU tissue
from replicates five, six and seven from the natural history study (Chapter 3).
4.4.7.1. Collagen Type I
Facet cartilage from all replicates and all regions including cervical, thoracic and
lumbar facet cartilage did not positively stain in any of the four zones of
cartilage in the ECM, lacunae or cells with antibodies to collagen type I. The
underlying subchondral layer of cartilage was stained positively in all samples.
An example of collagen type I staining within a section of facet cartilage is
shown in Figure 4.26.
Figure 4.26: Ovine cervical (5.C6/C7) facet cartilage stained with mouse anti-
sheep collagen type I monoclonal antibody (A) and mouse IgG1 isotype control
(B). 40x magnification.
Collagen type I staining was visible throughout most of the AF in all replicate
samples in cervical, thoracic and lumbar regions. It was particularly evident
within the outer AF where the intensity of the stain was at its highest. Within the
AF, the staining was distributed randomly. Some lamellae were more intensely
stained than others. The edges of each lamella were, in general, more intensely
stained than within the layers. Staining was seen around some of the cells
within the AF structure. Similarly to the facet cartilage, no staining was visible in
the CEP only in the underlying subchondral bone. This was observed in all
replicate samples from cervical, thoracic and lumbar regions. In the majority of
the samples, no staining was observed in the NP. However, for three samples
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in the cervical, thoracic and lumbar region, some staining was visible around the
lacunae of the NP cells. The intensity of the stain in these samples varied.
Examples of IVD sections stained with antibody to collagen type I are shown in
Figure 4.27.
Figure 4.27: Ovine lumbar (6.L1/L2) AF (A), thoracic (6.T11/T12) CEP (B) and
lumbar (7.L1/L2) NP (C) sections stained with mouse anti-sheep collagen type I
monoclonal antibody (i) and mouse IgG1 isotype control (ii). 40x magnification.
AF: Annulus fibrosus, CEP: cartilage end plate, NP: Nucleus pulposus.
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4.4.7.2. Collagen Type II
Facet cartilage in all replicates and regions stained positively for collagen type
II. In general, all zones of cartilage and underlying subchondral bone were
stained. The superficial, middle and calcified zones were more intensely stained
than the deep zone. This was observed for all replicate samples from all three
regions. The stain within these zones was randomly distributed. The intensity of
the stain did not increase around the chondrocytes or lacunae. An example of
staining within facet cartilage is shown in Figure 4.28.
Figure 4.28: Ovine cervical (6.C6/C7) facet cartilage sections stained with mouse
anti-sheep collagen type II monoclonal antibody (A) and mouse IgG1 isotype
control (B). 40x magnification.
The tissues of the ovine IVD stained positively for collagen type II. The majority
of the collagen type II stain within the AF was found in the inner AF, however,
the whole structure stained positively. Similarly to the facet cartilage, the stain
did not intensify around the cells. Within the inner AF, the stain intensified
around the edges of the lamellae layers. This was observed in all replicate
samples from all three regions. In the CEP, the stain was distributed randomly
in all replicates and regions. The stain was dispersed throughout the ECM. In
some samples, there was some accumulation of the stain around the lacunae of
the cells. Some samples stained more positively than others. Collagen type II
staining continued through to the subchondral bone as was observed in facet
cartilage. Collagen type II staining was dispersed randomly throughout all NP
samples. There was no accumulation of the stain around the lacunae of the
cells. Some samples stained more positively than others. Examples of IVD
sections stained with antibody to collagen type II are shown in Figure 4.29.
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Figure 4.29: Ovine cervical (6.C6/C7) AF (A), lumbar (7.L1/L2) CEP (B) and
thoracic (5.T11/T12) NP (C) sections stained with mouse anti-sheep collagen type
II monoclonal antibody (i) and mouse IgG1 isotype control (ii). 40x magnification.
AF: Annulus fibrosus, CEP: cartilage end plate, NP: Nucleus pulposus.
4.4.7.3. Collagen Type III
Facet cartilage in all replicate samples from all three regions stained positively
for collagen type III. The stain accumulated in lacunae and the surrounding
space around them in all four zones of the cartilage including the subchondral
bone. This was observed in all replicate samples from all cervical, thoracic and
lumbar regions. An example of collagen type III staining in facet cartilage is
shown in Figure 4.30.
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Figure 4.30: Ovine cervical (6.C6/C7) facet cartilage sections stained with rabbit
anti-sheep collagen type III polyclonal antibody (A) and rabbit IgG isotype control
(B). 40x magnification.
The tissues of the IVD stained positively for collagen type III in all replicate
samples from all three regions. The whole AF was positively stained. The stain
appeared to accumulate between the lamellae layers and around the cells of
the AF. This was observed in all samples and no differences were found
between the three regions. Staining within the CEP was mostly found around
the cells and their lacunae. Some very faint staining was also observed in the
ECM. The intensity of the stain varied between the samples but the same
observations were made. Similar observations were made within the NP where
most of the positive staining was confined to the cells and their surrounding
lacunae. Very faint staining was also observed randomly throughout some parts
of the ECM. Again, the level of intensity varied between the sample but no
differences were observed between the cervical, thoracic and lumbar regions.
Examples of IVD sections stained with antibody to collagen type III are shown in
Figure 4.31.
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Figure 4.31: Ovine lumbar (6.L1/L2) AF (A), thoracic (7.T11/T12) CEP (B) and
lumbar (6.L1/L2) NP (C) sections stained with rabbit anti-sheep collagen type III
polyclonal antibody (i) and rabbit IgG isotype control (ii). 40x magnification. AF:
Annulus fibrosus, CEP: cartilage end plate, NP: Nucleus pulposus.
4.4.7.4. Collagen Type VI
Facet cartilage in all replicates samples from all three regions stained positively
for collagen type VI. The staining patterns within facet cartilage were similar to
that observed for collagen type III. The stain was present around the lacunae of
each cell. In contrast to collagen type III, the stain was not dispersed around the
lacunae and the surrounding space but was located close to the lacunae and
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cells. In some of the replicate samples, the stain was found randomly dispersed
amongst the ECM in all four zones. The middle zone appeared to be more
intensely stained in comparison to the other zones. An example of collagen type
VI staining in facet cartilage is shown in Figure 4.32.
Figure 4.32: Ovine cervical (6.C6/C7) facet cartilage sections stained with rabbit
anti-sheep collagen type VI polyclonal antibody (A) and rabbit IgG isotype
control (B). 40x magnification.
AF tissue in all replicate samples from all regions stained positively for collagen
VI. Most of staining was present around lacunae and cells and along the fibres
in between the lamellae layers. Some staining was also found distributed
randomly within the lamellae layers. There were no differences in staining
between cervical, thoracic and lumbar samples. Within the CEP tissue samples,
positive staining was found largely around the lacunae of the cells. This was
confined to the lacunae and did not spread to the surrounding areas. In some
samples small traces of staining was found randomly among the ECM. This was
observed in samples from all three regions. The intensity of the staining within
the NP varied between samples. As with the other FSU tissues, most of the
staining was confined to the lacunae of the cells. However, in most samples
there was staining present in the ECM. This was distributed randomly.
Examples of IVD sections stained with antibody to collagen type VI are shown
in Figure 4.33.
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Figure 4.33: Ovine thoracic (5.T11/T12) AF (A), lumbar (7.L1/L2) CEP (B) and
cervical (6.C6/C7) NP (C) sections stained with rabbit anti-sheep collagen type VI
polyclonal antibody (i) and rabbit IgG isotype control (ii). 40x magnification. AF:
Annulus fibrosus, CEP: cartilage end plate, NP: Nucleus pulposus.
4.4.7.5. Chondroitin Sulphate
All facet cartilage in all replicate samples from all three regions stained
positively for chondroitin sulphate. The intensity of the stain varied between
different replicate samples. In all samples staining was present in the middle
and deep zones. The staining was distributed relatively evenly in the ECM and
around the lacunae of the cells. Staining around the lacunae was slightly more
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intense than that in the ECM. No key differences were highlighted between
cervical, thoracic and lumbar samples. An example of chondroitin sulphate
staining in facet cartilage is shown in Figure 4.34.
Figure 4.34: Ovine cervical (7.C6/C7) facet cartilage sections stained with rabbit
anti-sheep chondroitin sulphate polyclonal antibody (A) and rabbit IgG isotype
control (B). 40x magnification.
All IVD tissues from all replicate samples and regions stained positively for
chondroitin sulphate. Staining in the AF was very intense but varied between
samples. The staining was found distributed relatively evenly within the tissue
between the lamellae layers and within them. No differences were observed
between cervical, thoracic and lumbar samples. Staining for chondroitin
sulphate in the CEP was random and varied between different samples. In most
of the samples there was notably less stain within the ECM in comparison to the
AF/NP tissue. Minimal staining was present in most samples and was
distributed randomly within the ECM and around some lacunae. The NP tissue
was intensely stained in all replicate samples from all regions. The stain was
evenly distributed in the ECM and lacunae of cells. No differences were
observed between cervical, thoracic and lumbar regions. Examples of IVD
sections stained with antibody to chondroitin sulphate are shown in Figure 4.35.
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Figure 4.35: Ovine cervical (7.C6/C7) AF (A), cervical (5.C6/C7) CEP (B) and
cervical (5.C6/C7) NP (C) sections stained with rabbit anti-sheep chondroitin
sulphate polyclonal antibody (i) and rabbit IgG isotype control (ii). 40x
magnification. AF: Annulus fibrosus, CEP: cartilage end plate, NP: Nucleus pulposus.
4.4.7.6. Fibronectin
Facet cartilage from all replicate samples and regions stained positively for
fibronectin. The intensity of the staining varied from sample to sample. In
general, the staining was found distributed randomly in the ECM and some
lacunae in all four zones of the cartilage. The calcified zone was more
intensively stained than the other three zones. There was no positive staining
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past the calcified zone in the subchondral bone. An example of fibronectin
staining within ovine facet cartilage is shown in Figure 4.36.
Figure 4.36: Ovine cervical (7.C6/C7) facet cartilage sections stained with mouse
anti-sheep fibronectin monoclonal antibody (A) and rabbit IgG1 isotype control
(B). 40x magnification.
All IVD tissue in replicate samples from all regions stained positively for
fibronectin. The intensity of staining within the AF varied between samples. In
general, the stain randomly distributed throughout the lamellae layers. Staining
in between the layers was more intense than that within them. The lacunae
around the cells were also intensely stained. No differences were observed
between cervical, thoracic and lumbar sections. Staining in the CEP was mainly
observed in the top layer and was randomly distributed within the ECM and
lacunae. The lower layer of the CEP contained much less of the stain in
comparison and in most samples only some lacunae were positively stained
with some very small traces of stain within the ECM. No differences were
observed between regions. The NP was lightly stained in all samples. The stain
was distributed randomly in the ECM and in some instances around the
lacunae. Examples of IVD sections stained with antibody to fibronection are
shown in Figure 4.37.
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Figure 4.37: Ovine lumbar (5.L1/L2) AF (A), cervical (5.C6/C7) CEP (B) and lumbar
(7.L1/L2) NP (C) sections stained with mouse anti-sheep fibronectin monoclonal
antibody (i) and mouse IgG1 isotype control (ii). 40x magnification. AF: Annulus
fibrosus, CEP: cartilage end plate, NP: Nucleus pulposus.
4.4.7.7. Osteocalcin
Facet cartilage in all sample replicates in three regions showed very little
positive staining for osteocalcin. In all samples positive staining was found in
the subchondral bone. In some samples, traces of stain were found randomly
distributed in the ECM and lacunae of the calcified zone. An example of
osteocalcin staining in ovine facet cartilage is shown in Figure 4.38.
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Figure 4.38: Ovine thoracic (5.T11/T12) facet cartilage sections stained with
mouse anti-sheep osteocalcin monoclonal antibody (A) and mouse IgG2a
isotype control (B). 40x magnification.
Staining for osteocalcin in the AF and NP tissue in all samples from three
regions was negative. In the CEP, the underlying subchondral bone was
positively stained and this was distributed evenly within the matrix and strongly
around the cells. Examples of IVD sections stained with antibody to osteocalcin
areshown in Figure 4.39.
A B
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Figure 4.39: Ovine thoracic (5.T11/T12) AF (A), lumbar (5.L1/L2) CEP (B) and
lumbar (7.L1/L2) NP (C) stained with mouse anti-sheep osteocalcin monoclonal
antibody (i) and mouse IgG2a isotype control (ii). 40x magnification. AF: Annulus
fibrosus, CEP: cartilage end plate, NP: Nucleus pulposus.
4.4.8. Deformation Characteristics of Facet Cartilage
Indentation tests were carried out on C6/C7 facets including both left and right
inferior and superior facets from a three year old Texel sheep. The thickness of
the cartilage on each facet was determined using a needle indenter (Figure
4.40).
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Figure 4.40: The thickness of the cartilage on all four C6/C7 ovine facets.
The thickness of the cartilage of the C6/C7 facets varied between approximately
0.8 mm and 1.4 mm. The right superior facet contained the thickest cartilage
whilst the left inferior facet had the thinnest.
The strain values of facet joint cartilage determined over time when subject to
indentation are shown in Figure 4.41.
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Figure 4.41: Strain curves for four C6/C7 ovine facets. Red: right superior facet,
Green: right inferior facet, Purple: Left superior facet, Blue: left inferior facet. Errors
bars plotted as standard deviation.
The deformation properties of the right superior facet cartilage were
considerably higher than that of the other three facet cartilage samples. All
samples reached equilibrium at similar time points. The final deformation
measurements for C6/C7 right superior facet cartilage (1.323mm) was 0.195,
0.091 for right inferior facet cartilage (0.967mm), 0.075 for left superior facet
cartilage (1.114mm) and 0.069 for left inferior facet cartilage (0.783mm). The
mean of all four curves was plotted and is presented in Figure 4.42.
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Figure 4.42: Strain curve of the mean for all four C6/C7 ovine facets. Errors bars
plotted as standard deviation.
Great variation was observed between the four samples as can be seen from
the large error bars in Figure 4.42. The average strain after deformation was
approximately 0.1.
4.4.9. Quantification of GAG Content in Facet Cartilage
The amount of GAGs in thoracic facet cartilage was quantified using the GAG
assay (Section 2.2.11.1 and 2.2.11.2). Thoracic cartilage from the left inferior
facet of the FSU T2/T3 was removed from all the remaining tissue from the
natural history study. Due to tissue restrictions, each age group contained a
different sample number and some groups including the one and five to six year
age group had only one sample available for analysis. The results from the
analysis of GAG content are shown in Figure 4.43.
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Figure 4.43: GAG concentration (mg/ml dry weight) in ovine thoracic facets
across four age groups. Thoracic cartilage from the left inferior facet of T2/T3 in 0-1,
3-4, 5-6 and 8-10 year old sheep of different breeds was analysed. Each bar
represents a replicate value for the specific age group. GAG: Glycosaminoglycan.
The results from the analysis of GAG content of the ovine facet cartilages
showed a great deal of variation between the quantities of GAGs in different
samples. In general, there was a trend towards decrease in GAG content with
age as the mean levels appeared to decrease within the replicate groups. The
mean values plotted for each age group are presented in Figure 4.44.
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Figure 4.44: GAG concentration (mg/ml dry weight) in ovine thoracic facets
across four age groups. Thoracic cartilage from the left inferior facet of T2/T3 in 0-1,
3-4, 5-6 and 8-10 year old sheep of different breeds was analysed. GAG:
Glycosaminoglycan. Errors bars plotted as standard deviation.
In general, the facet cartilage from sheep in the healthy age groups, one year
olds and three to four year olds had a mean percentage GAG content of 9.69 %
(v/v dry weight). This was reduced to 5.54 % in the 8-10 year old age group.
The percentage GAG content in the 0-1 year old and 5-6 year old sheep facet
cartilages was determined for one replicate from each age group. The data for
these two samples, however, followed the trend of decreasing GAG content
with age.
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4.5. Discussion and Conclusions
This aim of this chapter was to analyse ovine FSU tissue including facet
cartilage, AF, NP and CEP tissue from healthy three year old sheep. Literature
on the facet cartilage is currently limited and mainly focused on the
biomechanical aspects rather than its biology. There are currently no biological
studies characterising three year old ovine facet cartilage and IVD tissue
reported in the literature. It was important to gain knowledge of the biology of
ovine FSU tissue, since in the longer term this will be used to model human
FSU tissue. As a result, knowledge of their similarities and differences will be
essential.
The previous chapter showed that there were no statistical differences between
the different breeds of sheep including Charollais, Suffolk and Texel. Therefore,
using sheep of different breeds for comparison studies was not a limitation. In
the work outlined in this chapter, a three year old Charollais sheep was used for
isolation and analysis of cell phenotype in the FSU tissues whilst three, three
year old Texel sheep were used for tissue analysis.
The histological study using H&E stained sections showed that ovine facet
cartilage in all cervical, thoracic and lumbar regions exhibit the typical four
zones of cartilage as found in articular cartilage from other joints (Broom, 1984;
Buckwalter and Mankin, 1997). This finding has been previously reported for
canine facet cartilage (Elder et al., 2009). The cartilage on the cervical facets
was thicker than that on the thoracic and lumbar facets and the four zones were
more defined. This may be due to the greater range of movement in the neck
region in sheep. As a result, the cartilage will need to be thicker to account for
increased loading in comparison to the thoracic and lumbar regions which do
not undergo as much movement. The CEPs in the cervical FSU`s were also
found to be curved and thicker in comparison to thoracic and lumbar CEPs.
Similarly, this may be due to the increase in biomechanical movement which
results in differences in shape in order to cope with the extra demand.
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The analysis of alcian blue stained sections showed an increase in positive
staining from the AF towards the NP as has been previously reported (Roberts
et al., 1994). The staining within the ECM of the NP did not appear as intense
as that in the AF however, the lacunae were strongly stained. This suggests
that the GAGs are more densely populated around the cells than randomly
within the ECM of the NP. This may be due to active secretion of GAGs from
the cells. Another interesting observation was the increase in intensity of the
alcian blue stain in between the lamellae of the AF. This may help the lamellae
layers expand easily during loading whilst allowing them to recover their
structure after loading. The facet cartilage in all three regions was intensely
stained in the top layer of the superficial zone in comparison to the rest of the
structure. This is an interesting and novel finding as previous studies have
suggested the superficial zone in typical articular cartilage from other joints
contains a higher amount of collagen running parallel to the surface and GAG
content increases with depth (Mow et al., 1984; Buckwalter and Mankin, 1997;
Eyre, 2002). However, the results of the Sirius red staining also showed the
presence of collagen in the superficial zone. This was particularly evident in the
cervical facet cartilage sections in comparison to the thoracic and lumbar facet
cartilage sections which had less Sirius red staining in the superficial zone.
Again, this could be due to the large range of motions in the cervical region. It
may be that in the thoracic and lumbar regions, protection of the facet cartilage
surface by hydration is more important than protection from tensile forces
afforded by collagen. The calcified zone of facet cartilage was also more
intensely stained in the facets from the cervical region compared to the facets
from the thoracic and lumbar regions. These findings are novel as there are
currently no histological studies using alcian blue staining of ovine facet
cartilage from cervical, thoracic and lumbar regions reported in the literature.
Sirius red staining within the FSU tissues showed that collagen was present in
the AF, NP, CEP and facet cartilage as previously reported for IVDs and
articular cartilage from other joints (Roberts et al., 1989; Urban et al., 2000;
Eyre, 2002; Roberts et al., 2006; Becerra et al., 2010). This has also been
previously reported in canine facet cartilage (Elder et al., 2009). Collagen within
the AF was densely distributed and relatively even throughout the structure in
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the majority of samples. The size and the colours of the staining indicated that
the fibres were large and fully mature. This suggests that they provide the AF
with great structural support that is essential for its function as previously
reported (Urban et al., 2000; Roberts et al., 2006). The staining within the NP
was very different with thinner fibres which were green and white in appearance
suggesting that they were thin fibres or perhaps newly formed. This supports
previous findings in the literature that collagen is distributed randomly within NP
tissue (Beard et al., 1980; Eyre, 1979; Roughley, 2004). Collagen within the
CEP was randomly distributed. The fibres were thin but mature. In comparison
to the cervical samples, in both thoracic and lumbar samples the staining for
collagen within the subchondral bone was much more intense than in the CEP
suggesting a greater and more supportive network of collagen in the underlying
bone. It has been reported that the attachment of the CEP to the underlying
subchondral bone is poor due to the attachment of collagen fibrils between
these two areas (Inoue, 1981). This may explain the lack of overlap in collagen
structure observed here. The collagen within facet cartilage largely consisted of
dense and mature fibres. The patterns were similar to that reported for articular
cartilage from other joint areas (Eyre, 2002). Some newly formed fibres were
present in the middle zone of cervical facet cartilage. The increased loading in
the cervical region may therefore mean that collagen is actively being
synthesised in facet cartilage. This may also indicate a greater turnover of
collagen in the mid-zone of cervical facet cartilage.
Elastin was sparsely present in all four tissues. In the AF, the presence of
elastin in between the lamellae layers allows the AF to retain its structure after
deformation during loading. This may also be linked to the increase in GAGs in
between the lamellae layers of the AF. Studies carried out in human and bovine
AF tissue have also reported this distribution of elastin (Yu et al., 2002; Yu et
al., 2005). Miller’s elastin staining in the NP, CEP and facet cartilage showed
that the elastin content was largely present around the cells and lacunae.
Previous studies in bovine IVD tissue have reported an extensive network of
elastin (Yu et al., 2002). A limitation of Miller’s elastin staining for identifying
elastin fibres is that they are easily masked by GAGs and collagen in the ECM.
This may explain the lack of positive staining within the ECM of these tissues. A
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more reliable method that could be used for future analysis of the elastin
network in ovine FSU tissues would be to pre-treat the tissues with
hyaluronidase and collagenases to unmask elastin from GAGs and collagen (Yu
et al., 2002).
Collagen type I staining within ovine facet cartilage tissue was negative but
positive within the underlying subchondral bone. This indicated that the cartilage
samples were healthy and not undergoing degeneration. The variation of
staining of collagen type I along with its presence within facet cartilage and NP
cells may have been the result of the being cultured in monolayer. Although
collagen type I staining of the FSU cells at passage four were negative in
Section 2.3.2 (Table 2.10), the phenotype at passage two may be different. In
addition, the cells were from a different age and breed of sheep and therefore
variations may occur. The presence of collagen type I in the subchondral bone
indicated its function to provide the essential biomechanical properties of bone
including load bearing and tensile strength (Gelse et al., 2003). This is also
likely to apply to the positive staining observed in the subchondral bone
underlying the CEP. In the AF, the outer region was densely stained with
collagen type I in both cells and tissue indicating its presence as has been
previously reported for AF tissue from other species (Eyre and Muir, 1977;
Beard et al., 1980; Antoniou et al., 1996; Schollmeier et al., 2000). This
suggested that the outer AF in ovine tissue is more fibrous and stronger in
comparison to the inner AF. The presence of osteocalcin staining indicated
where the bone underlying the facet cartilage and the CEP began.
Collagen type II and chondroitin sulphate staining was present in all ovine AF,
NP, CEP and facet cartilage tissue and cells. Within the AF, the most intense
staining for both of these markers was present in the inner region as has been
previously reported for AF tissue from other species (Eyre and Muir, 1977;
Antonoiu et al., 1996; Schollmeier et al., 2000). This suggested that the inner
AF is subject to more mechanical movement than the outer AF. This is due to
compression from the adjacent NP. The NP was also positively stained for
collagen type II and chondroitin sulphate. This has been previously reported for
NP tissue from other species (Antonoiu et al., 1996; Urban et al., 2000; Gan et
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al., 2003A). The presence of collagen type II and chondroitin sulphate within
tissues of the IVD and cartilage is very important for their function and is widely
documented in the literature. Although the qualitative distribution of these
markers has been documented in the IVD for various species, it has not been
previously carried out in facet cartilage.
Collagen III expression was evident in all FSU tissues and cells analysed here.
Interestingly, the pattern of staining within FSU tissue was very similar to that of
elastin. This may therefore suggest that collagen type III and elastin are co
expressed together and have a structure/function relationship. This has not
been previously reported in the literature. A previous study concluded that
collagen type III co-localises with collagen type II (Young et al., 2000). However,
in this study differences were observed in the staining patterns. Collagen III and
VI were highly expressed around the cells in the tissues as well as by the cells
identified by immunofluorescence in comparison to other collagen types other
than collagen type II. Collagen type III is a fibril forming collagen whilst collagen
type VI is associated with fibrocartilage. This may suggest that the cells within
both the facet cartilage and intervertebral disc are protected by a fibrous barrier.
Collagen VI has also been previously reported to make connections to the ECM
(Pullig et al., 1999). This enables the cells to be anchored into the matrix. These
observations have been previously reported for IVD tissue and articular
cartilage but not for facet cartilage (Wu et al., 1987; Roberts et al., 1991A;
Roberts et al., 1991B; Wotton and Duance, 1994). The relationship between
collagen III and VI has been previously considered (Koller et al., 1989; Chu et
al., 1990; Roberts et al., 1991A). Studies suggest that the homologous repeats
on the three polypeptide chains of collagen type VI may be capable of
interacting with collagen type III through the microfilaments on collagen type VI.
The elastin network present around the cells in the tissues analysed here may
provide further protection by allowing the structure to be maintained after
loading. The staining of collagen types III and VI around the cells in the IVD
suggest that they sit in pericellular capsules like chondrocytes in articular
cartilage as reported in previous work (Roberts et al., 1991A).
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The expression of fibronectin within the ECM of facet cartilage tissue and cells
showed that it was present within all zones of the cartilage which was consistent
with previous reports on articular cartilage from other joints which suggest that it
plays an important role in binding GAGs and organising components of the
ECM including collagen and aggrecan (Ruoslahti, 1988; Brown and Jones,
1990; Chevalier, 1993). This may also apply to IVD tissue and cells which also
showed high expression. Previous studies have indicated that high expression
of fibronectin may reflect degeneration in the IVD and articular cartilage (Lust et
al., 1987; Homandberg and Wen, 1998; Oegema et al., 2000). However, the
results from Chapter 4 have shown that the tissue analysed here was not
degenerate. It may be that analysing tissue of an older age group such as
between eight and 10 years of age may result in more intense staining for
fibronectin.
Some facet cartilage, NP and outer AF cells showed positive staining for
collagen type X. Collagen type X has been reported to be expressed in the
calcified zone of articular cartilage and the IVD (Mayne, 1989; Gannon et al.,
1991; Aigner et al., 1998; Eyre, 2002). Collagen type X has been shown to be
present within the human NP at a young age and expressed in older tissue
when the IVD undergoes degeneration (Boos et al., 1997). This may explain
this expression in some of the IVD cells in this study. Most of the cells in the
current work also expressed CD44 and SOX-9 as expected from the results of
previous studies (Sive et al., 2002).
The average GAG concentration in 3-4 year old ovine thoracic facet cartilage
was 7.44 % (w/w). This was within the range of GAG concentration for articular
cartilage. Only one pervious study has quantified GAG content in facet cartilage
(Elder et al., 2009). This study analysed lumbar facet cartilage of 2-4 year old
dogs. They found an average GAG content (dry weight) of 14.9 %. The
difference in values may be a result of differences in species and spinal region.
The indentation testing carried in the current work showed that ovine cervical
facet cartilage displayed biphasic properties as previously reported for ovine
cervical facet cartilage in 5-6 year old specimens (Latif et al., 2012).
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There were limitations to some of the methods used in this part of the study.
The process of cell isolation from cartilage and IVD tissue was particularly
difficult due to the low cell densities within cartilage and the NP. However, the
challenges were overcome and a large number of cells were obtained. All cell
phenotyping was, however, performed on cells which were cultured in
monolayer. FSU cells, in particular chondrocytes have been widely reported in
the literature to change phenotype in culture by dedifferentiating into fibroblasts
(von der Mark et al., 1977; Archer et al., 1990). However, studies described in
Chapter 2 showed that the cells from ovine facet cartilage, AF, NP and CEP
maintained collagen type II expression up to passage eight. As previous work
suggests that chondrocyte phenotype can be confirmed with collagen type II
expression, it can be assumed that the true phenotype was observed and that
this data was reliable for comparing the phenotype of the different cells (Zaucke
et al., 2001; Hoffman et al., 2010).
Another limitation was the lack of tissue available for GAG analysis. In some
age groups, including the 0-1 and 5-6 age groups, there was only one sample.
This therefore meant that statistical comparisons could not be made between
the age groups. However, as there were seven replicates in the 3-4 year old
group this allowed for a relatively accurate analysis of the percentage of GAGs
in healthy ovine facet cartilage and fulfilled the objective of this chapter.
Similarly, there was a lack of tissue was available for the indentation testing. As
whole cervical facets were needed to obtain cartilage pins for testing this was a
limitation as only one pin could be obtained per facet. As only four facets from a
3-4 year old Texel sheep could be obtained for this analysis, only four facet
cartilage pins were tested. The indentation test results could have been
analysed further to provide more information with regards to the biphasic
properties of facet cartilage. Finite-element (FE) modelling could have been
used to determine the permeability and elastic modulus of the cartilage.
However, due to time restrictions this was not possible.
In conclusion, the results from this chapter showed that, generally, facet
cartilage showed similar characteristics to that of articular cartilage from other
joint areas. The next stage of this study was to determine whether it was
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possible to treat ovine facet cartilage to produce a tissue which mimicked the
biomechanical properties of degenerate human facet cartilage. Since the strain
properties of healthy ovine facet cartilage had been determined this would allow
direct comparisons to be made.
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Chapter 5: A Degeneration Model of
Ovine Facet Cartilage
5.1. Introduction
The work carried out in Chapter 4 investigated the characteristics of healthy
ovine facet cartilage and IVD tissue. The aim of this chapter was to utilise
healthy ovine facet cartilage, from the 3-4 year age group and develop a
method of treating the cartilage such that it mimicked the features of
degenerated human facet cartilage. The model of the degenerated ovine facet
cartilage would have the potential to be used as in an in vitro pre-clinical model
to test novel cartilage substitution therapies such as biomaterials and therapies
produced via tissue engineering.
Chondroitinase ABC is an enzyme which depletes GAGs from tissue. It has
been previously used to deplete GAGs in bovine knee cartilage at a
concentration of 0.1 U.ml-1 (Katta et al., 2007; Katta et al., 2008B). Studies have
also shown that chondroitinase depletes GAGs and alters the friction and
deformation properties of articular cartilage (Schmidt et al., 1990; Sasada et al.,
2005; Basalo et al., 2006). Another study, however, reported that
chondroitinase ABC did not alter frictional properties of bovine articular cartilage
(Pickard et al., 1998). This method of treatment was investigated for use with
ovine facet cartilage.
By depleting GAGs from facet cartilage, the osmotic pressure and biphasic
properties should, theoretically, be depleted resulting in cartilage that is less
able to resist compression forces. As a result, the cartilage would have reduced
capacity to resist deformation under load. This may result in damage to the
other ECM components such as the collagen network when cartilage is subject
to loading. These changes have been observed in degenerated articular
cartilage (Rieppo et al., 2003; Basalo et al., 2005).
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5.2. Aims and Objectives
The aim of this chapter was to develop a method for reproducing the
biomechanical characteristics of human degenerative facet cartilage in ovine
facet cartilage. The approach taken was to reduce the GAG content.
Specific Objectives:
 Determine a suitable method for treatment of ovine cervical facet
cartilage with chondroitinase ABC.
 Treat ovine cervical facets with chondroitinase ABC using the
established method.
 Determine the macroscopical features of treated ovine cervical facets.
 Determine the quantity of GAGs within the cartilage of chondroitinase
ABC treated ovine cervical facets.
 Determine the indentation properties of chondroitinase ABC treated
ovine cervical facets.
 Determine the organisation of ECM and cells and distribution of GAGs,
collagen and elastin of chondroitinase ABC treated ovine cervical facets
using histology.
 Determine the distribution of chondroitin sulphate and collagen type II in
chondroitinase ABC treated ovine cervical facets using
immunohistochemistry.
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5.3. Experimental Approach
Initially it was necessary to determine a suitable method for the treatment of
ovine facet cartilage with chondroitinase ABC. This was carried out using
thoracic facets from a three year old spine. The devised method was then
applied to cervical facet cartilage from a three year old Texel spine (to ensure
that the treated facets could be tested using indentation tests). The treated
cervical facets were then subject to analysis using histology, indentation testing
and evaluation of GAG content.
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5.4. Methods
5.4.1. Determination of the Method of Chondroitinase ABC Treatment
Chondroitinase ABC is an enzyme previously used to degrade osteochondral
pins by removing the GAGs within the cartilage (Katta et al. 2008B). As the
original method was designed for 9 mm osteochondral pins from bovine
condyles, the concentration of the enzyme and incubation time required
investigation for use on the ovine facets. The original method involved
incubating the pins in 25 ml antibiotic solution (Section 2.1.2) for 16-18 hours at
4 ºC with agitation at 120 rpm. Pins were then incubated with 25 ml
chondroitinase ABC solution (0.1 U.ml-1) at 37 ºC with agitation at 120 rpm for
24 hours. Finally, the pins were washed in PBS at 20 ºC with agitation at 240
rpm twice for 20 minutes each.
To develop the method for facet cartilage, eight thoracic facets including left and
right inferior facets from levels T3/T4 to T6/T7 of a three year old spine (spine
one from the anatomical study in Chapter 3) were washed in antibiotic solution
(Section 2.1.2) for 16-18 hours before incubating in solutions of varying
concentrations of chondroitinase ABC using two incubation times as shown in
Table 5.1.
Chondroitinase ABC
concentration (U.ml-1)
8 hour incubation 24 hour incubation
0 Right T3/T4 Left T3/T4
0.025 Right T4/T5 Left T4/T5
0.05 Right T5/T6 Left T5/T6
0.1 Right T6/T7 Left T6/T7
Table 5.1: Thoracic facets incubated with a range of chondroitinase ABC
concentrations and incubation times.
The same conditions were used during the incubations as described in the
original method (Section 2.2.14). When the treatment was complete, the facet
cartilage was removed, freeze dried to constant weight, digested in papain and
analysed using the GAG assay (Section 2.2.11.1).
Chapter 5
228
5.4.2 Treatment of Ovine Cervical Facet Cartilage with Chondroitinase
ABC
A cervical section of an ovine three year old Texel spine was obtained and
stored at -20 °C. Three months later the cervical spine was allowed to thaw
overnight at 4 °C. FSUs C4/C5 and C5/C6 were removed and their eight facets
including both left and right superior and inferior facets were dissected, using
the method described in Section 2.2.5.2 and photographed (Section 2.2.6).
Six of the facets including the left inferior and superior facets of C4/C5 and all
four C5/C6 facets were treated with chondroitinase ABC as described in Section
2.2.14. The right inferior facet of C4/C5, the frozen negative control, was
immediately stored at -20 °C in a PBS-moist container after being photographed
whilst the six facets were undergoing treatment. The right superior facet of
C4/C5, the buffer negative control, was placed into chondroitinase ABC solution
without the chondroitinase ABC enzyme (Section 2.1.2) as a negative control.
Following treatment, all facets were re-photographed and the right inferior facet
of C4/C5 was allowed to thaw.
Pins were removed from each facet as described in Section 2.2.13.1 and were
indented as described in Section 2.2.13.2 to determine the indentation
properties of the chondroitinase ABC treated facet cartilage and both negative
controls. Each facet was then indented with a needle indenter to determine the
cartilage thickness as described in Section 2.2.13.3.
A 2 mm slice from the top of each facet was removed using a bone saw as
described in Section 2.2.5.2 and the slice was fixed, decalcified, tissue
processed and embedded in wax as described in Section 2.2.7. Sections were
obtained and stained with H&E, alcian blue, Sirius red and Miller’s elastin
(Section 2.2.7).
The facet cartilage was scraped from each remaining facet and placed into pre
weighed bijous. The cartilage was freeze-dried to constant weight and papain
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digested for 48 hours at 60 °C. The GAG content was quantified using the GAG
assay (Section 2.2.11.1).
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5.5. Results
5.5.1 Determination of the Method of Chondroitinase ABC Treatment for
Facet Cartilage.
Following treatment of the ovine thoracic facets with different concentrations of
chondroitinase ABC, the GAG concentrations were determined. The values
obtained from each facet are shown in Figure 5.1.
Figure 5.1: The GAG concentration (as a percentage of dry weight) in facets
treated with various concentrations of chondroitinase ABC. Each bar represents
one result from one facet. DW: Dry weight.
Without enzyme treatment the GAG concentrations in the facet cartilage were
18-28 % (w/w). The results showed that treatment of the facets with 0.025 U.ml-
1 chondroitinase ABC for eight or 24 hours had little effect on the GAG
concentration. Following treatment with 0.05 U.ml-1 of chondroitinase ABC, the
GAG concentrations in the facet cartilage reduced to less than 5 % (w/w) after
eight hours of incubation. The concentration did not reduce further after 24
hours of incubation. Treatment with the higher concentration of enzyme (0.1
U.ml-1) did not lead to a further reduction in GAG concentration. Therefore, in
the subsequent experiments to reduce the GAG concentration of the facets,
they were incubated in 0.05 U.ml-1 of chondroitinase ABC for approximately 16
hours.
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5.5.2. Morphology of Chondroitinase ABC Treated Ovine Facet Cartilage
A cervical section of an ovine Texel spine which had been stored in the freezer
for approximately three months was allowed to thaw overnight. The following
day, FSUs C4/C5 and C5/C6 were dissected and all eight facets including the
left and right superior and inferior facets from both FSUs were removed.
Photographs of all eight cervical facets from FSUs C4/C5 and C5/C6 were
taken before and after chondroitinase (or control) treatment. The right inferior
facet of C4/C5 was used as a negative control and was stored at -20 °C until
used for analysis. The right superior facet of C4/C5 was treated with buffer
alone as a negative control.
All C4/C5 facets had similar features before chondroitinase ABC treatment. The
soft tissue surrounding the facets was red and white in appearance. The
cartilage on the surface of all the facets was white, shiny and smooth in
appearance. No major defects were present on the surface with the exception
of the C4/C5 right superior facet. The facets after chondroitinase ABC treatment
appeared much paler and white in appearance. The soft tissue surrounding the
facets had lost any pink or red colour that it had had before treatment. This was
true for the facet cartilage of all samples. The surfaces of the cartilage on all
facets after treatment appeared to retain their macroscopical structure. The
cartilage was still smooth and appeared to have gained no defects.
Photographs’ of the C4/C5 facets before and after treatment (with the exception
of the right inferior facet which was photographed before being stored at -20 °C)
are shown in Figure 5.2.
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Figure 5.2: C4/C5 facets before and after chondroitinase ABC treatment. A: C4/C5
right inferior facet, B: C4/C5 left inferior facet, C: C4/C5 left superior facet, D: C4/C5
right superior facet before (i) and after (ii) chondroitinase ABC treatment. The C4/C5
right inferior facet was not treated and was stored at -20 °C immediately before being
treated. The C4/C5 right superior facet was treated with buffer alone (control).
All C5/C6 facets had similar features before chondroitinase ABC treatment. The
soft tissue surrounding the facets was red and white in appearance. The
cartilage on the surface of all the facets was white, shiny and smooth in
appearance. No major defects were present on the surface. The facets after
chondroitinase ABC treatment appeared much paler and white in appearance.
The soft tissue surrounding the facets had lost any pink or red colour it had had
before treatment. This was true for the facet cartilage of all samples. The
surface of the cartilage on all facets after treatment appeared to retain their
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macroscopical structure. The cartilage was still smooth and appeared to have
gained no defects. Photographs of the C5/C6 facets before and after treatment
are shown in Figure 5.3.
Figure 5.3: C5/C6 facets before and after chondroitinase ABC treatment. A: C5/C6
left inferior facet, B: C5/C6 right inferior facet, C: C5/C6 left superior facet, D: C5/C6
right superior facet before (i) and after (ii) chondroitinase ABC treatment.
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5.5.3. Quantification of GAG Content in Chondroitinase ABC Treated
Ovine Facet Cartilage
Facet cartilage from each of the eight facets was removed, freeze dried and
analysed using the GAG assay. The results from this are shown in Figure 5.4.
Figure 5.4: The percentage of GAGs (dry weight) in facet cartilage after
chondroitinase ABC treatment including negative controls. C4/C5 right inferior
facet did not undergo treatment (frozen negative control) and C4/C5 right superior facet
only underwent treatment in enzyme buffer without chondroitinase ABC (buffer
negative control). GAG: Glycosaminoglycan.
The quantity of GAGs in the frozen negative control (8.76 % w/w) was much
higher than that in the buffer negative control (3.73 % w/w). The chondroitinase
treated facet cartilage samples fell below that of the frozen negative control.
The quantity of GAGs within cartilage of C4/C5 and C5/C6 chondroitinase ABC
treated facets varied between 2-7 % (w/w) in samples. The lowest GAG
percentage of 1.97 % (w/w) was seen in the cartilage of the C5/C6 left superior
facet, lower than both negative controls. The highest GAG percentage was
observed in the cartilage of the C4/C5 left inferior facet (7.21 % w/w) lower than
the frozen negative control but higher than the buffer negative control.
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5.5.4. Indentation Testing of Chondroitinase ABC treated ovine Facet
Cartilage
All C4/C5 and C5/C6 4 mm facet pins were indented following chondroitinase
ABC treatment including both negative controls. A needle indenter was used to
determine the facet cartilage thickness and is plotted in Figure 5.5.
Figure 5.5: The thickness of the cartilage on all eight C4/C5 and C5/C6 ovine
facets. C4/C5 right inferior facet did not undergo treatment (frozen negative control)
and C4/C5 right superior only underwent treatment in enzyme buffer without
chondroitinase ABC (buffer negative control).
The thickness of the cartilage on all the facets after chondroitinase ABC
treatment varied between approximately 0.8 mm and 1.8 mm. The C5/C6 right
inferior had the thickest cartilage whilst the C5/C6 left superior facet had the
thinnest. In comparison to the GAG assay data obtained from all the C4/C5 and
C5/C6 facets in Figure 5.5, there appeared to be a similar trend in cartilage
thickness; with thicker cartilage having a higher GAG content.
The strain was deduced from the displacement values obtained from
indentation testing and plotted for each sample as shown in Figure 5.6.
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Figure 5.6: The indentation data for ovine C4/C5 and C5/C6 facet cartilage with
and without treatment with chondroitinase ABC. Dark blue: C5/C6 right superior,
Purple: C4/C5 right inferior (frozen control), Red: C4/C5 left inferior, Cyan: C5/C6 left
superior, Turquoise: C4/C5 right superior (buffer only control), Green: C4/C5 left
superior, Orange: C5/C6 left inferior, Pink: C5/C6 right inferior.
There was a large degree of variation in the strain exhibited by the C4/C5 and
C5/C6 facet cartilage samples. This was also true of the C5/C6 right superior,
C4/C5 left inferior and C5/C6 left superior facets. All of these samples showed
typical biphasic responses to load. The other facets however, appeared to
reach equilibrium within 500 seconds and did not display biphasic responses,
reaching equilibrium at much lower strains. The final strain measurement for the
C4/C5 left inferior facet was 0.101 (1.0791 mm), 0.0553 for the left superior
facet (1.0498 mm), 0.129 for the right inferior facet (1.545 mm) and 0.0765 for
the right superior facet (0.743 mm). The final strain measurement for the C5/C6
left inferior facet was 0.0307 (1.395 mm), 0.0829 for the left superior facet
(0.720 mm), 0.0127 for the right inferior facet (1.795 mm) and 0.141 for the right
superior facet (1.187 mm). The mean of all six treated facets alongside the
negative controls is shown in Figure 5.7.
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Figure 5.7: The indentation data for ovine C4/C5 and C5/C6 chondroitinase ABC
treated facet cartilage including negative controls. Green: C4/C5 right inferior facet
(frozen negative control), Blue: C4/C5 right superior facet (buffer negative control),
Red: the mean deformation of all six chondroitinase ABC treated facets. Error bars
represent the standard deviation of the mean for the six chondroitinase treated facets.
In comparison to both negative controls, the chondroitinase ABC treated facets
appeared to deform more quickly reaching equilibrium more quickly. The
chondroitinase ABC treated facets and the buffer negative control did not
deform as much as the frozen negative control. The frozen negative control
showed deformation values similar to that in the C5/C6 facets in Chapter 4
(Section 4.4.8). The C5/C6 values reached equilibrium at approximately 0.11
whilst the negative control of the left inferior C4/C5 facet reached it at
approximately 0.13.
5.5.5. Histological Characterisation of Chondroitinase ABC Treated Ovine
Facet Cartilage
Sections of the facet cartilage for each of the eight facets were obtained after
treatment with chondroitinase ABC, fixation, decalcification, processing and wax
embedding. The sections were stained with H&E and photographed.
The frozen negative control, C4/C5 right inferior facet, (Figure 5.8A) showed an
organised cartilage structure including the four zones of articular cartilage. The
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surface was smooth, intact and did not contain any fissures. The buffer negative
control, C4/C5 right superior facet, (Figure 5.8B) also showed a neat cartilage
structure with the presence of four zones, however, some fissures were present
on the surface.
The chondroitinase ABC treated C4/C5 and C5/C6 facet cartilage samples
(Figure 5.8C) appeared to also retain the normal four zone structure of articular
cartilage. In all samples, a clear superficial, middle, deep and calcified zone was
observed. No major differences could be seen between the negative controls in
comparison to the other facets. However, the frozen negative control appeared
to have a more intact surface in comparison to the other samples. In some
chondroitinase ABC treated samples the surface of the cartilage appeared torn
in some areas and had some visible fissures. However, the superficial layer was
not lost in these samples. The organisation of the cells was consistent in all
chondroitinase ABC treated samples and again no differences were observed in
comparison to both negative controls. Images of all eight facets stained with
H&E are shown in Figure 5.8.
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Figure 5.8: C4/C5 and C5/C6 facet sections stained with H&E after chondroitinase
ABC treatment including negative controls. A: C4/C5 right inferior facet, frozen
negative control, B: C4/C5 right superior facet, buffer negative control, C.i: C4/C5 left
inferior facet, C.ii: C4/C5 left superior facet, C.iii: C5/C6 right inferior, C.iv: C5/C6 right
superior facet, C.v: C5/C6 left inferior facet, C.vi: C5/C6 left superior facet. H&E:
Haematoxylin and eosin.
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5.5.6. Characterisation of Chondroitinase ABC Treated Ovine Facet
Cartilage sections stained with Alcian Blue
Sections of the facet cartilage for each of the eight facets were obtained after
treatment with chondroitinase ABC, fixation, decalcification, processing and wax
embedding. The sections were stained with alcian blue and photographed.
The frozen negative control, C4/C5 right inferior facet, (Figure 5.9A) showed
positive staining in all four zones. Traces of stain were found in the ECM but
largely around the lacunae of the chondrocytes. The deep zone stained more
intensely than the other zones. In the buffer negative control, C4/C5 right
superior facet, (Figure 5.9B) positive staining was distributed randomly in all
four zones of the cartilage but mainly in the superficial and deep zones.
Considerably less staining was observed in the frozen negative control in
comparison to the buffer negative control.
All facets which had been chondroitinase ABC treated (Figure 5.9C) showed
less staining in comparison to both negative controls. Facet cartilage from
C4/C5 left superior, C5/C6 left inferior, C5/C6 right inferior and C5/C6 left
superior facets showed low levels of GAGs. Blue staining was absent from
superficial, middle and deep zones. A band of blue staining was present in the
calcified zone. The C4/C5 left inferior and C5/C6 right superior facet samples
appeared to still contain some positive alcian blue staining in some of the
cartilage zones. This was present mainly in the deep and calcified zones.
Images of all eight facets stained with alcian blue are shown in Figure 5.9.
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Figure 5.9: C4/C5 and C5/C6 facet sections stained with Alcian blue after
chondroitinase ABC treatment including negative controls. A: C4/C5 right inferior
facet, frozen negative control, B: C4/C5 right superior facet, buffer negative control, C.i:
C4/C5 left inferior facet, C.ii: C4/C5 left superior facet, C.iii: C5/C6 right inferior, C.iv:
C5/C6 right superior facet, C.v: C5/C6 left inferior facet, C.vi: C5/C6 left superior facet.
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5.5.7. Characterisation of Chondroitinase ABC Treated Ovine Facet
Cartilage Sections Stained with Sirius Red
Sections of the facet cartilage for each of the eight facets were obtained after
treatment with chondroitinase ABC, fixation, decalcification, processing and wax
embedding. The sections were stained with Sirius red and photographed.
Positive staining was present in the frozen negative control, C4/C5 right inferior
facet, (Figure 5.10A) and was distributed randomly in the ECM. Only very small
traces of stain could be observed in the superficial zone but large amounts were
present in the middle, deep and calcified zones. Positive staining was also
observed in the buffer negative control, C4/C5 right superior facet, (Figure
5.10B). This was largely distributed randomly in the ECM in the middle, deep
and calcified zones. Similarly to the frozen negative control, only very faint
staining was observed in the superficial zone. More staining was present in the
frozen negative control than the buffer negative control.
The amount of positive Sirius red staining varied between all chondroitinase
ABC facet cartilage samples (Figure 5.10C). Cartilage in left inferior facets of
both C4/C5 and C5/C6 showed evenly distributed positive staining in the
middle, deep and calcified zones. Some faint positive staining was observed in
the C5/C6 left superior facet randomly distributed in the middle, deep and
calcified zones. Very faint staining was observed in the C5/C6 right inferior facet
around the lacunae of some of the cells and randomly distributed in the ECM in
all four zones. No staining was present in the C4/C5 left superior and C5/C6
right superior facets. Images of all eight facets stained with Sirius red is shown
in Figure 5.10.
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Figure 5.10: C4/C5 and C5/C6 facet sections stained with Sirius Red after
chondroitinase ABC treatment including negative controls. A: C4/C5 right inferior
facet, frozen negative control, B: C4/C5 right superior facet, buffer negative control, C.i:
C4/C5 left inferior facet, C.ii: C4/C5 left superior facet, C.iii: C5/C6 right inferior, C.iv:
C5/C6 right superior facet, C.v: C5/C6 left inferior facet, C.vi: C5/C6 left superior facet.
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5.5.8. Characterisation of Chondroitinase ABC Treated Ovine Facet
Cartilage Sections Stained with Miller`s Elastin
Sections of the facet cartilage for each of the eight facets were obtained after
treatment with chondroitinase ABC, fixation, decalcification, processing and wax
embedding. The sections were stained with Miller’s elastin and photographed.
Some positive blue/black staining indicative of elastin was observed in the
frozen negative control, C4/C5 right inferior facet, (Figure 5.11A) and the buffer
negative control, C4/C5 right superior facet, (Figure 5.11B). In both controls,
this was found in the lacunae within the deep zones of the cartilage.
Staining for elastin varied between facet samples treated with chondroitinase
ABC (Figure 5.11C). Most facet cartilage samples were not positively stained.
These included C4/C5 left inferior, C5/C6 left inferior, C5/C6 right inferior and
C5/C6 left superior facet cartilage. The left superior C4/C5 facet cartilage
samples showed positive staining around the lacunae of some of the
chondrocytes in the deep zone. The cartilage in the C5/C6 right superior facet
was positive for elastin around the lacunae of the cells in the deep zone and
some traces of positive staining was found randomly distributed in the ECM in
the middle and deep zones. Images of the eight facet cartilage samples stained
with Miller’s elastin are shown in Figure 5.11.
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Figure 5.11: C4/C5 and C5/C6 facet sections stained with Miller’s Elastin after
chondroitinase ABC treatment including negative controls. A: C4/C5 right inferior
facet, frozen negative control, B: C4/C5 right superior facet, buffer negative control, C.i:
C4/C5 left inferior facet, C.ii: C4/C5 left superior facet, C.iii: C5/C6 right inferior, C.iv:
C5/C6 right superior facet, C.v: C5/C6 left inferior facet, C.vi: C5/C6 left superior facet.
C.i. C.ii.
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5.5.9. Localisation of Specific Markers in Sections of Chondroitinase
Treated Ovine Facet Cartilage
In order to assess the presence and distribution of specific markers within the
eight facet cartilage samples, immunohistochemistry was carried out using
antibodies for chondroitin sulphate and collagen type II.
5.5.9.1. Chondroitin sulphate
Cartilage from frozen and buffer negative controls, facets C4/C5 right inferior
(Figure 5.12A) and right superior (Figure 5.12B) respectively, showed the
presence of intense brown staining in all zones of cartilage. More intense
staining was present in the frozen negative control than the buffer negative
control.
Chondroitin sulphate staining in chondroitinase ABC treated samples was
considerably less than both negative controls. Staining in the left inferior facet
(Figure 5.12C) was absent from the superficial and middle zones and was only
present in the lower half of the deep zone and in the calcified zone. Staining in
the left superior facet (Figure 5.12D) was absent in the superficial zone and
present in the lower middle zone and both deep and calcified zones. Images of
chondroitin sulphate staining in C4/C5 facet cartilage after chondroitinase ABC
treatment and negative control facets are shown in Figure 5.12.
Cartilage from C5/C6 facets showed considerably less staining in comparison to
the chondroitinase ABC treated C4/C5 facets and both negative controls.
Staining was absent from the superficial, middle and deep zones. A band of
staining was present in the lower calcified zone. Images of chondroitin sulphate
staining in C5/C6 facet cartilage treated with chondroitinase ABC is shown in
Figure 5.13.
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Figure 5.12: C4/C5 facet sections immunohistochemically stained with
antibodies to chondroitin sulphate including negative controls. A: C4/C5 right
inferior facet, the frozen negative control, B: C4/C5 right superior facet, the buffer
negative control, C: C4/C5 left inferior facet, D: C4/C5 left superior facet stained with
rabbit anti-sheep chondroitin sulphate polyclonal antibody (i) and rabbit IgG isotype
control (ii).
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Figure 5.13: C5/C6 facet sections immunohistochemically stained with
antibodies to chondroitin sulphate. A: C5/C6 right inferior facet, B: C5/C6 right
superior facet, C: C5/C6 left inferior facet, D: C5/C6 left superior facet stained with
rabbit anti-sheep chondroitin sulphate polyclonal antibody (i) and rabbit IgG isotype
control (ii).
A.ii.A.i.
B.i. B.ii.
D.ii.D.i.
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5.5.9.2. Collagen Type II
Positive staining for collagen type II was observed in the frozen negative
control, C4/C5 right inferior facet, (Figure 5.14A). This was largely present in the
superficial zone. Staining was also present in the middle, deep and calcified
zones distributed randomly in the ECM. Similarly, positive staining was
observed in the buffer negative control, C4/C5 right superior facet, (Figure
5.14B). This was largely present in the superficial and middle zones. Some
staining was also observed in the deep and calcified zones randomly distributed
in the ECM.
Cartilage from chondroitinase ABC treated C4/C5 facets (Figure 5.14C and
5.14D) showed positive staining for collagen type II in all four zones within their
cartilage structure. Staining within the left inferior facet cartilage was less
intense than that in the left superior facet. In the left inferior facet cartilage
staining was largely observed in the superficial zones and sparsely distributed
within the ECM. Staining was also present around the cells. In the inferior facet,
staining was largely observed in the superficial and middle zones. Staining was
sparsely distributed in the ECM randomly. No major differences were observed
between the C4/C5 chondroitinase treated facet cartilage and the negative
controls. Images of collagen type II staining within the cartilage of C4/C5 facets
is shown in Figure 5.14.
Cartilage from the chondroitinase ABC treated C5/C6 facets showed positive
staining for collagen type II in all four zones. Staining within the inferior facets
was largely within the middle zones. Staining in the other three zones was
distributed randomly within the ECM. In the left superior facet staining was
largely present in the deep zone of the cartilage structure whilst in the right
superior facet staining was largely found in the superficial zone. All remaining
staining was found randomly distributed in the ECM. No major differences were
observed between the C5/C6 chondroitinase treated facet cartilage and the
negative controls. Images of C5/C6 facet cartilage stained with collagen type II
is shown in Figure 5.15.
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Figure 5.14: C4/C5 facet sections immunohistochemically stained with
antibodies for collagen type II including negative controls. A: C4/C5 right inferior
facet, the frozen negative control, B: C4/C5 right superior facet, the buffer negative
control, C: C4/C5 left inferior facet, D: C4/C5 left superior facet stained with mouse
anti-sheep collagen type II monoclonal antibody (i) and mouse IgG1 isotype control (ii).
A.ii.A.i.
B.i. B.ii.
D.ii.D.i.
C.i. C.ii.
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Figure 5.15: C5/C6 facet sections immunohistochemically stained with
antibodies for collagen type II. A: C5/C6 right inferior facet, B: C5/C6 right superior
facet, C: C5/C6 left inferior facet, D: C5/C6 left superior facet stained with mouse anti-
sheep collagen type II monoclonal antibody (i) and mouse IgG1 isotype control (ii).
A.ii.A.i.
B.i. B.ii.
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5.6. Discussion and Conclusions
The aim of this chapter was to develop a model of degenerated ovine facet
cartilage which mimicked some properties of degenerated human facet
cartilage. The work in this chapter used the enzyme chondroitinase ABC to
remove GAGs from healthy ovine facet cartilage as this is one feature of
degenerated human facet cartilage. Results from histology and
immunohistochemistry showed that this was achieved whilst maintaining the
general structure of the cells and collagen and some biomechanical properties.
The photographs of the treated and untreated facets showed that after
undergoing enzyme buffer treatment with and without chondroitinase ABC, the
tissue became white and paler in appearance. This would have been due to
both the antibiotic and enzyme washes which removed any blood remaining
after dissection. The enzyme treatment did not cause any visible damage to the
surface of the cartilage after the washes at 4 and 37 °C. This finding was similar
to that of a previous study which showed that chondroitinase ABC did not affect
surface roughness (Katta et al., 2008B).
The results from the GAG analysis of the tissues showed variation between
samples. Again, the variation may have been due to the cartilage being sourced
from facets at different positions which have been shown to have different
cartilage thicknesses by needle indentation. The large difference between the
high GAG content of the right inferior C4/C5 facet and low GAG content of the
right superior C4/C5 facet may have been inherent in the tissues in situ or could
have been due to the GAGs being washed out of the buffer treated control
during incubation. The GAG content in chondroitinase ABC treated facets show
that most samples had GAG reduction in comparison to the C4/C5 right inferior
negative control, but not the buffer treated C4/C5 right superior facet control
rendering the data equivocal. Previous studies have shown a reduction in GAG
percentage in bovine articular cartilage after treatment with chondroitinase ABC
(Basalo et al., 2005; Basalo et al., 2006; Katta et al., 2008B).
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Indentation testing of all eight facets suggested that depleting the GAGs from
facet cartilage did not have a consistent effect on strain and deformation. Both
negative controls had strain curves which reached equilibrium within the strain
values of the treated facets. The C5/C6 right inferior facet had the lowest strain
value and thickest cartilage in comparison to the other samples. However,
facets with similar thicknesses had strain curves at the higher end of the scale.
The differences between the strain curves were most likely due to differences in
the properties of the cartilage from different facets within the FSUs, as indicated
by the differences in thicknesses. These results were contradictory to the
literature which suggests that chondroitinase ABC causes an increase in
deformation and therefore strain (Katta et al., 2008; Katta et al., 2009).
However, this is the first study carried out on chondroitinase ABC treated facet
cartilage. The mechanical properties of ovine facet cartilage may differ to that
from bovine knee cartilage. Despite this, the mean strain curve of the
chondroitinase treated facets appeared to increase more rapidly in comparison
to that of both negative controls (Figure 5.7). This suggested that although the
overall deformation of the facet cartilage was not affected by chondroitinase
ABC treatment, the rate at which the cartilage deformed was more rapid, which
may have been due to the loss of GAGs. If this theory is correct, the biphasic
properties of the treated cartilage may have been altered as the fluid phase
reached equilibrium more rapidly due to increased permeability due to the GAG
loss.
The H&E staining of both C4/C5 and C5/C6 facet cartilage showed that the
general structure of the facet cartilage was maintained in comparison to the
negative controls. The C4/C5 right inferior facet cartilage appeared to have a
smoother surface in comparison to the surface of all other facet cartilage
samples including that which underwent enzyme buffer only treatment. The
tearing of the cartilage surface may have been due to incubating facet cartilage
at 37 °C for 16 hours regardless of the content of the solution they were in. This
was likely as the tissue had not been fixed and some initial breakdown of the
tissue may have started occurring during the incubation stages. Therefore, it
was unlikely that this was caused by the enzyme. Any small differences that
occurred within the structure were likely to be a result of sample variation as no
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two facets have the same structure and composition. The alcian blue staining
showed great variation between the two control facet cartilage samples and
those that had undergone chondroitinase ABC treatment. The C4/C5 right
inferior facet, which was frozen after dissection and prior to analysis, showed
much less staining than the C4/C5 right superior facet which had undergone
enzyme buffer treatment. This was not expected, however, it is likely that
sample variation may have contributed towards this observation. Alcian blue
staining in all chondroitinase treated facet cartilage samples showed much less
staining intensity. In most samples, the results showed that chondroitinase had
stripped the GAGs through the cartilage zones as deep as the calcified zone.
The band of blue staining appeared to show where the chondroitinase ABC
enzyme had reached during the incubation time. Sirius red and Miller’s elastin
staining showed no differences between negative controls and chondroitinase
ABC treated facet cartilage. This result was consistent with previous work which
suggested that chondroitinase ABC did not alter the collagen type II framework
within articular cartilage (Rieppo et al., 2003; Basalo et al., 2005). However, a
previous study has suggested that chondroitinase ABC increased the number of
exposed collagen fibrils (Jo et al., 2006). Due to the limitations associated with
Sirius red staining, it was not possible to deduce this from this study. Scanning
electron microscopy would be suitable to determine this.
Similar findings were also seen in C4/C5 and C5/C6 facet cartilage sections
immunohistochemically stained with antibodies to collagen type II and
chondroitin sulphate. In facets treated with chondroitinase ABC, the enzyme
had removed chondroitin sulphate from most zones within the cartilage. No
observable differences were noted in collagen type II staining. Variations in
collagen II and chondroitin sulphate staining within the facet cartilage samples
was likely due to sample variation as each facet was located at different
positions within the spine. The thickness measurements obtained using needle
indentation showed that the thickness of the cartilage varied in each sample
which may have also reflected the amount of chondroitin sulphate that
chondroitinase ABC would have been able to remove.
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A major limitation of this study was the number of replicates. Unlike cartilage
from other joints, the facet has a small surface area and a curved shape. This
makes removing flat pins from facets difficult and restricts the number that can
be obtained from a spine. The only facets that are valid for pin taking are those
from the cervical region as a result of this. Due to these restrictions in addition
to a limited supply of ovine cervical spine tissue, only one of each type of
negative control and only six facets were treated using chondroitinase ABC and
analysed. If more time and a greater amount of tissue were available, the
replicate number could be increased.
The results from this chapter suggest that chondroitinase ABC depletes GAGs
from ovine cervical facet cartilage but that this does not have an effect on the
deformation and strain. However, the data indicated that this was due to the
variation between samples rather than the effect of the treatment. In retrospect,
and given the knowledge on the variation between the facet samples it would
have been prudent to conduct a paired experiment whereby analysis, using the
methods described in this chapter, would be carried out both before and after
treatment. Another method which could help to interpret the results in this
chapter would be to carry out FE modelling in order to determine the
permeability and elastic modulus of the treated and non-treated facet samples.
This would allow evaluation of the biphasic properties of the negative controls in
comparison to the chondroitinase ABC treated samples of ovine cervical facet
cartilage. For example, the elastic modulus would give a more accurate
measure of permeability and by how much cartilage deformed under a given
load. If differences were found between articular cartilage in the facet in
comparison to those found in other joints such as the hip or knee, this may help
to explain the indentation properties deduced in this chapter.
Other treatment methods in addition to the incubation of cartilage with
chondroitinase ABC have been previously used. Enzyme digestion is a common
method for replicating cartilage damage. Trypsin is an enzyme which has been
previously reported to remove proteoglycans in articular cartilage (DiSilvestro
and Suh, 2002). However, the effect of trypsin on cartilage has been reported to
be variable (Moody et al., 2006). Other methods could also involve using
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collagenases to remove collagen (Bank et al., 2000). Removing collagen will
make cartilage more permeable and less able to resist compressive loads by
holding repelling proteoglycans together. This would ultimately lead to its
degeneration. As well as enzymatic treatment, chemical treatment using a
chemical such as SDS could also degrade the structure of cartilage as well as
physical treatment. Physical treatment such as compression to induce
degeneration may also be a potential method and has been previously reported
to induce degeneration in the IVD in vivo (Lotz et al., 1998). Another in vivo
study involved injecting monosodium iodoacetate into the facet joints of mice
(Kim et al., 2011). The authors reported severely damaged facet joint cartilage,
proteoglycan loss and changes in the structure of the subchondral bone.
As the characteristics of degenerate human facet cartilage have not yet been
deduced in the study running parallel to the present work (Section 1.8), it was
not possible to compare the features observed here. This will ultimately be the
next step in this study.
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Back pain is currently a global problem affecting 84 % of people at some point
in their lives. The condition not only causes a great deal of discomfort and
affects quality of life, but leads to economic loss through work absence and
health care costs. The causes of back pain are muscular or a result of the
degeneration of FSU components including posterior ligaments, the IVD and
facet joints (Maniadakis and Gray, 2000; Mosley et al., 2012). Much attention
has focused on the IVDs as a source of pain however, in recent years this
attention has shifted towards the facet joints. Facet joint osteoarthritis is thought
to affect up to 15 % of people suffering from back pain. Similarly to osteoarthritis
in other joints in the body, including the knee and hip, the facet joint cartilage is
thought to be the tissue primarily affected.
Current therapies for back pain include analgesics, physiotherapy, spinal fusion
and TDRs (Section 1.5). Although some of these therapies have been reported
to relieve patient symptoms and contribute to a better quality of life, they are not
curative. Current therapies either treat the affected site leading only to short
term relief or completely remove the source of pain and/or replace it with an
artificial material which offers long term relief but may lead to additional
problems including ASD (Section 1.5.3). An ideal treatment would involve
replacing the tissue responsible for the source of pain with functioning tissue,
developed using tissue engineering. Attempts have been made in the last
decade to develop a tissue engineered functional IVD (Mizuno et al., 2004;
Mizuno et al., 2006; Nesti et al., 2008; Wan et al., 2008). However, only one
study has considered developing a cartilage substitution biomaterial for the
facet joint cartilage (Elder et al., 2010). A major limitation in the development of
such a therapy for the facet joint cartilage is the current lack of knowledge of its
biology.
Therapies for the IVD, developed using tissue engineering approaches have not
currently reached the clinic. Before such therapies could be used in patients,
they would require pre-clinical testing for safety and function. Limited literature
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exists regarding any pre-clinical models that could be used. To ensure full
testing of the replacement including mechanical and biological compatibility, it
would be necessary to use an in vivo model. Whilst in vivo models can be used,
it is both desirable and ethical that novel therapies are only tested in living
animals following extensive pre-clinical evaluation in vitro. The use of a
physiological, mechanically interactive natural FSU in vitro model for the pre-
clinical testing of novel therapies in the spine would provide a means of testing
a wide range of products for failure early in the product development cycle and
hence minimise the use of living animals. The first steps towards the
development of such a pre-clinical model were to determine a source of natural
healthy FSU`s for use in the model, to fully characterise the tissues and develop
degenerated FSU`s which exhibited biotribological characteristics similar to the
degenerated human FSU.
The aim of this study was to characterise healthy ovine facet cartilage and IVD
tissue including the AF, NP and CEP and develop a model for degeneration in
the ovine FSU. The age of sheep that would provide healthy and degenerate
tissue was investigated as well as determining whether major differences
existed between sheep of different breeds. Biological characterisation was
carried out to determine the structure of these tissues, the expression of
collagen types, proteoglycans and other important proteins and the phenotype
of the cells. Some biomechanical characterisation was carried out using
indentation tests to determine the percentage deformation and strain of ovine
facet cartilage. Chondroitinase ABC was used to deplete GAGs from ovine facet
cartilage in an attempt to mimic the features of degenerated human facet
cartilage.
The study was necessary because of the limited knowledge of the biology of
facet cartilage. Ovine tissue was used since the sheep spine has been
previously reported in the literature to exhibit similar biomechanical properties to
the human spine (Wilke et al., 1997; Moore et al., 1999; Wilke et al., 1999;
Kandziora et al., 2001). As a result, the sheep is the most suitable and
accessible animal model to be used as a source of tissue for future in vitro
models. However, the age at which sheep begin to show signs of spinal
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degeneration was unknown at the start of this study and therefore it was
necessary to undertake a detailed investigation of the relationship between the
age of the animals and degeneration of the FSU. Chondroitinase ABC has been
previously used to deplete GAGs from cartilage and was therefore used to
achieve the same result in ovine facet cartilage. As the loss of GAGs is a well-
known feature of cartilage degradation, this represented the first step towards
developing an ovine FSU which mimicked the biotribology of degenerated
human facet cartilage. In the future, this model could then be used in a
simulator to pre-clinically test cartilage substitution biomaterials and other tissue
engineering therapies.
This study was novel since, at the time of writing, only one study had
investigated the biological features of facet cartilage (Elder et al., 2009). This
study was limited to canine lumbar facet cartilage tissue. In the present study,
the biological features of ovine facet cartilage were studied from all cervical,
thoracic and lumbar regions. In addition, the cell phenotype was also deduced.
The anatomical study of ovine FSUs was also novel as there was no literature
which had documented changes in IVDs and facet cartilage in sheep of different
ages and breeds. Lastly, although chondroitinase ABC has been previously
used to deplete GAGs from articular cartilage, the method had not been used
on facet cartilage (Katta et al., 2008B).
The aim of the anatomical study was therefore to determine the age at which
ovine spines degenerate and whether significant differences were present
between different breeds including the Charollais, Suffolk and Texel sheep. The
different breeds of sheep used in this study were a major limitation. Due to
difficulties in obtaining ovine tissue of different ages it was not possible to
source spines of a given breed. As a result, some age groups consisted of more
than one breed. This would have undoubtedly contributed to variation in the
data generated. However, as statistical analysis only found one significant
difference between Charollais, Suffolk and Texel breeds of the same age, it was
assumed that the differences between these three breeds of sheep were
acceptable. The 8-10 year age group, however, consisted of only the Hebridean
sheep. This breed was not compared to sheep of different breeds in the 3-4
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year old age group because it was not possible to obtain young Hebridean
sheep. Therefore, it cannot be concluded that changes in the 8-10 year age
group were independent of breed.
Another limitation of the anatomical study was the sample size. Due to cost and
difficulties in obtaining ovine tissue, the sample size of each age group was
limited to three (with the exception of the 3-4 year age group which also
investigated differences in breed). The low sample size may have masked
differences in the parameters analysed between age groups. Given more time
to obtain sheep spines, a larger budget and more time, the sample size would
ideally have been increased to 6-10 which may have highlighted more
differences between age groups.
Grading systems were used to deduce the extent of degeneration present in the
tissues of the IVD and facet cartilage. These grading systems or similar grading
systems had been used in previous studies to track degenerative changes in
the spine (Thompson et al., 1990; Weishaupt et al., 1999; Gries et al., 2000;
Sive et al., 2002; Kettler and Wilke, 2006; Tischer et al., 2006; Li et al., 2011;
Varlotta et al., 2011A; Lee et al., 2012). The limitation of using grading systems
is that they are subjective and the grades assigned may vary considerably
between graders, despite being trained in a similar manner, particularly when
there is little distinction between each grade. This was evident in the results for
the IVD grading of the transverse histological sections in which the kappa test
found only a slight agreement between graders. This may have affected the
correlation between grade and age and may explain why no significant
differences were found between different age groups. Despite this, there was a
fair agreement between graders for the grading of the sagittal histological
sections of the IVDs and moderate agreements between graders for the grading
of the facet photographs and histological sections. One way to ensure accuracy
of grading data is to enrol a greater number of graders. In further studies of this
nature, three or four trained graders should ideally be used. In addition, given
more time, the grading would ideally have been repeated after six months and
again after one year to check the repeatability of the results.
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A limitation associated with the µCT data generated was the resolution of the
scans. They were taken at a standard resolution of 74 µm. If a higher resolution
had been used, this would have made it easier to distinguish between
trabeculae and between bone and the IVD. However, this was a minor issue
and one that did not have a great effect on the data. The use of µCT is a
powerful tool for determining the properties of the FSU and is non-invasive.
The grading results confirmed that degeneration in the sheep spine increased
with age particularly in the cervical samples where good correlations were found
for grades of degeneration in the sagittal histological sections of the IVDs, the
facet photography and the facet histology, with the exception of the transverse
histological sections of the IVDs. There was also a significant difference
between the 0-1 year and 5-6 year age group for the cervical sagittal
histological sections of the IVDs. In general, an increase in grade in most
samples was recorded at either 5-6 years or 8-10 years. The grading data
therefore suggested that degeneration began at five years of age. The µCT
results showed that IVD height generally decreased with age. Most of the
significant differences present were between the 0-4 and 5-10 year age groups
suggesting that degeneration began at 5-6 years of age. Generally, the greatest
effects of age on degeneration in the sheep spine were found in the cervical
FSU samples. This indicated that degeneration was present largely in the
cervical region of the spines. This may have been due to the greater range of
motion within the cervical spine of the sheep. As it was concluded that healthy
tissue could be obtained from 0-4 year old tissue and that skeletally mature
tissue was most likely to be present in the 3-4 year age group, 3-4 year old
tissue was used in the characterisation study (Chapter 4).
The aim of the characterisation study was to determine the structure of 3-4 year
old ovine Texel facet cartilage, AF, NP and CEP tissue including the distribution
of common collagen types, proteoglycans and other proteins that have
previously been reported to make up the extracellular matrix of these tissues in
the sheep and in other species. The phenotype of the cells from each of the
tissues (from a 3-4 year old Charollais sheep) was also determined as well as
the quantity of GAGs (from a range of ages and breeds of sheep) and
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percentage deformation within cervical facet cartilage from a 3-4 year old
sheep.
Previous studies have reported on the biology of chondrocytes and IVD cells
(Gruber and Hanley, 2000; Horner et al., 2002; Gan et al., 2003A; Risbud et al.,
2003; Brodkin et al., 2004; Acosta et al., 2006). This includes a study which
isolated human AF cells and analysed them in monolayer cultures at passages
one to four using antibodies to collagen types I and II, chondroitin sulphate and
keratan sulphate (Gruber and Hanley, 2000). They found that cells in monolayer
had a spindle-shaped morphology and chondroitin sulphate was present in
abundance around the cells. Collagen types I and II expression within and
around the cells, however, were sparse. Another study investigated the
phenotype of rabbit NP cells which were found to express collagen types I and
II and CD44 (Gan et al., 2003A). The phenotype of chondrocytes from
osteoarthritic sheep has also been investigated (Acosta et al., 2006). In this
study, gene expression and proliferation analysis of chondrocytes showed a
decrease in collagen type II and aggrecan expression in aged, osteoarthritic
and passaged cells. Facet cartilage cells have not been previously analysed.
A major limitation in the phenotyping of ovine FSU cells in the present study
was the fact that this was carried out on cells that had been cultured in
monolayer. Previous studies have reported a change in phenotype of
chondrocytes and dedifferentiation to fibroblasts in monolayer culture
particularly after passage 6 (von der Mark et al., 1977; Archer et al., 1990). In
order to investigate this, FSU cells were analysed at passages four, six and
eight to determine whether a change in phenotype occurred with increased
passage. The expression of collagen types I and II was monitored to identify
whether a change to the fibroblast phenotype occurred. The results showed no
change in phenotype between the passages and maintenance of collagen type
II expression indicating that the cells maintained their phenotype in culture and
the validity of the data. Moreover, the aim of the cell characterisation study was
to determine major difference in the phenotype of cells from the different tissues
of the FSU rather than determine their exact phenotype. Monolayer cell culture
can be used for comparative studies as the cells have undergone the same
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treatment and are tested under the same conditions. In order to report a more
accurate phenotype of the FSU cells, 3D culture could have been used. This
would involve transferring cells after isolation to a 3D environment such as
alginate beads or collagen gels (Horner et al., 2002). The study showed that
collagen types I and II were expressed by FSU cells with greater expression of
type II than type I in contrast to the study by Gruber and Hanley (2000).
Collagen types III and VI were also expressed along with small amounts of
collagen type X in some cells. Collagen type V was not expressed by any cells.
Other important markers including CD44, chondroitin-6-sulphate, fibronectin
and SOX-9 were also highly expressed by the FSU cells as has been previously
reported for chondrocytes and IVD cells (Hayashi et al., 1996; Knudson and
Loeser, 2002; Hattori et al., 2010; Henrotin, 2010).
A limitation in the tissue characterisation study presented here was the sample
size for the quantification of GAGs in facet cartilage. This was due to difficulties,
as previously mentioned, in obtaining ovine tissue. Only one replicate was
available in the 0-1 year and 5-6 year age groups and only two replicates in the
8-10 year age group. This in turn meant that no statistical analyses could be
performed to determine whether significant variation existed between the age
groups. However, as the main aim of the study was to determine the quantity of
GAGs in the 3-4 year age group, this was achieved.
A major limitation in the study of facet cartilage was the small size of facets and
small surface area of cartilage. This meant that only a small amount was
available to analyse. In the case of histology and immunohistochemistry which
only require thin sections of tissue, this was not an issue. However, for
biochemical assays and mechanical tests this presented some problems. The
GAG assay required dilution with papain buffer for optimal results and the
hydroxyproline assay was not optimised due to time restrictions. For indentation
testing, only cervical facets could be analysed as they were the only facets with
a large enough flat surface area from which pins could be removed. Only one
pin could be removed from each facet. As only one FSU was available for
indentation (due to tissue restrictions), only four facets could be removed and
four pins analysed. The percentage deformation of ovine (Texel) cervical facet
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cartilage in general could have been more accurately determined, given more
samples.
The tissues of the healthy IVD have been extensively investigated in previous
studies (Beard et al., 1980; Thompson et al., 1990; Roberts et al., 1991;
Antoniou et al., 1996; Bruehlmann et al., 2002; MWale et al., 2004; Wade et al.,
2011). These studies all report a tough collagenous AF, rich in collagen type I in
the outer region and type II in the inner region, and a hydrophilic, gelatinous NP
rich in collagen type II. Roberts et al. (1991) reported the presence of collagen
type VI around AF and NP in the all regions of the human, cow, sheep and rat
IVDs. Mwale et al. (2004) reported a GAG:hydroxyproline ratio of 27:1 in the
human lumbar NP and a ratio of 2:1 in the human lumbar CEP. This study
made an attempt to distinguish the ECM of the IVD and hyaline cartilage as
their components are extremely similar. Only one study has reported on the
biochemical structure of facet cartilage (Elder et al., 2009). This, however, was
from canines.
For the sheep FSU tissues analysed here, patterns of collagen and GAGs
matched the distribution patterns previously reported in the literature (Antoniou
et al., 1996; Buckwalter and Mankin, 1997; Temenoff and Mikos, 2000). The
average percentage of GAGs in dry weight facet cartilage was also in the
similar range to that of articular cartilage. Similar staining patterns between
collagens types III and VI and elastin appeared to exist within the facet cartilage
and IVD tissues suggesting a relationship between them. A relationship
between collagen types III and VI has previously been suggested in other
studies (Koller et al., 1989; Chu et al., 1990; Roberts et al., 1991A). Finally the
deformation of 3-4 year old ovine cervical facet cartilage appeared to show a
strain curve characteristic of articular cartilage. This suggests that facet
cartilage exhibits similar biphasic properties.
The characterisation study provided essential knowledge on the biology of ovine
facet cartilage and its nearby IVD tissue that has not previously been reported.
As well as providing a clearer understanding of facet cartilage. This can now be
compared to the biology of degenerated human facet cartilage to identify
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similarities and differences which will be essential when modelling human FSU
therapies in an ovine FSU model in a simulator. The next stage of the study was
to begin to explore methods by which ovine facet cartilage could be
manipulated to mimic the degenerate biotribology.
Studies have previously been carried out to try and mimic degenerated features
seen in human osteoarthritis both in vivo and in vitro (Lotz et al., 1998; Phillips
et al., 2002; Ariga et al., 2003; Holm et al., 2004; Jo et al., 2006; Rousseau et
al., 2007; Katta et al., 2008; Kim et al., 2011). Models of experimentally induced
degeneration can be the result of either mechanical or structural changes.
Mechanical alterations involve a change in loading and therefore distribution of
forces throughout the tissue whilst structural alterations affect tissue function by
affecting the molecular components (Lotz, 2004). Some authors have reported
disorganisation of tissue and an increase in the percentage of cells undergoing
apoptosis when tissue such as the AF is exposed to external compression (Lotz
et al., 1998; Ariga et al., 2003). Some studies have involved stab incision which
has resulted in the loss of proteoglycans and cellularity in addition to structural
changes (Holm et al., 2004; Rousseau et al., 2007). Chemical and biological
treatments have also resulted in proteoglycan loss and alterations in the
structures of neighbouring tissue including bone and cartilage (Jo et al., 2006;
Katta et al., 2008; Kim et al., 2011). Only one study has attempted to produce a
degenerated facet joint (Kim et al., 2011). This however was in an in vivo
system. No previous studies have attempted to degenerate facet cartilage in
vitro.
The initial approach that was taken to degenerate healthy ovine facet cartilage
was to deplete the GAGs using chondroitinase ABC. The results showed that
this successfully removed GAGs from facet cartilage. This had an effect on the
intensity of alcian blue staining and in general did not affect the overall structure
of the cartilage or the distribution of collagen and elastin. The major limitation of
the study was the number of replicates. Two negative controls and six treated
samples were analysed. The results from the GAG assay and indentation
testing showed great variation between the samples despite the samples
originating from neighbouring FSUs in the same spine. Testing of a greater
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number of samples might have identified differences between controls and
treated samples. In addition, if the study was repeated it would be useful to
conduct a paired test by testing each sample before and after treatment. This
was because in some cases, the differences in the biology between the treated
and controls were greater than the effect of chondroitinase ABC. This made
differences in GAG content and percentage deformation difficult to draw
conclusions from.
This study has the potential to lead to future studies in order to further
characterise ovine facet cartilage and its other surrounding tissues and develop
an in vitro model of a degenerated ovine FSU for pre-clinical testing. Firstly, any
future study should ideally have a high replicate number of at least n>10 to
draw accurate conclusions. In addition, the source of ovine tissue for use in
comparative and characterisation studies should be limited to only one breed. It
may also be useful to conduct a wider study into the study of sheep of different
breeds to highlight differences between them. This is important as currently
many studies have used ovine tissue of different breeds (Reid et al., 2002;
Melrose et al., 2009; Hasler et al., 2010).
The anatomical study could be expanded to include more replicates. It would
also be advantageous to include a greater number of graders and repeat
grading over time. The study of breeds could also be expanded to include a
greater range of sheep that have been used in research, such as the Merino
and white Swiss Alp breeds (Melrose et al., 2009; Hasler et al., 2010).
Characterisation of the ovine facet cartilage and IVD cells and tissue could also
be further expanded. Cells could be transferred to 3D culture immediately after
isolation. This would allow for the cells to be in an environment closer to their
natural one and therefore allow them to exhibit their true characteristics.
Methods for 3D cell culture that have previously been used and have proved to
be successful include culturing cells in alginate beads and hydrogels
(Bonaventure et al., 1994; Gruber and Hanley, 2000; Horner et al., 2002).
Another way in which FSU cells could be analysed is by organ culture as has
been previously carried out (Risbud et al., 2003). In this study, whole IVDs were
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cultured with their end plates intact. NP tissue was then removed using a micro
curette and the cells analysed under a confocal microscope using
immunofluorescence. Another way of determining FSU phenotype more
accurately would be to carry out gene expression studies. Similar studies have
been previously carried out in IVD tissue (Sive et al., 2002). In situ hybridisation
was used to identify SOX-9 and collagen type II using 35S cDNA probes which
indicated strong mRNA signals in healthy tissue. The use of this type of method
would provide information at the molecular level.
A limited range of chondrocyte and IVD markers were investigated in this study.
Other potential markers which could be used in future cell and/or tissue studies
include those for collagens types IV, V, X, keratan sulphate and COMP. In
addition, the hydroxyproline and DNA content of both facet cartilage and IVD
tissue could be quantified as has been previously carried out in canine facet
cartilage (Elder et al., 2009).
Different microscopy methods could be used to obtain more accurate and
detailed information on the structure and organisation of cartilage at high
magnification. For example, atomic force microscopy (AFM) and scanning
electron microscopy (SEM) could be used to determine the surface roughness
of facet cartilage in comparison to articular cartilage from other joints.
Transmission electron microscopy (TEM) could also be used to examine very
small sections of tissue from different areas of the facet cartilage and AF.
Cupermuronic blue staining could be used to stain ultra-thin sections of the
tissue prior to examination by TEM to view the arrangement of GAGs. As well
as microscopy, another useful imaging technique that could be used is
magnetic resonance imaging (MRI). This highlights differences in water content
and therefore can be used to identify changes of hydration within the different
zones of cartilage.
In order to improve the biomechanical characterisation of ovine facet cartilage in
this study, FE modelling may be an option for determining the biphasic
properties. FE modelling has been frequently used in the literature to obtain a
clearer understanding of the biphasic properties of articular cartilage
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(DiSilvestro and Suh, 2002; Latif et al., 2012; Sakai et al., 2012; Richard et al.,
2013). This would enable the permeability and Young’s modulus of cartilage to
be deduced. A previous study by Latif et al. (2012) has carried this out on 4-5
year old ovine facet cartilage rather than 3-4 year old samples.
In addition to chondroitinase ABC treatment, other methods could be used to
initiate degeneration in facet cartilage. Chymopapain has been previously used
in IVDs to initiate proteoglycan loss, decrease disc height and induce loss of
biomechanical stability. The effects of chymopapain on facet cartilage have not
been previously reported but may lead to similar changes. The limitations of
using chymopapain are its toxicity at high doses and lack of matrix specificity
(Lotz et al., 1998). The use of monosodium iodoacetate in facet joints to
stimulate osteoarthritis has been previously reported in the mouse (Kim et al.,
2011). This may have the potential to produce similar outcomes in vitro such as
damage to the facet cartilage, loss of proteoglycans and changes in
subchondral bone. Another biological treatment to degenerate facet cartilage is
to use collagenase (Banks et al., 2000). Mechanical treatment can also be used
by compressing facet cartilage using excessive loading. It may also be useful to
determine what happens after a stab incision has been created on the surface
of facet cartilage after a certain period of time.
Once a set of methods have been optimised to produce similar features to that
of degenerated human facet cartilage, other components of the FSU including
the IVD, CEP and vertebral bodies could then be modified to mimic
degeneration. Ideally, once a whole ovine FSU model, which mimics a
degenerated human FSU, has been created, it will be essential to transfer this
model into an in vitro organ culture system. This would allow a whole FSU to be
alive and functioning as it would in vivo. As a result, cartilage substitution
biomaterials and other therapies for the spine developed through tissue
engineering could then be tested in the model to determine the response of
viable degenerate tissue.
Chapter 6
270
6.1. Conclusions
In summary, the main findings of this study are:
 Degeneration in the ovine spine begins at 3-4 years of age.
 Ovine FSU tissue is rich in collagen types I, III, VI, chondroitin sulphate,
CD44, fibronectin and SOX-9.
 A structure/function relationship may exist between collagen types III and
VI and elastin.
 Ovine cervical facet cartilage displays biphasic properties.
 Chondroitinase ABC depletes GAGs from ovine cervical facet cartilage
but does not have a consistent effect on strain and deformation.
The work carried out in this study has contributed largely to increasing
knowledge of facet cartilage. Research into this tissue was previously very
limited and much of the work carried out was related to the biomechanics of the
facet joint. Biological studies relating to the facet joint were previously limited to
the joint capsule. In addition, an anatomical study of ovine FSUs of different
ages and breeds showed that degeneration begins at 5-6 years of age. This has
not previously been reported and is important information as the sheep model is
currently widely used in research today particularly in the spine.
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Appendix I: Distributers of Materials
and Chemicals
Chemical/Reagent Distributer
Alcian Blue tissue stain. Raymond A Lamb Ltd
Acetone European Bios
Amphotericin B Sigma-Aldrich Company Ltd.
Aprotonin Mayfair house
Avidin/Biotin blocking kit Vector Laboratories
Bovine serum albumin Sigma-Aldrich Company Ltd
Cement powder Cold Cure
Cement liquid WHW Plastics
Chloramine T Sigma-Aldrich Company Ltd
Chondroitin sulphate B Sigma-Aldrich Company Ltd
Chondroitinase ABC Sigma-Aldrich Company Ltd
Collagenase (Clostridium Histolyticum
type IA)
Sigma-Aldrich Company Ltd
Citric acid VWR International
DAB stain kit Vector laboratories
DABCO VWR International
1,9 dimethylene blue Sigma Aldrich Company Ltd
Dimethyl Sulphoxide (DMSO). Sigma-Aldrich Company Ltd
Disodium hydrogen orthophosphate VWR International
DPX mounting medium Thermo Fisher Scientific Ltd.
Dulbecco’s modified Eagle’s medium
(DMEM)
Gibco Life Technologies Ltd
EDTA Fisher scientific
Envision + dual link system – HRP
(DAB+)
Dako Cytomation
Eosin tissue stain Thermo Shandon
Ethanol Thermo Fisher Scientific Ltd
Appendix I
308
Foetal calf serum (FCS) Biosera
Formic acid Sigma-Aldrich Company Ltd
Gentamycin sulphate MP biomedical
Glacial acetic acid VWR International
Glycerol Sigma-Aldrich Company Ltd
Hoescht DNA stain 33258 Invitrogen
Hyaluronidase (type IV-S, bovine
testes)
Sigma-Aldrich Company Ltd
Hydrochloric acid VWR International
Hydrogen peroxide Sigma-Aldrich Company Ltd
ImmEdge Hydrophobic barrier pen Vector laboratories
Industrial methylated spirits Genta Medical
Isopropanol VWR International
L-Glutamine Invitrogen Ltd
Methanol Vickers Laboratories
Methylated Spirits VWR International
Miller’s stain Raymond A Lamb
Neutral Buffered Formalin (NBF) Sigma-Aldrich Company Ltd.
Nyastatin Sigma-Aldrich Company Ltd.
Oxalic acid VWR International
Paraffin wax pellets Raymond A Lamb Ltd
Papain VWR International
PBS tablets Oxoid
p-dimethylaminobenzaldehyde Sigma-Aldrich Company Ltd.
Penicillin Invitrogen
Perchloric acid Sigma-Aldrich Company Ltd.
Periodic acid Sigma-Aldrich Company Ltd.
Picric acid Sigma-Aldrich
Polymixin B Sigma-Aldrich Company Ltd.
Potassium permanganate Thermo Fisher Scientific Ltd.
Primaxin I. V. Merck Sharp & Dohme Ltd.
Propan-1-ol VWR International
Proteinase K Dako Ltd
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R.T.U Horseradish peroxidase
streptavidin
Vector Laboratories
Safronin-O Acros
Saponin Sigma-Aldrich Company Ltd.
Schiffs reagent Sigma-Aldrich Company Ltd.
Scott’s tap water European Bios
Silver nitrate AnalaR
Sirius red Raymond A Lamb Ltd
Sodium acetate Thermo Fisher Scientific Ltd.
Sodium azide VWR International
Sodium chloride VWR International
Sodium di-hydrogen orthophosphate VWR International
Sodium formate VWR International
Sodium hydroxide Thermo Fisher Scientific Ltd.
Sodium hydroxide (NaOH) pellets BDH Laboratory Supplies
Sodium thiosulphate AnalaR
Streptomycin Invitrogen
Trans-4-hydroxyl-L-proline Sigma-Aldrich Company Ltd.
TriGene disinfectant Scientific Laboratory Supplies Ltd
Tris-HCl Melford
Trizma base Sigma-Aldrich Company Ltd.
Trypan blue Cell Stain Sigma-Aldrich Company Ltd
Trypsin Sigma-Aldrich Company Ltd
Tween 20 Sigma-Aldrich Company Ltd
Vancomycin MP biomedical
Virkon disinfectant Bios Europe
Weigerts haematoxylin Raymond A Lamb
Xylene Genta Medical
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Appendix II: Distributers of
Equipment, Consumables, Plastic
and Glassware
Equipment/Consumables/Plastic
and glassware
Supplier
Automatic pipettes Gilson
Balances: GR200/GX2000 A & D
Bijous Bibby Sterlin Ltd.
Bone saw Exakt
Buffer tablets VWR
Camera Canon
Carbon dioxide incubator SANYO, Biomedical Europe BV
Cell B Software Olympus UK Ltd.
Cell culture flasks (T25 and T75) Nange Nunc International
Corperation.
Cell sieve (100µm) Sigma-Aldrich Company Ltd.
Cell medium aspirator Integra Biosciences
Centrifuge tubes Nange Nunc International Corperation
Coplin jar
Cryovials Nange Nunc International Corperation
Culture slides tissue culture 4 wells VWR International
Digital colour camera Media Cybernetics
Disposable microtome blades Raymond A Lamb Ltd.
Fine tip stainless steel forceps Raymond A Lamb Ltd.
Flat bottomed 96 well plate Scientific laboratory supplies
Freeze drier Thermo Fisher Scientific Ltd.
Fume Hood Whiteley, Hants, UK
Glass coverslips Scientific laboratory supplies
Glifton water bath Scientific laboratory supplies
Hacksaw Thackray Instruments
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Harrier 15/80 centrifuge SANYO E&E Europe BV, Biomedical
division.
Haemocytometer Fisher Scientific
Heraeus Hera Safe class II safety
cabinet
Thermo Electron Corporation, USA
Hotplate Raymond A Lamb Ltd.
Image-Pro Plus Media Cybernetics
Incubator (Heraeus) Jencons PLC
Leica RM 2125 RTF microtome Leica Microsystems (UK) Ltd.
Long hair brush No6 Raymond A Lamb Ltd.
Magnetic Stirrer Stuart Scientific
Measuring cylinders Fisher Scientific
Micro plate spectrophotometer Thermo scientific
Microtome blades Fisher Scientific
Nitrile powder free gloves Starlab Ltd.
Multitest slides MP Biomedicals.
Optical microscope (Olympus CK40-
SLP)
Olympus optical Co Ltd.
Olympus C-4040 zoom digital camera Olympus optical Co Ltd.
Paraffin section mounting bath Barnstead Electrothermal (Thermo
Fisher Scientific)
Pasteur pipettes Alpha Laboratories Ltd.
Petri dishes Bibby Sterlin Ltd.
pH meter: Jenway 3020 Jenway Ltd.
Pipette boy Integra Biosciences
Pipettes Gilson Inc.
Plastic histology casettes Simport
Plastic syringes, 1ml, 2ml 10ml. Terumo Medical Corporation.
Plate rocker Bibby Sterlin Ltd.
Pots 60ml, 150ml, 250ml. Bibby Sterlin Ltd.
Slide holder Raymond A Lamb Ltd.
Stainless steel surgical blades (22)
and scalpel (4)
Swan Morton
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Strippette disposable serological
pipettes
Corning Costar UK Ltd.
Surgical scissors Thackray Instruments
Standard forceps Thackray Instruments
Superfrost Plus slides Scientific Laboratory Supplies
Syringe filters (0.2µm) Sartorius Ltd.
Table shaker IKA
TipOne pipette tips Starlab UK Ltd.
Tissue processor Leica Microsystems
Universals Bibby Sterlin Ltd.
Water Bath Grant
Windsor wax incubator E18/31 Sandrest
Vacuum pump Edwards
µCT80 Scanco Medical, Switzerland
µCT100 Scanco Medical, Switzerland
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Appendix III: Presentations and
Publications
Publications:
 Gough, C. S., Wajayathunga, V. N., Tipper, J. L., Wilcox, R. K., Hall, R.
M., Ingham, E. (2011). The biology of the ovine functional spinal unit.
European Cells and Materials 22(3), 67.
 Gough, C. S., Mitchell, E. A., Wijayathunga, V. N., Tipper, J. L., Wilcox,
R. K., Hall, R. M., Ingham, E. (2012). The biology of the ovine functional
spinal unit. Journal of Tissue Engineering and Regenerative Medicine
6(S1), 396.
Presentations:
 Gough, C. S., Wajayathunga, V. N., Tipper, J. L., Wilcox, R. K., Hall, R.
M., Ingham, E. (2011). The biology of the ovine functional spinal unit.
Tissue and Cell Engineering Society Annual Meeting, Leeds, UK. (Poster
presentation).
 Gough, C. S., Mitchell, E. A., Wijayathunga, V. N., Tipper, J. L., Wilcox,
R. K., Hall, R. M., Ingham, E. (2012). The biology of the ovine functional
spinal unit. 3rd Tissue Engineering and Regenerative Medicine
International Society World Congress, Vienna, Austria. (Poster
presentation).
 Gough, C. S., Mitchell, E. A., Wijayathunga, V. N., Tipper, J. L., Wilcox,
R. K., Hall, R. M., Ingham, E. (2012). The biology of the ovine functional
spinal unit. Regener8 Annual Meeting, Newcastle, UK. (Poster
presentation).
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 Gough, C. S., Mitchell, E. A., Wijayathunga, V. N., Tipper, J. L., Wilcox,
R. K., Hall, R. M., Ingham, E. (2012). The biology of the ovine functional
spinal unit. Biomaterials and Tissue Engineering Group, 14th Annual
White Rose Work in Progress Meeting, York, UK. (Poster presentation).
